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Abstract
Fetal Alcohol Spectrum Disorders (FASD) represent the largest preventable cause
of cognitive deficits in the western world. The mechanism(s) of how prenatal alcohol
exposure (PAE) results in FASD remain unknown. Towards this end, mouse models of
PAE have successfully recreated endophenotypes that are characteristic of FASD. This
doctoral thesis examines the long-term epigenomic alterations associated with PAE. I have
examined both mice with PAE and human patients with FASD.
In the first set of experiments, mice with PAE and matched controls were raised to
adulthood and then their whole brains were examined for alterations to gene expression,
non-coding RNA (ncRNA) expression, and DNA methylation. Long-term alterations were
observed in genes related to neurodevelopment, cellular signaling, and immune processes.
Furthermore, there was an enrichment for alterations to genomically imprinted clusters of
ncRNA and genes related to PTEN/PI3K/AKT/mTOR signaling.
In the second set of experiments, buccal epithelial swabs were collected from young
children with FASD and matched controls. Children from a discovery cohort were
examined for alterations to DNA methylation, which revealed changes to genes involved
in neurodevelopment and synaptic signaling as well as hippo signaling. Select candidates
(COLEC11 and HTT) were confirmed by sodium bisulfite pyrosequencing. Examination of
a replication cohort revealed that while similar pathways are altered, the effect is not
identical and that sex and age may alter the methylation profile. A larger group of children,
representative of the general population, were then analyzed using a targeted sodium
bisulfite next-generation sequencing panel and pyrosequencing. No single gene examined
was found to be consistently affected in all FASD children.
Finally, the mouse and human results were compared to identify alterations to
shared loci, ontologies, and pathways. The clustered protocadherins, which are involved in
generating individual neuronal identity, showed increased DNA methylation in both
species. Together, the results suggest that a shared DNA methylation profile related to
neurodevelopment is present in both the brains of adult mice and the buccal epithelial swabs
of young children with PAE. These results may be used in future functional studies of
candidate loci as well as towards the development of much needed diagnostics and
precision medicine.
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Epigraph

“We might use the name ‘epigenetics’ for such studies, thus emphasizing their
relation to the concepts, so strongly favourable to the classical theory of epigenesis, which
have been reached by the experimental embryologists. We certainly need to remember that
between genotype and phenotype, and connecting them to each other, there lies a whole
complex of developmental processes. It is convenient to have a name for this complex:
‘epigenotype’ seems suitable.”
- Conrad Hal Waddington (The Epigenotype. Endeavour, 1942).
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Chapter 1
Introduction
1.1. Prenatal Alcohol Exposure
Alcohol consumption during pregnancy can result in the development of fetal
alcohol spectrum disorders (FASD) (Williams et al. 2015). FASD is an umbrella term for
a heterogeneous spectrum of related developmental disorders that are caused by prenatal
alcohol exposure (PAE), with the worst possible outcome being fetal alcohol syndrome
(FAS) (Lemoine et al. 1968; Jones et al. 1973; Williams et al. 2015). FAS shares
commonalities with other psychiatric disorders including growth deficiency and central
nervous system impairment. FAS is distinguished from other psychiatric disorders by a
history of maternal alcohol consumption during pregnancy and three distinct facial
features (Clarren & Smith 1978). First is a smooth philtrum: the vertical groove between
the nose and upper lip is flattened. Second is a thin vermilion: a thin upper lip. Third are
small palpebral fissures: a reduced width of the eye. However, these facial characteristics
used to distinguish FAS and partial FAS (pFAS) do not typically apply to the lower part
of the FASD spectrum, which is characterized by neurobehavioral and neuroanatomical
alterations without the distinctive facial features.
There are a total of 428 comorbidities related to FASD (Popova et al. 2016).
FASD is associated with congenital malformations to the ocular, auditory, skeletal,
cardiac, and renal systems. The clinical heterogeneity and uniqueness of each case
appears to be driven by the combination of dosage and timing of PAE, other exposures,
genetic background, sex, family history of PAE, as well as maternal genotype, nutrition
and stress (Kleiber, Diehl, et al. 2014). In Canada, from 2003-2010, ~10% of pregnant
women and ~20% of breast feeding women consumed alcohol (Lange et al. 2016). While
no official record exists for Canada, FASD is typically diagnosed in only 2-5% of
children (May et al. 2014). These numbers are comparable across many alcohol
consuming nations and represent a multi-billion dollar public health issue.
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The Institute of Medicine (IOM) of the National Academies has four diagnostic
categories for the disorders that constitute FASD: FAS, pFAS, alcohol-related
neurodevelopmental disorder (ARND), and alcohol-related birth defects (ARBD)
(Stratton et al. 1996; Chudley et al. 2005). The latest edition of the diagnostic and
statistical manual of mental disorders (DSM–5) now includes the psychiatric diagnosis:
Neurobehavioral Disorder Associated with Prenatal Alcohol Exposure (ND-PAE)
(American Psychiatric Association 2013). ND-PAE considers the neurobehavioral
alterations to be independent from the facial characteristics and is listed in the DSM–5
appendix under “conditions for further study” (Doyle & Mattson 2015).
Endophenotype is a psychiatric genetics concept that deconstructs a complex
behavioural phenotype into components with a clearer genetic connection (Gottesman &
Gould 2003). The endophenotypes of FASD overlap with other psychiatric disorders,
particularly attention deficit hyperactivity disorder (ADHD). While an individual can be
diagnosed with the two disorders, they are distinct disorders, and misdiagnosis of one can
lead to inappropriate medication and therapy (O’Malley & Nanson 2002; Greenbaum et
al. 2009; Peadon & Elliott 2010). Endophenotypes commonly associated with FASD
include impairments in cognition, learning, executive function, judgment, attention, and
social adaptation (Mattson & Riley 1998; Jirikowic et al. 2008; Green et al. 2014). The
molecular mechanisms behind FASD endophenotypes have been difficult to ascertain in
humans. However, animal models have greatly aided research into FASD
endophenotypes (Gil-Mohapel et al. 2010; Kiecker 2016). The results suggest that FASD
endophenotypes are a result of cellular and molecular aberrations to neurodevelopment
that are caused by PAE (Resendiz et al. 2014).

1.1.1. PAE Endophenotypes are Associated with Altered
Neurodevelopment
Human neurodevelopment is a complex process that takes a relatively long time to
produce a mature brain. Once an oocyte is fertilized by a sperm, they form a zygote that
undergoes the ~8-week process of embryonic development. During its voyage down the
fallopian tube, the zygote undergoes cleavage, which is a series of rapid cell divisions that
divide the large cytoplasm of the egg into a solid spherical mass of smaller nucleated cells
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known as blastomeres (Gilbert 2013). The spherical structure then begins to form a cavity
on the inside and results in a hollow ball of cells known as the blastocyst. The outer cells
of the blastocyst form the trophoblast, which is the first embryonic epithelium, and the
remaining cells are trapped inside and form the pluripotent inner cell mass (ICM). The
blastocyst then arrives in the uterus after four days and implants into the endometrium of
the uterine wall after a few more days to begin gastrulation.
During gastrulation the embryo forms three distinct germ layers: endoderm,
mesoderm, and ectoderm (Gilbert 2013). The endoderm forms into parts of the digestive
system, liver, lungs, and thyroid. The mesoderm forms into a number of muscle types,
bone, cartilage, dermis, gonads, circulatory system, and lymphatic system. The ectoderm
forms into the surface ectoderm, neural tube, and neural crest. The surface ectoderm
forms the epidermis, nails, hair, tooth enamel, parts of the eye, and buccal epithelium.
The neural tube forms into the brain, spinal cord, retina, and part of the endocrine system.
The neural crest forms into the peripheral nervous system, epinephrine-producing
(medulla) cells in the adrenal gland, various pigment cells, and facial bone and cartilage.
It also generates connective tissue in the eye, tooth, skin, fat, arteries as well as
connective tissue the salivary, lachrymal, thymus, thyroid, and pituitary glands. The
diversity of differentiated cell types has led to the neural crest being referred to as the
fourth germ layer; however, these stem cells are in fact derived from the neural tube and
the diverse fates are determined largely by where they migrate. In later embryonic
development and differentiation, a strip of specialized cells in the endoderm known as the
notchcord induces a portion of the ectoderm to become the neuroectoderm, which is also
known as the neuroepithelium (Gilbert 2013). The neuroectoderm then transforms into
the neural plate.
During neurulation, the neural plate folds into the neural tube. As neurulation
occurs, the neural plate border separates from the neuroectoderm and serves as boundary
between the neuroectoderm and surface ectoderm. The neural plate borders, which are
peripheral to the neural plate, then fold in on themselves and once connected are known
as the neural crest. During this period, the neural tube may fail to close completely and
result in neural tube defects. The closing of the neural tube is sensitive to certain
environmental conditions with folate (Vitamin B9) and Vitamin B12 supplementation
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greatly reducing the chances of a neural tube defect (Ray et al. 2002). In human PAE
pregnancies, ethanol was found to impair the transfer of folate across the placenta
(Hutson et al. 2012). Folate and B12 are involved in one-carbon metabolism, which is used
to derive the methyl groups of the epigenome and also nucleic acid synthesis (Kobor &
Weinberg 2011). After the neural plate closes, it becomes the neural tube. The neural
crest cells will then migrate great distances, which leaves the neural tube disconnected
from the epidermis. In order to migrate, neural crest cells must undergo an epithelialmesenchymal transition (EMT). During EMT, epithelial cells undergo morphological
change, lose their current cell-to-cell adhesion, and become migratory multipotent
mesenchymal stem cells. Inside the neural tube are neural stem cells that will differentiate
into neurons and glia. Thus, in addition to the fetal stages of pregnancy, PAE can also
alter embryonic development and produce a number of overlapping and distinct clinical
outcomes.
Embryonic development represents the first trimester of human pregnancy and
results in a fetus just over 1 inch in size that continues to undergo slower cell divisions as
it grows and refines existing structures (Gilbert 2013). The developing brain forms
intermediate structures and refines a network of synaptic connections throughout the
second and third trimester of pregnancy. Notably, throughout fetal development and into
young adulthood DNA cytosine methylation in the developing brain continues to
reconfigure itself during neurodevelopmental events (Lister et al. 2013). Any of the above
developmental processes may be disrupted by PAE.
A single occasion of PAE during the third trimester of pregnancy has been shown
to trigger widespread but select acute apoptosis of neurons (Farber et al. 2010) and
oligodendrocytes (Creeley et al. 2013) in the fetal macaque brain. Furthermore, PAE
induced apoptosis in the fetal macaque brain is comparable to PAE induced apoptosis in
the developing rodent brain (Young & Olney 2006). The above observations suggest that
PAE causes neurodevelopmental aberrations, which result in life long anomalies
associated with FASD. The above conclusion, however, is too general and has provoked
more refined studies on the mechanism behind the effect of PAE on neurodevelopment.
These mechanistic studies have been greatly aided by more sensitive molecular
technologies assessing the effect of PAE at the genomic level. Specifically, such studies
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have focused on the effect of PAE on genome-wide gene expression and the epigenome,
which are discussed below.

1.1.2.

PAE Alters Short-Term and Long-Term Gene Expression
Insight into the effects of alcohol on the developing brain have been assessed

using animal models, which typically include rats for neuroscience-based studies and the
C57BL/6J (B6) strain of mice for molecular-biology-based studies (Valenzuela et al.
2012; Zhou 2015). The most common in vivo PAE paradigm involves injecting acute
doses of ethanol during different developmental time points and represents a binge
exposure (Kleiber, Diehl, et al. 2014). Studies of PAE in mice have identified differential
expression of diverse genes, many of which are involved in development.
Gene expression microarrays have been used to examine PAE in a B6 mouse
model with binge injections (3.8 g/kg, twice a day) from gestational days (GD) six to
eight (Lee et al. 2004). Craniofacial malformations were observed in both embryos
(GD10) and fetuses (GD15). An alteration to “palate, lung, and nasal epithelium clone
(plunc)”, which is involved in palate closure, was confirmed by polymerase chain
reaction (PCR). These findings provided early evidence that PAE results in genome-wide
alterations in both embryos and fetuses and that the altered genes are involved in
processes related to the morphological abnormalities associated with FASD.
Other studies have used gene expression microarrays to identify PAE induced
alterations to genes with functions that include cellular division and proliferation, cell
signaling, cell migration, apoptosis, cell-to-cell adhesion, metabolism, and protein
synthesis and degradation. In 2004, Gutala et al. isolated cortical neurons from GD14
C57BL/6J mouse fetuses and subjected them to 5 days of ethanol treatment in vivo
(Gutala et al. 2004). They screened 638 genes and identified 56 down-regulated and 10
up-regulated genes. Gene expression associated with “protein synthesis” (ribosome) and
“ubiquitin-proteasome” was decreased by alcohol exposure. They also confirmed the
genes involved in “ubiquitin-proteasome” by qPCR. Heat shock proteins and members of
the PI3K/AKT/mTOR pathway (mTOR, Pten, and Marcks) were also altered. In 2005,
Hard et al. examined a B6 model of binge injections on GD7 and GD9 and the fetal
brains were examined for differential gene expression on GD18 (Hard et al. 2005).
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Twenty-five PAE genes were identified, all of which were down-regulated. Notable
candidates identified by the authors were Timp4, Bmp15, Rnf25, Akt1, Tulp4, and
Dexras1. These identified genes have roles in cellular proliferation, differentiation,
signaling, and apoptosis. In 2007, Green et al. examined two substrains of C57BL/6 mice
and collected embryonic head folds 3 hours after binge injection on GD8 (Green et al.
2007). The group observed alterations to 2,906 non-redundant genes, including several
hub genes (Mapk1, Ald3a2, Cd13, Pfkm, Tnfrsf1a, Rps6, Igff1, Egfr, and Pten). There was
a significant overall down-regulation of pathways related to the ribosome and
proteasome. There was also a significant overall up-regulation of the pathways related to
cell adhesion and regulation of actin cytoskeleton. Furthermore, experimentation with a
mitochondrial GABAA receptor antagonist also uncovered a role for Akt1 and strainspecific effects. Together, the results from Gutala et al., Green et al., and Hard et al.
suggest that cellular signaling is altered by PAE, particularly the PI3K/AKT/mTOR
pathway.
In 2011, Zhou et al. examined the effects of ethanol on GD8 B6 whole embryo
culture (Zhou, Zhao, et al. 2011). They found that 34 out of 127 (27%) alcohol treated
embryos had neural tube defects while only 3 out 139 (2%) controls showed obvious
defects. When comparing two array experiments, 87 probe sets were replicated. There
were a total of 49 probe sets that had decreased expression, while 38 showed increased
expression. The genes were functionally involved in neurodevelopment, chromatin, eye
and heart development, retinol metabolism, cell cycle, and cell adhesion. Several genes
were also observed to be turned on or off by alcohol exposure. The group also observed
de novo expression of aldehyde dehydrogenase 1B1 (Aldh1B1), which catalyzes the
conversion of retinaldehyde to retinoic acid. Retinoic acid is involved in cellular signaling
for developmental events.
A number of laboratories have reported on mouse models of PAE based on
voluntary and moderate maternal consumption throughout gestation that produce peak
blood alcohol concentrations of ~80–120 mg/dl (Allan et al. 2003; Boehm et al. 2008;
Brady et al. 2012). Kaminen-Ahola et al. examined a B6 maternal voluntary exposure
paradigm and found that PAE results in craniofacial changes and growth restriction
(Kaminen-Ahola, Ahola, Flatscher-Bader, et al. 2010). It was found in this case that PAE
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induced growth alterations were not observable prior to birth but were apparent in
weanlings. Furthermore, they cross-fostered the weanlings to show that this observation
was not the result of altered maternal care by alcohol consuming mothers. Gene
expression related to the metabolism of exogenous and endogenous compounds, iron
homeostasis, and lipid metabolism was altered in the liver of young PAE mice. In 2014,
Dobson et al. used qPCR to examine a guinea pig model of voluntary maternal PAE and
found it disrupts the expression of genes involved in insulin and insulin-like growth factor
(IGF) signaling in the adult prefrontal cortex (Dobson et al. 2014). Insulin signaling is
capable of activating the PI3K/AKT/mTOR pathway (Laplante & Sabatini 2009). In 2016
Ramani et al. examined a moderate voluntary exposure paradigm and observed that PAE
during the first trimester results in the upregulation of mRNA and protein for an
astrocytic connexin (Cx30), which is involved in forming gap junctions in the
hippocampus of young mice (Ramani et al. 2016). Together, these results show that
rodents can be used to model a number of PAE paradigms, which include acute binge
injections at different developmental time points or variations of a more continuous
moderate exposure by voluntary maternal consumption.
The laboratory of Shiva Singh established a B6 maternal continuous preference
drinking (CPD) paradigm that resulted in offspring with mild developmental delays,
anxiety-related traits, and deficits in learning and memory (Kleiber et al. 2011). Analysis
by qPCR revealed a down-regulation of a glutamate receptor (Grin2c) and glycine
receptor subunit (Glra1). This paradigm was extended by evaluating global gene
expression changes that occurred in adult brains of CPD PAE mice (Kleiber et al. 2012).
The results indicated that alcohol induces subtle but consistent changes to gene
expression. Gene enrichment analysis showed overrepresented gene ontology
classifications of cellular, embryonic, and nervous system development. A number of the
identified genes were previously implicated in FASD-relevant neurobehavioral
phenotypes such as cognitive function, anxiety, ADHD, and mood disorders. Ultimately,
the above findings suggest that altered gene expression is detectable long after PAE and
most likely represents altered gene regulation and a shift in cellular populations for life
(Kleiber, Diehl, et al. 2014).
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The Singh laboratory has also examined how the variability seen in FASD
phenotypes relates to the timing of alcohol exposure. In these experiments a binge
exposure paradigm was used, in which B6 mice were exposed to two acute doses of
alcohol (5 g/kg of body weight) at neurodevelopmental times representing the human
first, second, or third trimester equivalent (Kleiber et al. 2013; Mantha et al. 2014;
Kleiber, Laufer, et al. 2014). This method has been previously reported to result in peak
blood alcohol concentrations of over 300 mg/dl (for 4–5 hours following injection) and
can induce the apoptosis of millions of neurons by both a blockade of NMDA glutamate
receptors and excessive activation of GABAA receptors (Ikonomidou et al. 2007;
Wozniak et al. 2004). The first set of experiments utilizing the binge injection models set
out to examine physiological, developmental, and behavioural deficits associated with the
paradigms examined (Mantha et al. 2013). The results showed that alcohol exposure at
any time during gestation causes delays in motor skill and reflex development. Also, the
results provided further support for long-term PAE induced deficits in learning and
memory, as assessed by the Barnes maze. These same mice were also used to assess
changes in the adult brain transcriptome (Kleiber et al. 2013). The results suggested that
alcohol disrupts biological processes that are actively occurring at the time of exposure.
These include cell proliferation during trimester one, cell migration and differentiation
during trimester two, and cellular communication and neurotransmission during trimester
three. Furthermore, although alcohol altered a distinct set of genes depending on
developmental timing, many of these show interrelatedness and can be associated with
one another via ‘hub’ molecules and pathways. However, the regulatory mechanism
maintaining the long-term alterations to gene expression remained hypothetical.

1.2. Epigenetic Mechanisms May Underlie the Altered Gene
Expression of PAE
In addition to gene expression, PAE alters epigenetic marks (Haycock 2009;
Kobor & Weinberg 2011; Basavarajappa & Subbanna 2016). Epigenetic marks maintain
gene expression profiles related to development and tissue specificity without altering
DNA sequence and are heritable in dividing cells. Epigenetic marks are distinct from
transcription factors, however, they influence each other as gene expression is initiated by
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transcription factors recruiting RNA polymerase. Epigenetic marks include DNA cytosine
methylation (Smith & Meissner 2013), select histone post-translational modifications
(Gurard-Levin & Almouzni 2014), and a diverse array of non-coding RNA (ncRNA)
species (Pauli et al. 2011; Rinn 2014). These marks enable spatial and temporal control of
gene expression by acting together to create distinct states of variation that have unique
functions in the brain (Sweatt et al. 2012). While each mammalian cell has a (nearly)
identical genome, there are layers of diversity that give each cell type a unique epigenome
that is reflective of ontogeny. Epigenetic experimentation has provided invaluable insight
into the molecular mechanisms of inheritance and disease that lie outside genetic
contribution.

1.2.1.

PAE Alters Histone Post-Translational Modifications
There are five types of histone proteins found in the chromatin of mammalian

cells: the four core histones (H2a, H2b, H3, and H4) and histone H1, which is bound to
the linker DNA between nucleosomes (Marzluff et al. 2002). Each time a mammalian cell
divides, it must rapidly synthesize large amounts of histones. The unique properties of the
histone genes are critical for cell cycle regulation (Marzluff et al. 2002). There are
approximately 10–20 genes encoding each of the core histone proteins in mammals. The
bulk of the replication-dependent histone genes are found in two clusters in both mouse
and human (Albig & Doenecke 1997; Albig et al. 1997). The largest cluster is termed
HIST1, and there is an orthologous Hist1 cluster on mouse chromosome 13 (Wang et al.
1996). The mouse Hist1 cluster contains 45 core histone genes with 6 histone H1 genes.
A smaller number of histone genes are present in HIST2 on human chromosome 1, and
this cluster is orthologous to the Hist2 cluster on mouse chromosome 3 (Wang et al.
1996). In addition there is a second small cluster of histone genes on human chromosome
1, termed HIST3, and the orthologous Hist3 cluster is located on mouse chromosome 11
(Marzluff et al. 2002).
A relatively large number of histone post-translational modifications (PTMs) exist
(Gurard-Levin & Almouzni 2014) and a number of PTMs may act as epigenetic marks.
Multiple PTMs are possible on the same histone. Mono-, di-, and tri- methylations (me1,
me2, and me3) and acetylation (ac) are intensely studied PTMs. Histones H2A, H2B, H3,
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and H4 represent the core nucleosome subunits. The core subunits are present in
duplicate, where the octamer wraps around ~150 bp of DNA and interacts with the linker
histone (H1). PTMs typically occur on the exposed N-terminus tail of the histone subunit
that is accessible to chromatin modifying machinery. For instance, the exposed lysines
(K) at the 4th, 9th, and 27th position in amino acid sequence on Histone H3 (H3K4, H3K9,
and H3K27) and H4K20 are relatively well characterized for their function in regulating
gene expression. Histones bind to DNA and form chromatin, which also includes DNA
methylation and some ncRNAs. PTMs are widely hypothesized to constitute a histone
code at a specific locus that encodes gene regulatory information (Jenuwein & Allis
2001). Ultimately, PTMs effect the recruitment of other proteins onto chromatin and can
then functionally affect transcription.
Histone PTMs have been shown to be altered by PAE. In 2011, Guo et al.
examined a rat model of PAE that corresponds to the third trimester of human pregnancy.
They found a reduction in a histone acetyltransferase (CREB binding protein) in the
developing cerebellum along with a reduction in H3 and H4 acetylation levels (Guo et al.
2011). In 2013, Veazey et al. examined the effect of alcohol exposure on GD12.5 B6
cortical neuroepithelial cells maintained as neurosphere cultures (Veazey et al. 2013). The
group found that promoters of genes involved in neurodevelopment were under-enriched
for H3K4me3 and H3K27me3 after ethanol exposure. Notably, while the group observed
large-scale change to chromatin structure, they only observed a few matching alterations
to transcription. Together, the above studies demonstrate that more than one histone PTM
is altered by PAE.
PAE has also been shown to alter histone PTMs on genes coding for enzymes that
establish histone PTMs. Subbanna et al. examined a human trimester 3 equivalent mouse
model of binge PAE. They observed that PAE increased histone methyltransferase (G9a)
activity and lead to an increase in H3K9me2 and H3K27me2 (Subbanna et al. 2013).
Later, Subbanna et al. found increased H3K14ac in the first exon of G9a and also
observed that G9a immunoprecipitates with DNA methylation machinery (DNMT3A and
MeCP2) (Subbanna et al. 2014). These observations show that PAE alters cooperating
epigenetic marks. In 2015, Veazey et al. examined in vitro and in vivo models where it
was found that the specific alterations to histone PTMs appear to depend on alcohol
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dosage, the specific gene, as well as the time elapsed since alcohol exposure (Veazey et
al. 2015). Notable candidates included the Hox genes. The predicted regulatory
correlation was not observed for individual PTMs and altered gene expression; however,
they observed an increase in repressive chromatin modifications that was correlated with
significant alterations to the transcripts coding for DNA and histone methyltransferase
enzymes. Ultimately, the above studies demonstrate the combinatorial nature of the
epigenome and show that epigenetic machinery is also deregulated by PAE. Furthermore,
the alterations to histone PTMs may sometimes, but not always, lead to altered gene
expression.

1.2.2.

PAE Alters Non-Coding RNA Expression
Gene expression is not limited to coding RNA, as ncRNAs represent a variety of

RNA species that can be altered by PAE. Small nucleolar RNAs (snoRNA) are a class of
RNA that guide the methylation and pseudouridylation of ribosomal RNA (rRNA),
transfer RNA (tRNA), and small nuclear RNA (snRNA) (Bachellerie et al. 2002). Also
noteworthy are orphan snoRNAs, which have taken on novel functions in alternative
splicing, growth, and neurodevelopment (Laufer & Singh 2012).
Another class of ncRNA are microRNAs (miRNA) (Filipowicz et al. 2008).
miRNAs are small (~23 bp) endogenous RNA molecules that canonically target the 3’
untranslated region (UTR) of messenger RNA (mRNA) and result in post-transcriptional
repression (Bartel 2009). The targeting of a mature mammalian miRNA is dependent
upon the seed region (six bp; nucleotides 2-7), which is where a nearly perfect match
occurs between miRNA and mRNA. Furthermore, several nucleotides thereafter may
tolerate some mismatches and hybridize as well. There are thousands of miRNAs in the
mammalian genome and ~60% of protein coding genes may be regulated by miRNAs
(Friedman et al. 2009).
miRNAs exist in the genome as independent genes, polycistronic gene clusters, or
introns. miRNAs are also present in the introns and/or exons of some large non-coding
RNAs (lncRNA). miRNAs are processed from a larger pri-miRNA precursor that can
have a 5’ cap, poly-A tail, and form a secondary structure with a hairpin loop (Filipowicz
et al. 2008; Bartel 2009). A Drosha-DGCR8 complex, also known as the microprocessor
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complex, processes the pri-miRNA and produces a ~70 bp stem loop known as premiRNA. However, introns containing miRNAs do not undergo pri-miRNA processing as
their splicing results in pre-miRNA. Exportin-5 recognizes pre-miRNA in the nucleus and
exports it to the cytoplasm. Dicer recognizes the pre-miRNA, cleaves the stem loop, and
leaves a ~20 bp RNA duplex. Afterwards, one strand (the guide strand) of the duplex is
selected as mature RNA, while the other (passenger) strand is either degraded or is
selected in some situations to carry out alternative targeting. Mature miRNAs are loaded
into the RNA-induced silencing complex (RISC), which is a ribonucleoprotein complex
that contains a number of proteins including DICER and AGO. The miRNA loaded RISC
complex can then target transcripts, resulting in translational repression or mRNA
destabilization. Imperfect matching at the seed region enables a single miRNA to target
many genes and a single gene to be targeted by many miRNAs, which allows for the
regulation of complex gene expression profiles. A number of miRNAs have been
implicated in various abnormalities that often show co-morbidity with FASD, including
anxiety, depression, and other psychiatric disorders (O’Connor et al. 2012).
PAE has been shown to alter miRNA expression. In 2007, Sathayan et al.
examined the effect of alcohol exposure on miRNA expression in GD12.5 B6 cortical
neuroepithelial cells maintained as neurosphere cultures (Sathyan et al. 2007). The group
found that both high and low ethanol doses alter different miRNAs that influence the cell
cycle and apoptosis. One of the altered miRNAs was shown to be regulated by a GABA
receptor, while another miRNA is genomically imprinted. Genomically imprinted genes
are expressed in a parent-of-origin-specific manner that is based on differential DNA
methylation of an imprinting control region (ICR). Thus, the ex vivo results of Sathayan et
al. show that different PAE doses alter distinct miRNAs and that PAE responsive
miRNAs are regulated by different mechanisms. In 2009, Wang et al. examined miRNA
expression in fetal B6 brains exposed to a number of alcohol dosages and observed the
deregulation of several miRNAs (Wang et al. 2009). Together the above results
demonstrate that PAE induces altered miRNA expression.
Studies of PAE induced miRNA expression have also revealed that the gene
expression alterations are dynamic. In 2012, Guo et al. examined the effect of a chronic
and intermittent exposure on B6 primary cortical neuronal cultures, and observed the
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differential expression of 42 miRNAs after 10 days of exposure (Guo et al. 2012). The
group also examined the effects of ethanol removal. Five days after removal of the
chronic ethanol exposure, they observed a profile of 26 deregulated miRNAs – 20 of
which were unique to the removal. The predicted target genes had functions related to
transcription, protein phosphorylation, and neurodevelopment. Some of the miRNAs were
predicted to target MeCP2, which showed both decreased mRNA and protein levels.
These finding suggest that, in addition to the immediate effect of alcohol on the
developing fetus, there may also be an alcohol removal effect that alters
neurodevelopment as well.
In addition to mice, zebrafish have proved to be a useful model for studying PAE
induced alterations to miRNA expression. Soares et al. found that ethanol upregulates
several miRNAs in embryos with putative targets involved in cell cycle control,
apoptosis, and transcription (Soares et al. 2012). Tal et al. observed the reciprocal
deregulation of miRNAs and predicted target mRNAs, which are involved in brain
morphogenesis (Tal et al. 2012). Notably, a knockdown of mir-9 or mir-153c
phenocopied the PAE induced alterations to larval and juvenile swimming behaviour. The
above zebrafish experiments provide strong evidence that alterations to miRNAs can
result in PAE endophenotypes.
Finally, miRNAs themselves may be regulated by other epigenetic marks altered
by PAE. In 2013, Pappalardo-Carter et al. examined the role of mir-9 and related target
gene expression in zebrafish embryos and mouse cortical neuroepithelial cells maintained
as neurosphere cultures (Pappalardo-Carter et al. 2013). The group observed that mir-9
was suppressed by alcohol and that a mir-9 knockdown in the zebrafish embryos
produced similar craniofacial defects to PAE. Furthermore, there was increased CpG
methylation at a mir-9 locus in the mouse cell line, which suggests an association
between alterations to DNA methylation and alterations to miRNA expression.

1.2.3.

PAE Alters DNA Methylation at Specific Genomic Loci
One of the most examined mechanisms of the epigenome is DNA methylation: a

highly dynamic modification that is used to store additional information on nucleotides.
The most widely studied DNA methylation mark is 5-methylcytosine (5mC). During
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embryonic development, there are two waves of genome-wide DNA de-methylation
(Seisenberger et al. 2013). The first follows the fertilization of the preimplantation
embryo, and the second is during the establishment of primordial germ cells in the
embryo that will go on to form sperm and oocytes. The first wave of DNA de-methylation
retains genomic imprinting, and the second resets it. After the waves of de-methylation,
methylation is established de novo, maintained across cell division, and also locally
modified throughout development as cells become committed to their lineage (Hemberger
et al. 2009). DNA methyltransferases (DNMTs) are an enzyme family capable of
establishing and maintaining DNA methylation. In vertebrates, DNMTs are involved in
establishing methylation at CpG dinucleotides and other sequences in the genome. CpG
islands are a regulatory feature composed of greater than 50% GC content and range from
300 to 3000 bp (Gardiner-Garden & Frommer 1987; Fatemi et al. 2005). When
methylated, CpG islands typically result in the repression of gene expression and are seen
in promoters or the first exon of ~40% of mammalian genes (Fatemi et al. 2005; Brenet et
al. 2011). Furthermore, ~70% of human gene promoters have a higher CpG content than
is expected when compared to the rest of the genome (Saxonov et al. 2006). Intragenic, or
gene body, CpG islands may have a role as alternative tissue-specific promoters
(Maunakea et al. 2010). Finally, CpG islands are also mutational hotspots due to the
tendency of 5mC to spontaneously undergo deamination and mutate to thymine. Genomewide scans of CpG sites have revealed that CpG island shores, rather than CpG islands,
may be the primary sites of normal tissue-specific differentially methylated regions
(DMRs) (Yasui et al. 2007; Irizarry et al. 2009; Doi et al. 2009). CpG island shores are
~250 bp in size, up to 2 kb away from a CpG island, and typically outside of gene
promoters. DMRs in CpG island shores often show a strong inverse relationship with
gene expression. CpG island shores are associated with developmental genes and are
conserved across mice and humans. Additionally, there are CpG island shelves that are
located 2-4 kb from a CpG island and also the open sea, which refers to genomic regions
that show no significant CpG enrichment (Sandoval et al. 2011). Overall, DNA
methylation is a widely used epigenetic mark in mammals and occurs at a number of
distinct genomic features.
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DNA methylation is the most studied marker for PAE induced epigenomic
dysregulation (Haycock 2009). In 1991, Garro et al. observed that binge PAE exposure in
pregnant mice resulted in global hypomethylation of fetal DNA (Garro et al. 1991). The
group also observed that low levels of acetaldehyde, a metabolite of ethanol, were able to
interfere with DNA methyltransferase activity in vitro. In 1999, Maier et al. found that
PAE can result in increased methylation and decreased expression of brain-derived
neurotrophic factor (Bdnf) in the developing olfactory bulb of rats exposed during the
equivalent of the first two trimesters of human pregnancy (Maier et al. 1999). Together,
the above two studies suggested that PAE alters DNA methylation.
In 2009 Haycock & Ramsay examined the effect of PAE on genomic imprinting
in pre-implantation mouse embryos by examining the H19 differentially methylated
region (DMR) (Haycock & Ramsay 2009). They observed that while PAE embryos were
severely growth restricted, hypomethylation of the paternal allele at this specific region
was only detectable in the placenta. Genomic imprinting is an epigenetic process that
utilizes DNA methylation and other marks to enable parent-of-origin specific monoallelic
expression of genes related to growth and development. Ouko et al. examined the sperm
of alcohol-consuming adult human men and found hypomethylation at the imprinted H19
and Dlk1-Dio3 DMRs (Ouko et al. 2009). Thus, the above studies suggest that genomic
imprinting is deregulated by PAE.
Later in 2009, Liu et al. examined the genome-wide effects of ethanol in a B6
whole embryo culture (Liu et al. 2009). Gene expression arrays and methylated DNA
immunoprecipitation (MeDIP) arrays (MeDIP-Chip) revealed that genes of promoters
with a high CpG content had decreased methylation and increased expression from binge
exposure with an enrichment for genes on chromosomes 7, 10, and X. A 10-fold increase
of methylation was observed on chromosomes 10 and X in exposed embryos with neural
tube defects when compared to those without. The alterations to methylation were seen in
a large number of genes associated with olfaction as well as genes involved development,
chromatin, and genomic imprinting. The altered methylation was associated with changes
in the expression of 84 genes. This study suggests that PAE induced alterations to
methylation are not random. The findings also demonstrate that most genes showing
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significantly altered methylation do not show significantly altered expression when
examined.
A number of studies have examined the mechanism behind PAE induced
alterations to DNA methylation. In 2010, Kaminen-Ahola et al. used the Agouti viable
yellow (Avy) B6 mouse model, which provides a visual phenotype when methylation is
altered at a single gene (Kaminen-Ahola, Ahola, Maga, et al. 2010). This revealed that
voluntary maternal consumption of 10% alcohol causes hypermethylation. This study
showed that PAE at the embryonic stage can result in a long-lasting alteration to DNA
methylation. In 2011, Downing et al. examined methylation of the imprinted Igf2 locus in
mouse embryos and observed a subtle ~8% decrease to methylation at a single CpG site
with associated transcripts showing a -1.5 fold change (Downing et al. 2011). Notably,
placing mothers on a methyl-supplemented diet attenuated some of the PAE
endophenotypes. Later in 2011, Zhou et al. examined the effects of alcohol exposure on
rat neural stem cell culture and found altered migration, neuron formation, and growth
that was similar in an effect to the DNA methyltransferase inhibitor 5-aza-cytidine (Zhou,
Balaraman, et al. 2011). During differentiation, it was found that alcohol exposure
prevented the reprogramming of genes related to neurodevelopment, neuronal receptors,
and olfaction. The specific sites showing altered methylation were correlated with
transcription factors related to neurodevelopment. Overall, these studies link PAE
induced differential DNA methylation to birth defects.
Continuous maternal preference drinking also produces offspring with altered
DNA methylation. In 2013, Chen et al. used immunostaining to visualize altered DNA
methylation programming in the developing C57BL/6J mouse hippocampus (Chen et al.
2013). In 2015, Marjonen et al. examined a voluntary maternal preference drinking model
of PAE and found that early gestational alcohol exposure results in alterations to gene
expression in the adolescent post-natal day (PND) 28 hippocampus, bone marrow, and
main olfactory epithelium (Marjonen et al. 2015). The group observed gene expression
changes related to olfaction, immune response, epigenetics (miRNAs and a histone), and
two keratin associated proteins in the hippocampus. Genes showing differential
expression belonged to similar families reported by Kleiber et al. in 2012, which analyzed
some arrays generated for this thesis (Kleiber et al. 2012). Marjonen et al. also used
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bisulfite sequencing and found alterations to DNA methylation in CpG islands upstream
of some of the genes. Furthermore, magnetic resonance imaging (MRI) of post-natal day
60 PAE adult mice revealed an enlargement of the left hippocampus and decreased
volume of the left olfactory bulb. While the differential expression in the hippocampus
was low and not possible to confirm by quantitative reverse transcription PCR (qPCR),
some of the gene expression alterations identified by the gene expression array of the
hippocampus were also confirmed in the bone marrow or main olfactory epithelium by
qPCR. These observations suggest that differences present in adults with PAE are a longterm result of earlier alterations in embryonic stem cell populations, which differentiate
into a number of tissues and maintain some signature of developmental alterations.
DNA

methylation

alterations

induced

by

PAE

are

also

transmitted

transgenerationally. In 2012, Govorko et al. examined a rat model of continuous maternal
preference drinking from GD7 to GD21. The group examined Pomc, a gene that produces
multiple peptide hormones, and found that adult (PND60-80) F1 offspring had alterations
in the hypothalamus, which is involved in stress reaction (Govorko et al. 2012; Sarkar
2016). The neurons showed increased CpG methylation at the Pomc promoter, suppressed
gene expression, and a resulting phenotype of altered stress response. Alterations to DNA
and histone methyltransferase gene expression levels were also seen. The alterations to
the methylation, expression, and function of Pomc were also found to be transmitted to
both the F2 and F3 generations by the male germ-line with sperm showing alterations to
Pomc methylation. These findings show that the DNA methylation alterations induced by
PAE can transmit not only through mitosis but also meiosis.

1.2.4. PAE May Alter the Epigenetic Landscape of
Neurodevelopment
PAE appears to alter a number of epigenetic marks in overlapping and distinct
regions. The altered genes are enriched for functions related to cellular fate commitment
events that occur during neurodevelopment. Thus, it appears that PAE results not only in
immediate toxicity, but also creates distinct epigenotypes that may influence later
developmental events. Conrad Waddington proposed the concept of the epigenotype
(Waddington 2012), which led to his theory of canalization and the epigenetic landscape
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(Waddington 1942; Bird 2007; Reik 2007). The epigenetic landscape is an abstract
concept that describes the dynamic epigenomic profiles of stem cells during development.
As cells differentiate, they become increasingly committed to certain lineages and are
poised (or primed) at the epigenetic level for later events and certain responses
(Waddington 1942; Lesch et al. 2013). The brain is highly dependent on the epigenome
for neurodevelopmental processes (LaSalle et al. 2013). Developmental trajectories are
also sensitive to the environment, where exposures may alter quality of life long after the
initial exposure and immediate toxicology (LaSalle 2013). This effect appears to be due
to an altered epigenetic programming related to future development that is continuing to
exert an effect as well as a shift in vulnerable cell populations. Therefore, early life
exposures may continue to exert an effect on adult hippocampal neurogenesis. One third
of neurons in the hippocampus are subject to exchange over a lifetime, with annual
turnover rate of 1.75% in the renewing fraction of adult humans that is also similar in
mice (Spalding et al. 2013). Ultimately, the above suggests that some PAE
endophenotypes may be maintained by long-term alterations from the initial exposure.
Studies examining one-carbon metabolism have provided insight into how PAE
initiates disruptions to DNA methylation, while also demonstrating the preventable nature
of some long-term alterations. Alcohol exposure during embryonic development affects
the transfer of folate from the mother to the developing embryo (Hutson et al. 2012). This
is of significance to the developing embryo because folate is a methyl donor and essential
in establishing and maintaining DNA methylation. The lack of folate has the potential to
cause aberrant epigenetic profiles. Treatments that contain methyl donors, such as
choline, have been able to attenuate some of the effects of PAE (Zeisel 2011). Of
particular interest to this thesis is the observation that co-incubation of alcohol-exposed
mouse embryos with folic acid, a synthetic form of folate, was able to prevent altered
expression of a miRNA and target gene (Wang et al. 2009). Such results argue that the
alcohol-induced molecular cascade might involve DNA methylation. In 2013, Bekdash et
al. examined the hypothalamus of adult offspring of a voluntary maternal consumption rat
model and found a decrease in activating histone and an increase in repressive histone
marks and DNA methylation (Bekdash et al. 2013). Furthermore, they observed increased
methylation of the Pomc promoter and a decrease in Pomc mRNA expression. Notably,
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these alterations could be attenuated with choline supplementation during PAE. Using the
same model in 2014, Gangisetty et al. demonstrated a mechanistic role for MeCP2 in
altering Pomc expression upon PAE (Gangisetty et al. 2014). Overall, these studies
suggest that altered DNA methylation is mechanistically responsible for some PAE
induced differential gene expression and that the prevention, or even potentially the
reversal, of these alterations can attenuate some of the endophenotypes.
Given the above observations, it appears that PAE can alter DNA methylation in
specific regulatory sequences. For example, CTCF is a highly conserved ubiquitous 11zinc-finger protein with multiple functions in 3D chromatin organization and gene
regulation, including chromatin insulator activity as well as transcriptional activation and
repression (Williams & Flavell 2008). CTCF binds to a set of signal sequences that are
sensitive to methylation (Filippova 2007) and mediates chromosomal interactions (Ling et
al. 2006). There are over 100 000 CTCF-binding sites in the mouse genome (Shen et al.
2012). CTCF-binding sites involved in the DMR of H19 have shown significant
differential methylation in PAE placental tissue (Haycock & Ramsay 2009) and in the
sperm of alcohol-consuming mice (Knezovich & Ramsay 2012). These results argue that
the observed affect of PAE on gene expression may be caused by the effect of PAE on
DNA methylation at specific regulatory sequences, which include imprinted regions.

1.2.4.1. Genomic Imprinting
A number of studies of PAE have observed methylation changes occurring in genes
that are known to be genomically imprinted (Liu et al. 2009; Shukla et al. 2011; Sittig et
al. 2011; Dietz et al. 2012). Genomic imprinting enables parent-of-origin specific
monoallelic expression of a select set of genes that are important in early development,
particularly neurodevelopment (Kernohan & Bérubé 2010). These genes are crucial
during not only neurodevelopment but also the normal functioning of the brain (Davies et
al. 2008). Interestingly, ~30% of imprinted genes are hypothesized to be ncRNAs,
including miRNAs (Morison et al. 2005). The above observations suggest that PAE is
best explained as a sequence of events in response to ethanol that may begin with
differential methylation of imprinted genes encoding for ncRNAs, which regulate gene
expression. For example, moderate and voluntary maternal PAE alters adult levels of a
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vesicular glutamate transporter in the mouse hippocampus (Zhang et al. 2015). This
glutamate transporter showed increased mRNA levels that were correlated with decreased
DNA methylation and increased (activating) H3K4me3 at the transporter promoter.
However, while mRNA levels of the transporter were increased, the protein levels were
decreased, which suggested post-transcriptional regulation. The discrepancy between
mRNA and protein was found to be caused by the increase of an imprinted miRNA from
the Sfmbt2 cluster and further functional experimentation showed that the miRNA binds
to the 3’UTR of the transporter mRNA. This observation highlights the complexity of the
interactions that shape the epigenetic landscape as well as their potential for disruption by
PAE. Ultimately, it appears that the epigenetic landscape is one of the prime
mechanism(s) for the long-term deregulation of brain gene expression following PAE.
Yet the genome-wide details of this mechanism, particularly DNA methylation and
ncRNA, have not been assessed. Also, perhaps more importantly, there remains the
possibility that some of the epigenetic alterations observed in animal models are also
present in children born with the clinical diagnosis of FASD.

1.2.4.2. Systems Biology Approaches
Given the interactive nature of the epigenetic landscape, single gene approaches do
not capture the full complexity of alterations to the epigenome. The genome-wide
analyses presented in this thesis make use of systems biology approaches. The genes
identified are grouped in three ways. First, gene ontologies allow for genes to be grouped
according to annotations of known functions and relationships across three categories:
biological process, cellular component, and molecular function. Second, gene lists can
also be assembled into associative genetic interaction networks, which are based on gene
ontologies and other annotated or computationally predicted relationships. Finally, gene
lists can be assembled into canonical protein pathways, which represent a generalized,
linear, and well-studied cellular signaling pathway.
Systems biology approaches can be based on the principles of independent
component analysis (Lee & Batzoglou 2003). These approaches offer added insight to a
series of observations from single genes with low-fold changes and borderline statistical
significance by grouping them according to modular functions that show a significant
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enrichment. A 1.2-fold change in many genes of a pathway could produce a biologically
significant result that is comparable to a 20-fold increase in a single gene (Barabási &
Oltvai 2004; Subramanian et al. 2005). Nevertheless, in a network, certain genes serve as
hubs where they connect a large number of genes and can also allow for cross-talk
between different cellular signaling events. An alteration to a hub can theoretically be
more catastrophic than many similar alterations to a number of lesser connected nodes in
the network. Overall, systems biology allows for the analysis of complex and large-scale
alterations, which are typical of PAE.
Hypothesis: Alterations to DNA methylation and ncRNA expression are associated with
the long-term effect of prenatal alcohol exposure in (i) mice and (ii) humans with FASD.
Objectives:
1. To examine the differential epigenetic landscape associated with the long-term effects
of PAE in adult mouse C57BL/6J brains by comparing to matched controls and
assessing alterations in:
a. gene expression using the Affymetrix GeneChip® Mouse Gene 1.0 ST array.
b. miRNA expression using the Affymetrix GeneChip® miRNA 2.0 array.
c. DNA methylation using the NimbleGen MM9 2.1M deluxe promoter array v2.
2. To examine the association of PAE with DNA methylation in buccal swab DNA
from children born with a diagnosis of FASD and compare to matched controls using:
a. Illumina Infinium HumanMethylation450 BeadChips (450K) to assess
genome-wide methylation changes.
b. pyrosequencing confirmations of gene-specific CpG methylation differences.
c. a targeted NGS bisulfite sequencing panel to confirm gene-specific CpG
methylation differences.
Thesis Organization:
The results of this thesis are organized into three chapters. Chapter 2 describes an
exploration of long-term alterations in a mouse model. Chapter 3 characterizes alterations
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present in young human children with FASD. Chapter 4 presents a comparison of the
alterations to DNA methylation in PAE mice and human children.

1.3.
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Chapter 2
Exploration of Long-Term Alterations to the
Epigenome of a PAE Mouse Model
2.1

Overview
This chapter examines the mechanisms initiating and maintaining the long-term

effect of prenatal alcohol exposure (PAE) in a mouse (C57BL/6J) model of fetal alcohol
spectrum disorder (FASD). The results presented include the long-term in vivo effects of
PAE on brain: 1) Gene Expression, 2) microRNA (miRNA) and small nucleolar RNA
(snoRNA) expression, and 3) DNA Cytosine Methylation. The three data sets from
different treatment paradigms were integrated to reveal alterations to the epigenetic
landscape of the whole brain of adult mice. The results show that PAE causes long-term
epigenomic alterations and identify a comprehensive set of affected genes that have been
independently implicated in endophenotypes related to Fetal Alcohol Spectrum Disorders
(FASD). Ultimately, this chapter highlights an epigenomic hypothesis that may be
applied towards understanding the developmental course of the effect of PAE. Most, but
not all, of the results included in this chapter are already published in Laufer et al. 2013
and some are published in Kleiber et al. 2012.

2.2

Introduction
Understanding how PAE results in the development of FASD presents a number

of biological as well as ethical challenges. As it stands, most of the relevant experiments
cannot be undertaken on humans. In order to address these challenges, the laboratory of
Shiva Singh has established a C57BL/6J (B6) mouse model to examine the long-term
effects of PAE across a number of exposure paradigms. In the binge exposure paradigms,
mice were exposed to ethanol at specific developmental stages to model the first, second,
or third trimester of human pregnancy (T1, T2, and T3) (Kleiber et al. 2013; Mantha et al.
2014; Kleiber, Laufer, et al. 2014). It was found that PAE at any time during
embryonic/fetal development results in delays to developmental milestones as well as
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deficits in learning and memory (Mantha et al. 2013). The aforementioned mice were also
reared to adulthood and showed differential brain gene expression in genes related to
developmental events disrupted by PAE (Kleiber et al. 2013). The changes to expression
were observed primarily in genes involved in cell proliferation (T1), cell differentiation
and migration (T2), and neurotransmission and cellular communication (T3) (Kleiber,
Diehl, et al. 2014). Thus, PAE primarily alters the expression of genes in a manner that
depends on the developmental timing of exposure. While few of the genes were shared
across paradigms, a much larger number are associated by gene families, ontologies,
‘hubs’ in associative gene networks, and/or by canonical protein pathways. These results
follow Green et al. (2007) who found changes in the expression of 2,906 genes in
embryonic head folds 3 hours after a single binge injection on gestational day (GD) 8
(Green et al. 2007). There was a significant down-regulation of KEGG pathways related
to the ribosome and proteasome and also a significant up-regulation of pathways related
to focal adhesion, adherens junction, tight junction, and regulation of actin cytoskeleton.
They also observed that PAE altered the expression of a number of hub genes, some of
which are involved in the PI3K/AKT/mTOR signaling pathway. Furthermore, Zhou et al.
examined the effects of ethanol in a whole embryo culture of GD8 B6 mice and found
changes in the expression of genes for alcohol metabolism, retinol metabolism,
hematopoiesis, neurodevelopment, cell cycle, histones, cell adhesion, homeobox genes,
and oncogenes (Zhou, Zhao, et al. 2011).
Chronic and moderate exposures have been examined in a voluntary maternal
continuous preference drinking (CPD) paradigm in B6 mice. The resulting PAE mice
display relatively mild developmental delays, anxiety-related traits, and deficits in spatial
learning (Kleiber et al. 2011). This treatment protocol has been previously shown by
others to produce peak maternal blood alcohol concentrations of ~80–120 mg/dl (Allan et
al. 2003; Boehm et al. 2008; Brady et al. 2012). The brains of adult PAE mice were also
analyzed by gene expression arrays (Kleiber et al. 2012). Genes involved in embryonic
and nervous system development showed subtle but consistent changes in expression.
Furthermore, some of the genes identified have previously been associated with FASDrelevant endophenotypes. Such genome-wide gene expression results following different
PAE paradigms are now common in the literature and pose the next logical question:
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What maintains changes in brain gene expression caused by PAE in B6 mice? One of the
most logical mechanisms that may account for long-term changes in gene expression are
ethanol induced changes to epigenetic marks. Epigenetic marks maintain gene expression
profiles without altering DNA sequence and are heritable in dividing cells. Epigenetic
marks are involved in gene regulation at two distinct levels. The first occurs at the level
of transcription, which is mainly accomplished by chromatin modifications, such as DNA
methylation and histone post-translational modifications (Métivier et al. 2008). To this
end DNA methylation has become among the most studied of such processes because of
the relative ease and effectiveness of analytic technology. Furthermore, the second level
of epigenetic regulation may be achieved post-transcriptionally by miRNAs and allows
for the fine-tuning of gene expression (Moazed 2009). miRNAs are key regulators of
eukaryotic gene expression that act via translational repression and mRNA decay
(Friedman et al. 2009). The two aforementioned levels of epigenetic regulation are
particularly crucial during embryonic development, where changes to the epigenome are
critical in ongoing differentiation (Monk et al. 1987; Howlett & Reik 1991).
It is logical to argue that epigenetic mechanisms may provide the foundation for
long-term alterations in gene expression and behavioral outcomes by ethanol’s direct
effect on epigenetic features, particularly DNA methylation (Garro et al. 1991; Haycock
2009; Kobor & Weinberg 2011). Such a hypothesis is backed by a number of independent
and unrelated reports. For example, Liu et al. examined a whole embryonic culture of B6
mice at early neurulation (Liu et al. 2009). They observed alterations to methylation in
genes involved in development and chromatin organization as well as in genes regulated
by genomic imprinting (Igf2r and Ube3a). Furthermore, Kaminen-Ahola et al. examined
the Agouti viable yellow (Avy) B6 mouse model and found that continuous maternal
preference drinking of 10% alcohol from GD0.5 to GD8.5 results in hypermethylation of
the metastable epiallele, as well as postnatal craniofacial and growth defects in congenic
PAE siblings. (Kaminen-Ahola et al. 2010). This study demonstrated that PAE during
embryogenesis results in a long-term alteration to DNA methylation at a specific locus.
The transcriptional alterations induced by PAE are not limited to protein-coding
genes. Interestingly, they also include miRNA expression (Miranda 2012). Sathayan et al.
examined the effect of alcohol exposure on miRNA expression in GD12.5 B6
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neurosphere cultures (Sathyan et al. 2007). It was observed that high and low ethanol
doses alter different miRNAs. The target genes were generally involved in apoptosis and
the cell cycle. Furthermore, Wang et al. showed that PAE induces altered expression of
mir-10a and its target gene Hoxa1 (Wang et al. 2009). Co-incubation of alcohol-exposed
mouse embryos in folic acid, which is involved in establishing DNA methylation,
prevented the alteration to miRNA and target mRNA. Such observations suggest that
altered DNA methylation has the potential to directly or indirectly alter the expression of
a specific set of miRNAs underlying PAE induced alterations to gene expression.
Genomically imprinted genes typically utilize differential DNA methylation at an
imprinting control region (ICR) and studies have observed PAE induced alterations to
imprinted genes (Liu et al. 2009; Shukla et al. 2011; Sittig et al. 2011; Dietz et al. 2012).
Approximately 30% of genomically imprinted genes are hypothesized to be ncRNAs,
including miRNAs (Morison et al. 2005). In the placenta, PAE was shown to induce
alterations to DNA methylation at CTCF-binding sites within the differentially
methylated region (DMR) of the imprinted gene H19 (Haycock & Ramsay 2009).
Genomic imprinting has been further examined in mouse embryos, where Downing et al.
observed a ~8% decrease to methylation at a single CpG site in the imprinted Igf2 DMR
(Downing et al. 2011). Furthermore, associated transcripts showed a -1.5 fold change in
gene expression. These observations were also extended mechanistically by placing
mothers on a methyl-supplemented diet, which ameliorated some of the PAE
endophenotypes. The above and related observations in the literature suggest that PAE
may alter DNA methylation and thus suppress transcriptional machinery by altering the
binding sites of a number of transcription factors. Based on these observations, I
hypothesize that large-scale alterations to the epigenome, which may be initiated by PAE,
occur in functional sites and maintain the observed long-term alterations to gene
expression and behaviour that underlie FASD.
In this chapter, I present comprehensive epigenomic results from four paradigms
of PAE. These include continuous preference drinking (CPD) by pregnant B6 mothers as
well as injections (binge) during the B6 equivalent of the first (T1), second (T2), or third
(T3) trimester of human pregnancy. The results are used to develop a generalized
mechanism for alterations to gene expression and behaviour associated with PAE/FASD.
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Specifically, the results identify long-term changes in DNA methylation, ncRNA, and
mRNAs in the adult brain resulting from multiple PAE paradigms in B6 mice. The results
of this chapter ultimately offer novel insights into the mechanisms maintaining FASD
endophenotypes and may also be used towards translating rodent model research to
human FASD studies.

2.3

Materials & Methods
The methodologies and workflow for the B6 mouse model are overviewed in

Figure 2.1. The PAE paradigms utilized in this research relied on an established model
for CPD (Kleiber et al. 2011) and three established binge injection paradigms (Mantha et
al. 2013). The brains of the ethanol exposed and matched control animals were collected
on post-natal day (PND) 70.

Mice

2.3.1

Male and female B6 mice were originally obtained from Jackson Laboratories
(Bar Harbor, ME) and maintained at the Health Sciences Animal Care Facility at the
University of Western Ontario (London, Ontario, Canada). The studies followed
Canadian Council of Animal Care guidelines and approved by the Animal Use
Subcommittee of the University of Western Ontario (Appendix K). All mice were
housed in standard cages at 21–24°C with 40–60% humidity at a 14-hour light/10-hour
dark cycle with access to food and water ad libitum. Virgin females of 8 weeks of age
were time-mated and assessed for pregnancy based on the presence of vaginal plugs
(GD0). Pregnant females were transferred to individual cages during gestation. The
individual females were exposed to ethanol or control using different treatment paradigms
involving binge injections or continuous preference drinking by pregnant females. The
resulting offspring were weaned on PND21 and housed in cages with two to four samesex littermates. Only male offspring were used for all experimentation described in this
research.
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2.3.1.1

Chronic Alcohol Treatment of Pregnant Females by

Continuous Preference Drinking (CPD)
Female mice were placed in individual cages, where they were acclimated to
increasing concentrations of ethanol (towards a final of 10%) diluted in water, alongside
freely available drinking water, for 2 weeks to establish a stable drinking pattern
previously described by Kleiber and Wright (Kleiber et al. 2011; Kleiber et al. 2012). The
female mice were then time-mated, where they had only access to water, and once the
male was removed the ethanol was replaced to ensure exposure from GD0 to PND10.
Control dams had access to water only. Voluntary maternal alcohol consumption and
water consumption were measured daily from GD0 to PND10 for each female at 10:00
AM. Resulting pups, both alcohol-exposed and matched controls, were weaned at PND21
and housed in same-sex colony cages of two to four mice until PND70. These mice were
raised and assessed by Ben Laufer & Eric Diehl.

2.3.1.2

Binge Alcohol Treatment of Pregnant Females by Acute

Injections
The binge exposure models used in this thesis were established by Kleiber and
Mantha (Mantha et al. 2013; Kleiber et al. 2013). Pregnant dams were subcutaneously
injected with two 2.5 g/kg body weight doses of ethanol in 0.15 M saline (alcohol-treated)
spaced 2 hours apart (at 0 hours and 2 hours), or with saline alone (control), at GD8 and
GD11 (trimester 1; T1) or GD14 and GD16 (trimester 2; T2) (Ikonomidou et al. 2007;
Mantha et al. 2014). Control and alcohol-treated dams were age- and weight-matched.
Given that the third trimester human equivalent occurs postnatally in mice (Dobbing &
Sand 1979), a binge exposure during this neurodevelopmental period was modeled by
treating pups on PND4 and PND7 via subcutaneous injection (trimester 3; T3) (Kleiber,
Laufer, et al. 2014). In this model, pups from one litter were matched across treatment
groups for sex and weight to control for litter effects. Injections represented two doses of
2.5 g/kg body weight spaced 2 hours apart with matched controls receiving 0.15 M saline.
All resulting offspring were weaned on PND21 and housed in cages with two to four
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same-sex littermates. T1 & T2 mice were raised by Katarzyna Mantha and the T3 mice
were raised by Morgan Kleiber.

2.3.1.3

Tissue Collection and Nucleic Acid Isolation

Alcohol-treated and matched control adult males (PD70) resulting from the four
treatment paradigms (n=12 per paradigm with six alcohol-exposed and six matched
controls) were sacrificed using CO2 and cervical dislocation. Whole brains were
extracted, snap frozen in liquid nitrogen, and stored at −80°C until RNA and DNA
isolation. Whole-brain total RNA was isolated from frozen tissues using TRIzol®
Reagent (Invitrogen, Carlsbad, CA), purified using the RNeasy® Mini Kit (QIAGEN,
Valencia, CA), and quantified using a NanoDrop ND-1000 spectrophotometer (Thermo
Fisher Scientific Inc., Wilmington, DE). Total RNA quality was assessed using the
Agilent 2001 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA). Further, whole
brain DNA was isolated from the interphase layer of TRIzol using sodium citrate,
followed by ethanol precipitation and purification using the QIAamp® DNA Micro Kit
(QIAGEN, Valencia, CA). DNA was then quantified using a NanoDrop ND-1000
spectrophotometer (Thermo Fisher Scientific Inc., Wilmington, DE) and all samples had
OD260/OD280 nm ratios of 1.8–2.0 and OD260/OD230 nm ratios of 2.0–2.4.
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Binge Injections

Continuous Preference Drinking

Gene Expression 1.0 ST Array

miRNA 2.0 Array

Methylation 2.1M
Promoter Array

Candidate Genes

Candidate miRNAs

Candidate Promoters

miRNA target filter

Genomic Locations

Figure 2.1. Flowchart of workflow used to analyze different exposure paradigms.
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RNA Analysis

2.3.2

The RNA studies included in this thesis investigate both coding and non-coding
RNAs. These studies relied on RNA isolated from the same mice and were used for
hybridization on Affymetrix GeneChip® Mouse Gene 1.0 ST arrays and Affymetrix
GeneChip® miRNA 2.0 arrays respectively. The RNA expression analysis primarily
examined the CPD PAE paradigm (3 arrays with samples pooled in duplicate); however,
the binge injection paradigms were also examined (2 arrays with samples pooled in
triplicate).

2.3.2.1

Gene Expression Arrays

Affymetrix gene expression arrays are single channel arrays that have proved
useful for the study of ethanol exposure in mice (Kerns & Miles 2008). The Affymetrix
GeneChip® Mouse Gene 1.0 ST array (Affymetrix, Santa Clara, CA) consists of 770,317
unique 25-mer perfect match probes that are targeted across 28,853 transcripts, with
1,305 of those being ncRNA, and an average of 27 probes for a gene.
The Affymetrix GeneChip® Mouse Gene 1.0 ST array was used to analyze PAE
induced alterations to gene expression. Single-stranded complementary DNA (sscDNA)
was prepared from 200 ng of total RNA as per the Ambion WT Expression Kit for
Affymetrix GeneChip Whole Transcript WT Expression Arrays (Applied Biosystems,
Carlsbad, CA) and the Affymetrix GeneChip WT Terminal Labeling kit and
Hybridization User Manual (Affymetrix, Santa Clara, CA). Total RNA was first
converted to complementary DNA (cDNA), followed by in vitro transcription to make
cRNA. By subjecting the cDNA to a cRNA conversion, a biotinylated Uracil analogue is
incorporated. The biotin molecules can then be used to attach fluorescent molecules to
label the cRNA. Subsequently, 5.5 µg of sscDNA was synthesized, end-labeled, and
hybridized for 16 hours at 45°C to Mouse Gene 1.0 ST arrays. GeneChip Fluidics Station
450 performed all liquid handling steps, and GeneChips were scanned with the GeneChip
Scanner 3000 7G using the Command Console v1.1 (Affymetrix, Santa Clara, CA). All
hybridizations were performed at the London Regional Genomics Centre at the Robarts
Research Institute, University of Western Ontario. Probe level (.CEL file) data were
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generated using the Affymetrix Command Console v1.1. The .CEL files identify
intensities of individual probes.
Probes, which have multiple replicates and target exons, were assembled into
probesets that represent single genes. This summarization of the .CEL files was done in
Partek Genomics Suite v6.5 (Partek Inc., St Louis, MO) by quantile normalization using
the RMA algorithm adjusted for GC content and log2-transformed (Irizarry et al. 2003).
Partek software was then used to determine gene level one-way ANOVA p-values and
fold changes. All arrays were analyzed by using a 1.2-fold cut-off with a significance
threshold of p=0.05 to generate a list of genes of interest to be assessed further using
bioinformatic analysis of gene ontologies and pathways. The gene expression array
results for the T1, T2, T3, and CPD paradigms were deposited within the NCBI GEO
database under accessions GSE34469 (T1 & T2), GSE34549 (T3) and GSE34305 (CPD,
experiment 2). The data from CPD mice were generated by Ben Laufer, T1 & T2 mice by
Katarzyna Mantha, and T3 mice by Morgan Kleiber.

2.3.2.2

miRNA Expression Arrays

The Affymetrix GeneChip® miRNA 2.0 array is based on a similar design as the
Affymetrix GeneChip® Mouse Gene 1.0 ST array, and has probes that are 25-mer.
However, smaller probes are used if the miRNA is less than 25 bases. The miRNA array
targets 722 mouse mature miRNAs, 690 mouse pre-miRNA, and 2,334 small RNAs from
humans that include snoRNAs. It also has 9 probes per a probe set for a miRNA. The
workflow is also similar to Affymetrix GeneChip® Mouse Gene 1.0 ST arrays.
In order to investigate the effect of PAE on miRNAs, all samples were analyzed at
the London Regional Genomics Centre (Robarts Research Institute, London, Ontario)
using Affymetrix miRNA 2.0 arrays. Briefly, 1 µg total RNA from each treatment
paradigm was labeled using the Flash Tag Biotin HSR kit (Genisphere, Hatfield, PA) and
hybridized to Affymetrix miRNA 2.0 arrays for 16 hours at 45°C. Probe level (.CEL file)
data were generated using Affymetrix Command Console v1.1. Probes were summarized
to gene level data in Partek Genomics Suite v6.6 (Partek Inc., St Louis, MO) by using the
RMA algorithm (Irizarry et al. 2003). Partek software was used to determine differences
between control and ethanol-treated samples by a one-way ANOVA and corresponding
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P-values and fold changes. For each treatment model, the miRNAs present on this array
were filtered using stringency criteria of 1.2-fold change (p<0.05) and subjected to a
hierarchical clustering analysis by using Euclidean distance and average linkage to assess
consistency in ethanol response between the arrays of different treatment paradigms. The
miRNA expression array results for all treatment protocols were deposited within the
NCBI Gene Expression Omnibus (GEO) database under accession GSE34413. Analyses
of CPD mice were performed by Ben Laufer, T1 & T2 mice by Katarzyna Mantha and
Ben Laufer, and T3 mice by Morgan Kleiber and Ben Laufer.

2.3.2.3

Quantitative PCR Confirmation

The quantitative polymerase chain reaction (qPCR) allows for real-time
quantification of DNA amplification by optically measuring fluorescent dyes after laser
excitation (Fraga et al. 2008). Taqman® is a methodology that utilizes sequence-specific
oligonucleotide probes attached to both a fluorophore and a quencher molecule, which
prevents fluorescence. During qPCR, the probe will hybridize to complementary DNA
and will then be degraded by Taq polymerase, which releases the fluorophore from the
quencher and allows it to be detected after excitation. qPCR technology can also be
coupled with reverse transcription (RT) to enable the study of both coding and noncoding RNA expression.
In order to confirm gene expression results, cDNA was reverse transcribed from
whole-brain RNA of the CPD paradigm (n=6) and matched controls (n=6). For mRNA
expression, cDNA was created using Applied Biosystems High-Capacity cDNA Reverse
Transcription Kit (Foster City, CA) and sequence specific TaqMan™ assays (Foster City,
CA), which were used according to the manufacturer’s protocol. For miRNA expression,
the Applied Biosystems TaqMan™ MicroRNA Reverse Transcription Kit (Foster City,
CA), which uses stem-loop reverse transcription primers (Chen et al. 2005), and sequence
specific TaqMan™ MicroRNA Assays (Foster City, CA) were used according to the
manufacturer’s protocol. All TaqMan™ probes were selected using the Applied
Biosystems (Carlsbad, CA) search engine to identify previously characterized TaqMan™
assays. GAPDH was chosen as an endogenous control for mRNA expression, while
snoRNA 202 was chosen as an endogenous control for miRNA expression (Gao et al.
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2010). The target and control reactions were run in separate tubes on the same plate for
each sample as per the manufacturer’s protocol. Three technical replicates were averaged
for both the endogenous control and gene of interest for each sample. qPCR reactions
were performed on the Applied Biosystems StepOne™ Real-Time PCR System 2.0
according to the manufacturer’s protocol. Fold change was calculated using the ΔΔCt
method (Schmittgen & Livak 2008). The ΔΔCT method allows for relative quantification
of gene expression from qPCR experimentation. CT is the threshold cycle, which is the
PCR cycle where fluorescence exceeds a threshold value. The ΔΔCT method compares
CT’s for an experimental gene to a reference gene across both the experimental and
control group. The results were analyzed using Applied Biosystems DataAssist™
Software v3.0. Statistical significance was assessed by an unpaired Student’s t-test.

2.3.2.4 Bioinformatic Analysis of Differentially Expressed Probe
Sets (mRNAs and miRNAs)
The chromosomal locations for all miRNAs were determined by using miRBase
and Ensembl (Flicek et al. 2011; Kozomara & Griffiths-Jones 2011). Genomically
imprinted

regions

were

identified

by

the

mouse

imprinting

catalog

(www.mousebook.org).
Data from the CPD paradigm were analyzed through the use of Ingenuity®
microRNA target filter [Ingenuity® Systems (www.ingenuity.com)] to generate lists of
interactions between genes and miRNAs of interest from the TargetScan Human database
(mouse was not available at the time). Results were filtered based on a moderate or high
confidence of interaction (Lewis et al. 2005; Vergoulis et al. 2012), brain specificity, and
an inverse miRNA to target mRNA expression relationship. miRNAs were filtered based
on a 1.15 fold change and a p<0.3 cut-off. This analysis is referred to as the original
(2012) analysis.
At a later date, updated (2016) annotations and improved software became
available for the gene expression and miRNA arrays. These updates offered some
improvement and thus were utilized for a re-analysis. Enrichr was used for biological,
cellular, and molecular ontologies (Chen et al. 2013). Partek Pathways was used for
canonical KEGG pathways. Gene annotations were obtained from UniProt (UniProt-
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Consortium 2014). An updated and more stringent (1.2 fold change, p<0.05) miRNA
target filter analysis was done in Partek using Mouse TargetScan 6.2. This analysis is
referred to as the updated (2016) analysis.

DNA Analysis

2.3.3

The DNA studies included in this thesis investigate DNA cytosine methylation.
These studies relied on DNA isolated from the same CPD mice used for RNA analysis.

2.3.3.1

DNA Methylation (MeDIP-Chip) Arrays

The DNA methylation analysis of the mice utilized MeDIP-Chip tiling arrays of
promoter regions and analyzed the CPD PAE paradigm. The NimbleGen MM9 2.1M
deluxe promoter array v2 is a two channel array that contains 2.1 million 50-75mer
probes that utilize methylated DNA immunoprecipitation (MeDIP) and a tiling approach
to examine DNA methylation. MeDIP involves enriching for 5mC with an antibody to
immunoprecipitate ~500 bp fragments with the mark (Weber et al. 2005; Mohn et al.
2009). In MeDIP-Chip, the MeDIP reaction is then coupled to a microarray chip, where
the enriched DNA is labelled green with Cy3 and the input sample from before
enrichment is labelled red with Cy5. The deluxe promoter array tiles approximately 8.2
kb upstream and 3 kb downstream all 22,425 MM9 mouse gene promoters, 20 kb
upstream of 510 mature miRNA transcripts, 16,002 CpG islands, and other biologically
relevant sites identified from ENCODE. It also includes positive, negative, and non-CpG
control sites. MeDIP-Chip allows for a relative level of methylated DNA enrichment to
be analyzed by bioinformatic algorithms, which can determine differentially methylated
regions (DMRs). However, MeDIP-Chip does not offer single nucleotide resolution, as
the lower detection limit is 2 methylated CpG sites per a DNA fragment. Previous
versions of this array have been used successfully in PAE rodents embryos and
candidates were confirmed using Sequenom EpiTYPER DNA methylation analysis (Liu
et al. 2009; Zhou, Balaraman, et al. 2011).
In order to examine PAE-induced alterations to genome-wide DNA methylation
by MeDIP-Chip, equal amounts of brain DNA from two non-littermate males from the
CPD paradigm were pooled per biological replicate (n=3) to reduce potential litter effects.
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All methylated DNA immunoprecipitation (MeDIP), sample labeling, hybridization and
processing were performed at Arraystar Inc. (Rockville, MD). Briefly, genomic DNA was
sonicated to 200- to 1000-bp fragments followed by immunoprecipitation of methylated
DNA using Biomag™ magnetic beads coupled to mouse monoclonal antibody against 5methylcytidine (Diagenode). The DNA was eluted, whole genome amplified, and
purified. The total input and immunoprecipitated DNA were labeled with Cy3- and Cy5labeled random 9-mers, respectively, and hybridized to the NimbleGen MM9 DNA
Methylation 2.1M Deluxe array (Roche NimbleGen Inc., Madison, WI). Scanning was
performed with the Axon GenePix 4000B microarray scanner.
Raw data from three arrays were extracted as pair-files by NimbleScan software
(Roche NimbleGen Inc.). Median-centering, quantile normalization, and linear smoothing
by Bioconductor packages Ringo, limma and MEDME were performed to generate
normalized log2-ratio data. From the normalized log2-ratio data, a sliding-window peakfinding algorithm provided by NimbleScan v2.5 (Roche NimbleGen Inc.) was applied to
find the enriched peaks with specified parameters (sliding window width: 750 bp; mini
probes per peak: 2; maximum spacing between nearby probes within peak: 500 bp). The
identified peaks were mapped to genomic features: transcripts and CpG Islands. The MA
plots and box-plots were applied to assess the quality of raw data and effect of
normalization. A correlation matrix was used to describe correlation among replicate
experiments.
To compare differentially enriched regions between ethanol-exposed (E) and
matched control (C) mice, the log2-ratio values were averaged and then used to calculate
the M′ value [M′=Average(log2 MeDIPE/InputE) – Average(log2 MeDIPC/InputC)] for
each probe. The NimbleScan sliding-window peak-finding algorithm (Scacheri et al.
2006) was run on the data to find the differential enrichment peaks (DEPs). The
differential enrichment peaks, called by the NimbleScan algorithm, were filtered
according to the following criteria: (i) at least one of the two groups had the median value
of log2 MeDIP/Input ≥0.3 and a median value of M′ >0 within each peak region; (ii) at
least half of the probes in a peak had the median value of coefficient of variability (CV)
≤0.8 in both groups within each peak region.
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Using an R script, a hierarchical clustering analysis was completed. The probe
data matrix was obtained by using PeakScores from DMRs selected by DEP analysis.
‘PeakScore’ is a measure calculated from the P-values of the probes within the peak and
reflects the significance of the enrichment. This analysis used a ‘PeakScore’ ≥2 to define
the DEPs by using the NimbleScan sliding-window peak-finding algorithm. The peak
score is a –log10 transformed P-value, which is the average of the P-values for all probes
within the peak. Therefore, a ‘PeakScore’ ≥2 means the average P-value was ≤0.01. This
analysis is referred to as the original (2012) analysis.
For the purpose of comparing more directly to the next chapter of this thesis an
updated analysis of the methylation data was also later carried out using Partek Genomics
Suite Version 6.6. While Partek had gained some capability to analyze the methylation
array from raw scans in 2016, it was only under limited support and not fully featured.
This analysis is referred to as the updated (2016) analysis.
For the updated (2016) analysis, the 635 nm and 532 nm scans (.pair files) were
analyzed in Partek Genomics Suite Version 6.6 and normalized using the default settings
for the tiling workflow. An ANOVA was used to analyze each probe and then the modelbased analysis of tiling-arrays (MAT) algorithm (Johnson et al. 2006) was used to detect
differentially methylated regions (DMRs). The DMRs were then annotated to genes if
they occurred in the gene body or were 5000 bp to -3000 bp from the transcriptional start
site. The list of genes overlapping DMRs with a MAT p-value of <0.005 was used for
bioinformatic analysis. The software was not able to produce a proper principle
components analysis, heatmaps, or fully present sequence annotations. Thus, the updated
(2016) analysis is presented in addition and as complement to the original (2012)
analysis.

2.3.3.2

Bioinformatic Analysis of Differently Methylated Genes

For the original (2012) analysis, the top gene promoters identified from the DNA
methylation arrays were subjected to Ingenuity Pathway Analysis. The genes
corresponding to all previously identified significantly affected promoters were subjected
to an Ingenuity Core Analysis. The Ingenuity Knowledge Base (genes only) was used to
examine direct and indirect relationships. Results were filtered to consider only molecules
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and/or relationships specific to species (mouse, rat, or human) and tissues (nervous
system). From the identified ‘Behavior, Neurological Disease, and Psychological
Disorders’ network, 30 significantly differentially methylated peaks belonging to
different regions of the promoters of hub genes were examined for CTCF-binding sites
using the CTCFBS prediction tool (Bao et al. 2008). The genes identified as having
CTCF-binding sites were then subjected to a pathway analysis using GeneMANIA
(Warde-Farley et al. 2010). Gene annotations were obtained from UniProt (UniProtConsortium 2014). For the updated (2016) analysis, Enrichr (Chen et al. 2013) was used
for ontologies and Partek Pathways for canonical pathways.

2.4
2.4.1

Results
Differential Gene (mRNA) Expression
The first set of experiments in this chapter identified alterations to gene expression

in CPD PAE brains at PND70 using Affymetrix GeneChip® Mouse Gene 1.0 ST arrays.
Principle component analysis (PCA), which examines total signal from the arrays,
correctly distinguishes CPD PAE mice from matched controls (Figure 2.2). After
filtering, there were 783 significantly (p<0.05) altered (fold-change cut-off of 1.2)
transcripts. A heatmap of the significant alterations distinguishes CPD from matched
controls and illustrates that the majority of differentially expressed transcripts are upregulated by PAE at this level of filtering (Figure 2.3). Notably, 456 of the differentially
expressed transcripts were ‘housekeeping’ internal control exons and introns that did not
have available annotations. Furthermore, 31 of the differentially expressed transcripts
were miRNAs and 116 transcripts were largely unannotated expressed sequences
identified by consortiums, with most having no predicted protein function. The top
differentially expressed transcripts with a gene symbol are presented in Table 2.1. The
269 genes annotated with symbols were analyzed with Enrichr for gene ontologies and
Partek pathways identified several altered canonical pathways (Table 2.2).

48

PCA Mapping (71.6%)

Attribute
Alcohol
Control

180

137

94

51

PC #2 22.2%

8

-35

-77

-120

-163

-206
-250
-204
-159
-114
-69-25
2065 -250
110
155
200

-230

-187

-145

-61

-103

PC #3 17.2%

-20

22

64

106

148

PC #1 32.2%

Figure 2.2. PCA analysis of gene expression arrays from CPD PAE (red) and matched
control (blue) adult brains. Each point represents a single array and ellipsoids have been
placed around groups to allow for visual clustering.
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190

Figure 2.3. Heatmap of significant (p<0.05) differential (fold change cut-off 1.2) gene
expression in CPD PAE and matched control adult brains. The expression (intensity) of
each gene (probe set) is normalized by being standardized to a mean of 0 and a standard
deviation of 1. Genes with no change are displayed with a value of zero (grey),
upregulated genes have a positive value (red), and down-regulated genes have negative
values (blue).
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Table 2.1. Top differentially-expressed transcripts in CPD adult mouse brains that were annotated with a gene symbol.
PAE Upregulated
Fold Change

p-value

Symbol

Gene Name

Gene Function

1.9

0.002

Gm26315

Unknown

Unknown

1.8

0.027

Gm10115

Unknown

Unknown

1.6

0.022

AY512949

Unknown

Unknown

1.6

0.004

Gm16498

Unknown

Unknown

1.6

0.002

Gm22260

Unknown

ncRNA

1.6

0.010

Gm10304

Unknown

Expressed in adult male diencephalon

1.5

0.014

Gm23422

Unknown

ncRNA

1.5

0.038

Gm22951

Unknown

ncRNA

1.5

0.009

9330155M09Rik

Unknown

Expressed in adult male hypothalamus

1.5

0.017

Prp2

Proline rich protein 2

Secreted Protein

PAE Downregulated
Fold Change

p-value

Symbol

Gene Name

Gene Function

-1.4

0.0126

Mrpl46

39S ribosomal protein L46, mitochondrial

Mitochondrial translational regulation

-1.3

0.0386

Prg4

Proteoglycan 4

Skeletal and cartilage development

-1.3

0.0002

Nuak1

NUAK family SNF1-like kinase 1

Cell Adhesion and DNA Damage

-1.3

0.0377

Vmn1r-ps77

Vomeronasal 1 receptor, pseudogene 77

Pheromone receptor pseudogene

-1.3

0.0031

Zfp518a

Zinc finger protein 518A

Transcriptional Regulation

-1.3

0.0427

Ucma

Unique cartilage matrix-associated protein

Skeletal and cartilage development

-1.3

0.0035

Ssna1

Sjoegren syndrome nuclear autoantigen 1

Cytoskeleton and Cell Cycle

-1.3

0.0087

Phkg2

Phosphorylase b kinase gamma catalytic chain

Neural and hormonal regulation of glycogen breakdown

-1.3

0.0080

Cldn1

Claudin-1

Cell Adhesion

-1.3

0.0002

Serping1

Plasma protease C1 inhibitor

Complement and coagulation cascade [Immune Process]
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Table 2.2. Ontologies and pathways for differentially-expressed genes (p<0.05, and a
fold-change cut-off of 1.2) from CPD adult mouse brains.
Enrichr GO Biological Processes
Regulation of complement activation
Regulation of protein activation cascade
Dendritic spine morphogenesis
Regulation of humoral immune response
Regulation of cell communication by electrical coupling
Dendritic spine organization
Aging
Enrichr GO Cellular Location
Extracellular space
Blood microparticle
Voltage-gated calcium channel complex
Platelet alpha granule lumen
Chloride channel complex
Outer membrane
Serine/threonine protein kinase complex
Enrichr GO Molecular Function
Solute:cation antiporter activity
Peptidase activator activity
Peptidase regulator activity
Hormone activity
Growth factor binding
Nucleotidyltransferase activity
Antiporter activity
Partek KEGG Pathways
Complement and coagulation cascades
Purine metabolism
Taste transduction
Prion diseases
Pyrimidine metabolism
Antigen processing and presentation
Ribosome
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Overlap
3/27
3/29
2/8
3/45
2/10
2/13
5/204
Overlap
15/1120
4/161
2/38
2/48
2/50
3/137
2/56
Overlap
2/28
2/37
4/209
3/122
3/123
3/140
2/62
Overlap
5/71
7/171
4/59
3/31
5/99
4/72
5/133

p-value
2.6E-04
3.2E-04
7.6E-04
1.1E-03
1.1E-03
1.7E-03
1.8E-03
p-value
1.7E-04
7.3E-03
1.5E-02
2.3E-02
2.4E-02
2.8E-02
3.0E-02
p-value
6.8E-03
1.1E-02
1.2E-02
1.5E-02
1.5E-02
2.1E-02
2.9E-02
p-value
3.2E-03
9.1E-03
9.5E-03
1.0E-02
1.2E-02
1.8E-02
3.6E-02

Prenatal ethanol induced mRNA (Pnet-ps) was the most significant (p=0.0001)
differentially expressed (1.2 fold increase) gene in the CPD model. Pnet-ps was also
significantly up-regulated in the T1 model (1.3 fold change, p=0.003) (Kleiber et al.
2013). Pnet-ps is a pseudogene that appears to be a lncRNA. However, the biological
function and genomic properties remain a mystery as there is only one report that used
subtractive hybridization, which is a technique able to detect novel transcripts. In that
report four transcripts were examined in the neural tube of mouse embryos 1 hour after
ethanol treatment (Du & Hamre 2003). While three of the genes detected were previously
annotated, one novel transcript (Pnet-ps) was detected and showed a seven-fold increase
in expression in ethanol-treated embryos. This expression was found to be induced in
PAE embryonic brains and also possibly present at a low level in control hearts. In this
chapter, both the CPD and T1 models showed a subtler increase; however, the
observation demonstrates that a transcript which shows highly increased expression 1
hour after PAE is still altered in the same direction 70 days later in the adult brain.
Trdn was the only protein coding gene to be altered across all exposure
paradigms. It showed a significant (p<0.05) 1.3, -1.6, -2.2, and 1.2 fold change in the T1,
T2, T3, and CPD paradigms respectively. Trdn is involved in the release of calcium ions
from the sarcoplasmic reticulum, which is a key step in the contraction of cardiac and
skeletal muscle (Roux-buisson et al. 2012). Notably, Trdn showed a significant (p<0.05)
1.5 fold change in PND7 hippocampus from a rat model that was developmentally
exposed to a polychlorinated biphenyl (PCB), which acts as a teratogen (Royland &
Kodavanti 2008).

2.4.2

Differential ncRNA Expression
The second set of experiments in this chapter identified differences related to

ncRNA expression by utilizing Affymetrix GeneChip® miRNA 2.0 arrays and
Affymetrix GeneChip® Mouse Gene 1.0 ST arrays. The differential ncRNA expression is
represented by two sets of observations. The first set of observations is of the reciprocal
differential expression of miRNAs and target genes in CPD PAE mice at PND70. The
second set of observations is of miRNA and snoRNA expression in multiple exposure
paradigms at PND70. In addition to CPD, binge PAE (injection) at the first (T1), second
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(T2) and third (T3) trimester equivalents of human development were analyzed to
confirm and expand on the CPD results in the second set of observations. The long-term
gene expression alterations from the binge injection models have been compared (Kleiber
et al. 2013; Kleiber, Diehl, et al. 2014) and detailed ncRNA expression analysis is
available for the T2 (Mantha et al. 2014) and T3 (Stringer et al. 2013; Kleiber, Laufer, et
al. 2014) binge exposure paradigms.

2.4.2.1 Reciprocal Differential miRNA and Target Gene
Expression
For the original (2012) analysis, IPA’s miRNA Target Filter® was used to
analyze all possible miRNA and target-gene interactions from the miRNA and gene
expression array data sets for the CPD PAE paradigm. The results were filtered based on
the confidence of interaction, brain specificity, and an inverse miRNA to target mRNA
relationship (Appendix A). The miRNA analysis was also updated in 2016 (Table 2.3).
An updated (2016) target filter analysis was carried in Partek out under more stringent
conditions using the mouse-specific TargetScan database and updated annotations for
both arrays (Table 2.4).
The Partek miRNA target filter revealed two mRNAs (Slitrk2 and Otx2) that had a
reciprocal alteration with a shared miRNA (mir-130b, 1.2 fold increase) (Table 2.4).
Slitrk2 was downregulated (–1.2), whereas one of the IPA target filter predicted miRNAs
(mir-17*) was upregulated (Appendix A). Slitrk2 is expressed in the developing embryo
and adult neurons, where it has an inhibitory effect on neurite outgrowth (Aruga &
Mikoshiba 2003). Otx2 was downregulated (–1.3) along with one of its IPA target filter
predicted miRNAs (mir-152) being upregulated (Appendix A). Otx2 is a homeobox gene
that is involved in embryonic head development as well as in the neuroplasticity of
GABAergic interneurons in the visual cortex and has been implicated in mood disorders
(Acampora et al. 1995; Sabunciyan et al. 2007; Sugiyama et al. 2009). Interestingly, both
of the above genes are involved in neurodevelopmental processes and were predicted by
the Partek target filter to be targeted by a single miRNA.
Aak1 (1.2 fold change, p=0.007) showed increased expression, while a number of
miRNAs predicted to target it by both IPA and Partek being downregulated (Table 2.4

54

and Appendix A). In the T2 binge PAE model, Aak1 (1.2 fold change, p=0.027) showed
an increase in expression and two miRNAs predicted to target it, mir-10b (-1.5 fold
change, p=0.002) mir-342-5p (-1.3 fold change, p=0.025), showed decreased expression
(Mantha et al. 2014; Kleiber, Diehl, et al. 2014). AAK1 is a kinase that regulates clathrinmediated endocytosis, which is a process that recycles synaptic vesicles at presynaptic
terminals (Conner & Schmid 2002; Saheki & De Camilli 2012). Furthermore, AAK1 is a
positive regulator of the Notch signaling pathway and directly interacts with an active and
membrane-tethered form of Notch that results in part from metalloprotease cleavage by
the ADAM gene family (Gupta-Rossi et al. 2011). Other notable candidates identified by
the Partek miRNA target filter include Rnf165 and Nlrc5 (Table 2.4). RNF165 was
shown to mediate motor axon extension by BMP-Smad signaling (Kelly et al. 2013).
NLRC5 has a role in immune response, where it is a negative regulator of the NF-kappaB
and type I interferon signaling pathways (Cui et al. 2010). Finally, both the original
(2012) and updated (2016) analysis of altered miRNAs found that let-7 miRNA(s) were
down-regulated (Table 2.4). Notably, let-7 miRNAs promote differentiation over
pluripotency and are involved in neurodevelopment (Mayr et al. 2007; Worringer et al.
2014; Ivakhnitskaia et al. 2016)
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Table 2.3. Updated (2016) analysis of significant differentially-expressed mouse
miRNAs in CPD adult brains (p<0.05 and 1.2-fold change cut-off).
miRNA

p-value

Fold Change

mmu-miR-466d-3p

0.023

1.6

mmu-miR-181c

0.040

1.6

hp_mmu-mir-686

0.020

1.3

hp_mmu-mir-147

0.018

1.3

hp_mmu-mir-708

0.044

1.3

hp_mmu-mir-28

0.028

1.3

mmu-miR-130b

0.017

1.2

mmu-miR-322*

0.023

1.2

hp_mmu-mir-291a

0.015

1.2

hp_mmu-mir-146b

0.011

1.2

mmu-miR-151-5p

0.017

1.2

hp_mmu-mir-181b-2

0.046

1.2

mmu-miR-291a-5p

0.037

1.2

mmu-miR-669o

0.039

-1.2

hp_mmu-mir-491

0.005

-1.2

mmu-miR-27b*

0.010

-1.2

mmu-miR-488

0.048

-1.2

hp_mmu-mir-22

0.032

-1.3

hp_mmu-mir-707

0.045

-1.3

hp_mmu-mir-325

0.046

-1.3

mmu-miR-683

0.002

-1.3

hp_mmu-mir-193

0.016

-1.3

mmu-let-7g

0.012

-1.3

hp_mmu-mir-340

0.024

-1.3

mmu-let-7f

0.041

-1.3

hp_mmu-mir-98

0.001

-1.3

mmu-miR-1306

0.025

-1.3

mmu-miR-146a

0.042

-1.4

mmu-miR-93*

0.007

-1.4

mmu-let-7f*

0.039

-1.4

mmu-miR-122

0.026

-1.5

mmu-miR-150*

0.034

-1.5

mmu-miR-369-5p

0.025

-1.7

mmu-miR-299*

0.029

-1.8

Note: hp = hairpin precursor and * = star
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Table 2.4. Updated (2016) Partek miRNA target filter analysis (p<0.05 and 1.2-fold
change cut-off) of differentially expressed genes and associated miRNAs identified in
CPD adult brains.
miRNA

p-value

Fold Change

Gene

p-value

Fold Change

mmu-miR-146a

0.0424

-1.4

Trp53rka

0.0196

1.2

mmu-miR-683

0.0022

-1.3

Aak1

0.0007

1.2

mmu-let-7g

0.0116

-1.3

Aak1

0.0007

1.2

mmu-let-7f

0.0410

-1.3

Aak1

0.0007

1.2

mmu-let-7g

0.0116

-1.3

Nlrc5

0.0103

1.3

mmu-let-7f

0.0410

-1.3

Nlrc5

0.0103

1.3

mmu-miR-130b

0.0170

1.2

Otx2

0.0162

-1.3

mmu-miR-683

0.0022

-1.3

Rnf165

0.0128

1.2

mmu-let-7g

0.0116

-1.3

Rnf165

0.0128

1.2

mmu-let-7f

0.0410

-1.3

Rnf165

0.0128

1.2

mmu-miR-488

0.0476

-1.2

Rnf165

0.0128

1.2

mmu-miR-130b

0.0170

1.2

Slitrk2

0.0002

-1.2

Results were obtained from the 2016 analysis of gene and miRNA expression arrays
respectively.
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2.4.2.2

Confirmations of Differential Expression

The results observed on the two independent array platforms for the CPD PAE
mice were then examined by quantitative PCR (qPCR). Although the qPCR results
showed similar fold changes to the arrays for all genes of interest examined (Pten,
Nmnat1, Slitrk2 and Otx2), they were not statistically significant (p=0.122, p=0.129,
p=0.452 and p=0.078, respectively).
However, it is worth noting that the gene expression and miRNA arrays used were
independent platforms that contained different probes for the same snoRNAs and
miRNAs. The results showed that some ncRNAs are similarly affected on the two
(miRNA and gene expression) arrays. For example, the MBII-52 snoRNA (Snord115)
belonging to Snrpn-Ube3a is upregulated (Appendix D).
Despite difficulties with confirming gene expression, a miRNA identified in the
CPD model by the original (2012) IPA analysis was confirmed by qPCR. mir-679-5p,
which is located in the Dlk1-Dio3 region, showed a 1.45-fold increase (p=0.019) in mice
that were treated with ethanol during neurodevelopment via maternal CPD (Figure 2.4).
The results provide support for the two independent (miRNA and gene expression) array
platforms that showed 1.2 (p=0.03)- and 1.4 (p=0.04)-fold increases, respectively.
Notably, this miRNA was not identified as significant in the updated (2016) miRNA
analysis.
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Figure 2.4. A bar graph depicting the quantitation of mmu-mir-679-5p expression in
control and CPD PAE adult brains. This miRNA was identified in the original (2012)
analysis. The y-axis depicts the relative mir-679 expression normalized to snoRNA 202,
expressed as a mean ± s.e.m. of both biological (n=6) and technical (n=3) replicates.
*p<0.05.
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2.4.2.3 Differential ncRNA Expression in All Exposure
Paradigms
The original (2012) analysis of the mouse miRNA arrays shows that all PAE
paradigms resulted in changes to global miRNA expression. The effect of each treatment
paradigm was relatively consistent between biological replicates. Consequently, alcoholtreated and matched control ncRNA expression patterns consistently group together when
hierarchically clustered (Appendix B), however, they do not represent the same
transcripts across paradigms.
The pattern of expression between alcohol-exposed and matched control brains is
quite distinct. Notably, the miRNAs that were affected were primarily specific to the
developmental timing of alcohol treatment (Appendix C). Treatment during T1, T2, or
T3 resulted in the unique expression for 21/24 (88%), 38/45 (84%) and 60/68 (88%) of
the affected miRNAs for each of the three trimesters, respectively. This number for the
CPD paradigm was also comparable [28/32 (88%)].
Finally, the altered miRNAs from the four exposure paradigms map to
genomically imprinted regions in the mouse genome. Interestingly, 8/32 (25%) of
identified miRNA transcripts in the CPD treatment paradigm, 2/24 (8%) in the T1
paradigm, 13/45 (29%) in the T2 paradigm, and 13/68 (19%) in the T3 paradigm mapped
to three known imprinted regions of the mouse genome. The genomic locations include
the Snrpn-Ube3a region of chromosome 7 (Appendix D), the Dik1-Dio3 region of
chromosome 12 (Appendix E), and the Sfmbt2 region of mouse chromosome 2
(Appendix E).
Ultimately, these results suggest that the long-term changes in ncRNA expression
following PAE are subtle and treatment specific, with the relative exception of Snord115
(H/MBII-52).
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2.4.3

Differential DNA Methylation
The third experiment in this chapter examines genome-wide as well as specific

differences in DNA methylation in CPD PAE adult brains by utilizing NimbleGen MM9
2.1M deluxe promoter arrays (v2).
The original (2012) analysis revealed that the differences across individuals,
although variable, show a significant (p<0.01) effect of PAE on genome-wide DNA
methylation. Upon hierarchal clustering analysis, it was observed that experimental and
control mice group together according to exposure (Figure 2.5). Furthermore, the results
reveal significant differentially methylated regions (DMRs) in 6660 regions that are
associated with PAE. A total of 16% of transcripts and 18% of the miRNAs that showed
significant (p<0.05) differential expression (fold change > ±1.2) also showed significant
(p<0.01) differential methylation in their gene promoters. Furthermore, ~50% of
imprinted regions showed significant differences in methylation.
Next, all the promoters identified were subjected to Ingenuity Pathway Analysis®
(IPA®). After filtering, this analysis revealed that a large number of genes associated
with cell death as well as nervous system development and function are significantly
enriched (Table 2.5). An IPA associative genetic interaction network analysis revealed
that the ‘Behavior, Neurological Disease, and Psychological Disorders’ network was the
most significantly affected network, with an IPA® score of 65. From this network a
number of highly connected ‘hub genes’ were identified.
Among the most prominent hub genes was App: its promoter is less methylated in
the treated mice. Furthermore, the promoters of a set of interacting genes (Akt1, Ghr,
ApoE, Ntrk1) within this hub are also differentially methylated following PAE. Finally,
IPA’s canonical pathway analysis showed that the top two pathways were Cdk5 signaling
(p=9.01E–7), with 47/78 molecules affected (Figure 2.6), and Pten signaling (p=1.9E–
06), with 54/95 molecules affected (Figure 2.7).
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Figure 2.5. Hierarchical clustering of significant (p<0.01) differential methylation in
CPD PAE adult mouse brains identified by the original (2012) analysis. The heatmap was
plotted based on the log2 ratio of probes within the peak regions of each sample.
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Table 2.5. Top ontologies identified by the original (2012) Ingenuity analysis of
significantly (p<0.01) differentially methylated gene promoters.
Molecular and Cellular Functions
Name
Cell Death
Cellular Development
Cellular Function and Maintenance
Cellular Movement
Cell Signaling
Physiological System Development and Function
Name
Nervous System Development and Function
Tissue Morphology
Behavior
Embryonic Development
Organismal Development
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p-value
# Genes
4.06E-04 - 4.97E-02
224
6.24E-04 - 4.52E-02
166
9.57E-04 - 4.97E-02
86
4.12E-03 - 4.52E-02
41
8.43E-03 - 4.97E-02
26
p-value
# Genes
3.86E-05 - 4.97E-02
273
1.64E-04 - 4.23E-02
97
1.62E-03 - 1.58E-02
24
1.23E-02 - 4.23E-02
29
1.23E-03 - 4.23E-02
25

Figure 2.6. Ingenuity pathway analysis of the CDK5 signaling pathway. Genes identified
by the original (2012) analysis as showing significant (p<0.01) differential methylation in
CPD PAE mice are highlighted. The legend for symbols is in Appendix F.
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Figure 2.7. Ingenuity pathway analysis of the PTEN signaling pathway. Genes identified by the original (2012) analysis as showing
significant (p<0.01) differential methylation in CPD PAE mice are highlighted. The legend for symbols is in Appendix F.
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In addition to the genome-wide results, ontologies, and pathways, a functional
examination of the results was also undertaken. The original (2012) DNA methylation
data were integrated with the gene expression data to reveal gene families that showed
significant differential methylation and some corresponding alterations in gene
expression. Furthermore, an analysis of CTCF binding sites was also carried out on the
promoter sequences of a critical gene network identified in the original (2012) analysis.

2.4.3.1

Gene Families

The replication-dependent histone gene clusters showed significant (p<0.01)
increases in methylation following CPD, including Hist1h1e, Hist1h2aa, Hist1h2ak,
Hist1h2ba, Hist1h2be, Hist1h2be, Hist2h2bb, Hist2h3b, Hist2h4, and Hist3h2ba.
Notably, Hist1h2ab showed a significant (p=0.007) 1.2 fold decrease in expression in the
CPD model. Finally, members of the histone gene family typically showed a similar
decrease in expression in all binge exposure paradigms (Kleiber et al. 2013).
Genes from the HoxA, HoxC, and HoxD clusters showed significant (p<0.01)
decreases in methylation. The genes altered by CPD were Hoxa3, Hoxa4, Hoxa6, Hoxa7,
Hoxa13, Hoxc8, Hoxc13, Hoxd1, Hoxd3, Hoxd8, and Hoxd11. These altered Hox genes
have promoters with high CpG content. Hoxc8 showed a significant (p=0.01) 1.2 fold
increase in expression in the CPD model and Hoxd10 showed a significant (p=0.04) 1.3
fold increase in expression in the T1 model (Kleiber et al. 2013). Significant increases in
methylation by PAE were also observed for Rhox2a, Rhox2c, Rhox2e, Rhox2h, Rhox3a,
Rhox3h, Rhox9, Rhox10, and Rhox11. These genes have promoters with low to
intermediate CpG content. Furthermore, Rhox1 showed a significant (p<0.02) 1.2 fold
increase in expression in the CPD model.
In the CPD model, significant (p<0.01) alterations to methylation in both
directions were seen in Adam1a, Adam1b, Adam3, Adam4, Adam10, Adam12, Adam23,
Adam30, Adam32, Adam33, Adamts8, Adamts14, Adamts15, Adamts17, Adamtsl2,
Adamtsl5, and Adamtsl5. Adamts9 showed a significant (p<0.008) 1.2 fold increase in the
CPD model and several miRNAs predicted to target it by IPA were significantly (p<0.05)
down-regulated ~1.2 fold (Appendix A). In the T3 model Adamts9 showed a significant
(p=0.00001) 1.2 fold decrease, while Adam9 showed a 1.1 fold decrease and a miRNA
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(mir-26b) predicted to target it showed a 1.3 fold increase (Kleiber et al. 2013; Kleiber,
Diehl, et al. 2014; Kleiber, Laufer, et al. 2014).
The Keratin associated proteins Krtap4-13, Krtap4-16, Krtap5-1, Krtap5-4,
Krtap8-2, Krtap10-10, Krtap26-1, and Krtap31-2 showed a significant increase in
methylation. Krtap17-1 showed a significant decrease in methylation. Both Krtap10-10
and Krtap31-2 showed a significant (p<0.03) 1.2 fold increase in gene expression in the
CPD model. Promoters for these genes had low to intermediate CpG content. Krtap’s are
clusters of genes unique to mammals that are undergoing rapid evolution and are
expressed during the terminal differentiation of hair cells (Shimomura & Ito 2005; Wu et
al. 2008). Twenty-eight kertain genes, of both the cytoskeletal and cuticular type, showed
significant differential methylation that was typically an increase. Keratinocyte
differentiation-associated protein (Krtdap) also showed a significant increase in
methylation. Furthermore, 64 transmembrane (Tmem) family genes showed significant
(p<0.01) altered methylation in the CPD model. Notably, in the CPD model none of the
genes with altered methylation showed altered expression. However, Tmem19, Tmem60,
Tmem150b, and Tmem235 showed significant (p<0.03) 1.2 fold decreases in expression
while Tmem217 showed a significant (p<0.02) 1.2 fold increase in expression. The
original (2012) target filter analysis also identified two miRNAs with increased
expression that were predicted to target Tmem19 (Appendix A).

2.4.3.2

CTCF Binding Sites

The results included in this chapter suggest that PAE causes significant changes in
DNA methylation in the developing brain that last to adulthood (Figure 2.5). The DMRs
of the original (2012) analysis cover a relatively large number (6610) of gene promoters
(6131 unique) that are related to molecular, functional, and phenotypic abnormalities
implicated in FASD (Table 2.5). The most significant network identified by IPA (score
65) is that of ‘Behavior, Neurological Disease, and Psychological Disorders’, which has a
distinct set of ‘hub genes’. Among the most prominent hub genes affected is App
(amyloid precursor protein), which is a protein that helps direct the migration of neurons
during early development (Priller et al. 2006). These results suggest that the hub genes
identified (Akt1, Ghr, ApoE, Ntrk1) are involved in FASD endophenotypes.
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The results also suggest a gene regulatory mechanism underlies some FASD
endophenotypes. The alterations in promoter methylation might interfere with
transcriptional machinery as demonstrated by the role of differential methylation of H19
(Hark et al. 2000). Notably, altered methylation was seen in the H19 promoter, which is
involved in CTCF binding and imprinting (Figure 2.8A) (Lin et al. 2011). This specific
peak has previously been identified as showing significant differential methylation in
FASD placental tissue (Haycock & Ramsay 2009). CTCF binds to the H19/Igf2 ICR in a
DNA-methylation-sensitive manner, where it acts as insulator activity for the
unmethylated maternal ICR by blocking the Igf2 promoter from engaging enhancers
downstream of H19 that are shared by H19 and Igf2 (Figure 2.8C) (Hark et al. 2000).
The deletion or mutation of the four CTCF-binding sites within the ICR causes a
paternalization of the maternal allele that results in biallelic Igf2 expression and H19
repression (Engel et al. 2006).
In addition to the H19 locus, CTCF binds to DMRs at a number of other imprinted
loci. One of these is the secondary DMR of Gtl2 (Meg3) (Figure 2.7 and Table 2.6),
which also relies on differential methylation at a CTCF-binding site (Nowak et al. 2011)
and showed a significant (p<0.009) 1.2 fold decrease in expression in the T3 injection
paradigm (Kleiber, Laufer, et al. 2014). Given the role of CTCF in imprinted regions
implicated in FASD, other important genes that were affected were examined for CTCF
binding sites in their promoters. From the ‘Behavior, Neurological Disease, and
Psychological Disorders’ network, 30 significantly altered DMRs were examined for
CTCF-binding sites using the CTCFBS prediction tool (Bao et al. 2008). Of these 30
regions, 12 (40%) showed sequences that represented predicted CTCF-binding motifs
(Figure 2.7). Eight of these promoter regions showed increased methylation and four
showed decreased methylation. The results on H19 and App are similar to previous
research (Liu et al. 2009). However, these results show that the changes are present in
adult brain tissue long after PAE. The 12 DMRs with CTCF binding sites were then
subjected to a pathway analysis (Figure 2.9) using GeneMANIA (Warde-Farley et al.
2010), with the results supporting those of IPA. However, it is worth noting that other
methylation-sensitive regulatory proteins are likely to be involved in the altered
transcriptomics resulting from PAE.
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Figure 2.8. The functional potential of altered CTCF-binding-site methylation after PAE in significant (p<0.01) differentially
methylated regions identified by the original (2012) analysis. Increased (A) and decreased (B) methylation after PAE at select gene
promoters (‘P’) with CTCF sites. (C) Schematic of H19/IGF2 imprinting regulation and the effects of PAE. The black rectangle
represents the H19/Igf2 ICR. On the maternal allele, CTCF binds to the ICR and blocks the Igf2 promoter from accessing the 3′ shared
enhancers (E). On the paternal allele, the ICR is methylated and H19 transcription is repressed. White lollipops represent nonmethylated DNA and black lollipops represent methylated DNA.
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Figure 2.9. GeneMANIA network analysis of significant (p<0.01) differentially
methylated genes containing CTCF-binding sites from the top associative network
identified in the original (2012) analysis by Ingenuity Pathway Analysis (“Behavior,
Neurological Disease, and Psychological Disorders”).
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Finally, the updated (2016) analysis identified significant (p<0.005) alterations to
DNA methylation in 4304 gene promoters and/or CpG islands that belonged to 2898
unique annotated genes. The top differentially methylated genes are presented in Table
2.6. The analysis also revealed significant (p<0.002) alterations in methylation to
Snord116 and Ipw, which are ncRNAs within Snrpn-Ube3a. A larger amount of
significant alterations were seen in gene ontologies and canonical pathways. The updated
ontologies and pathways indicate alterations to ion transport across the membrane, cellto-cell adhesion events, proliferation and differentiation (cancers) as well as
developmental, cellular, immune, and synaptic signaling events (Tables 2.7 & 2.8).
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Table 2.6. Updated (2016) analysis of genes in CPD adult brains with the greatest differential DNA methylation (p=0.0001).
PAE Hypermethylated
Score

Symbol

Gene Name

Gene Function

36

Ntm

Neurotrimin

Cell Adhesion and Neuron Recognition

29

Mroh2a

Maestro heat-like repeat-containing protein family member 2A

Unknown

27

Slc22a5

Solute carrier family 22 member 5

Sodium-ion dependent carnitine transporter

27

Arhgap26

Rho GTPase-activating protein 26

Actin cytoskeleton and nervous system development

25

Bcl11b

B-cell lymphoma/leukemia 11B

Tumor-suppressor

24

Syn3

Synapsin-3

Neurotransmission and synaptogenesis

20

Foxp4

Forkhead box protein P4

Transcriptional repressor

18

Pisd-ps

Phosphatidylserine decarboxylase, pseudogene

Unknown pseudogene

17

Gnas

Guanine nucleotide-binding protein G(s) Alpha Subunit

GPCR signal transduction [Imprinted Gene]

17
Meg3
Maternally expressed 3 [Also known as Gtl2]
PAE Hypomethylated

lncRNA [Imprinted: Dlk1-Dio3]

Score

Symbol

Gene Name

Gene Function

-14

Xiap

X-linked inhibitor of apoptosis

E3 ubiquitin protein ligase [Regulated by Akt]

-10

Map2k1

Dual specificity mitogen-activated protein kinase kinase 1

MAPK signal transduction

-10

Pmfbp1

Polyamine-modulated factor 1-binding protein 1

Organization of cytoskeleton

-9

Clcn5

H(+)/Cl(-) exchange transporter 5

Proton-coupled chloride transporter

-9

Mir188

MicroRNA 188

Post-transcriptional regulation

-9

Mir532

MicroRNA 523

Post-transcriptional regulation

-9

Eif3e

Eukaryotic translation initiation factor 3 subunit E

Translational regulation

-9

Izumo4

Izumo sperm-egg fusion protein 4

Reproduction [immunoglobulin superfamily protein]

-9

Mob3a

MOB kinase activator 3A

Metal ion binding

-9

Gldc

Glycine dehydrogenase (decarboxylating), mitochondrial

Glycine degradation
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Table 2.7. Ontologies for the updated (2016) analysis of significant (p<0.005) differential
DNA methylation in CPD mice.
Enrichr GO Biological Processes
Calcium ion transmembrane transport
Inorganic cation transmembrane transport
Response to steroid hormone
Response to mechanical stimulus
Divalent inorganic cation transport
Gland development
Divalent metal ion transport
Cellular response to lipid
Epithelial cell development
Regulation of ion transmembrane transport
Enrichr GO Cellular Location
Cell-cell junction
Postsynaptic membrane
Synaptic membrane
Cell cortex
Integral component of plasma membrane
Contractile fiber part
Lamellipodium
Centrosome
Perinuclear region of cytoplasm
Golgi membrane
Enrichr GO Molecular Function
Channel activity
Passive transmembrane transporter activity
Metal ion transmembrane transporter activity
Substrate-specific channel activity
Inorganic cation transmembrane transporter activity
Divalent inorganic cation transmembrane transporter activity
Calcium ion transmembrane transporter activity
Ion channel activity
Cation channel activity
Calcium channel activity
Gated channel activity
RNA polymerase II regulatory region DNA binding
SH3 domain binding
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Overlap
33/128
82/440
71/369
40/176
50/238
47/220
49/234
61/315
27/107
60/314
Overlap
65/335
42/195
46/228
22/83
162/1066
35/167
25/111
62/360
69/411
54/308
Overlap
85/427
85/427
78/400
79/406
92/497
39/154
34/127
76/396
58/285
28/108
60/323
55/288
28/119

p-value
1.9E-04
2.5E-04
2.9E-04
4.1E-04
4.2E-04
4.5E-04
5.0E-04
6.6E-04
9.2E-04
9.7E-04
p-value
3.6E-04
6.7E-04
1.3E-03
1.4E-03
2.1E-03
2.7E-03
4.7E-03
5.7E-03
6.2E-03
7.0E-03
p-value
3.9E-05
3.9E-05
1.4E-04
1.4E-04
1.9E-04
9.0E-05
1.0E-04
2.7E-04
4.0E-04
6.2E-04
2.2E-03
2.0E-03
2.1E-03

Table 2.8. Pathways for the updated (2016) analysis of significant (p<0.005) differential
DNA methylation in CPD mice.
Partek KEGG Pathways
Overlap p-value
Pathways in cancer
94/234 6.2E-05
Focal adhesion
60/148 1.1E-03
Arrhythmogenic right ventricular cardiomyopathy
26/48
1.5E-03
Melanogenesis
31/70
6.2E-03
Prostate cancer
28/61
6.2E-03
ECM-receptor interaction
27/60
8.7E-03
Renin-angiotensin system
9/11
9.5E-03
Acute myeloid leukemia
19/38
1.2E-02
Calcium signaling pathway
50/136 1.2E-02
TNF signaling pathway
32/78
1.3E-02
Phosphatidylinositol signaling system
25/57
1.4E-02
Glycosphingolipid biosynthesis - globo series
7/8
1.7E-02
Basal cell carcinoma
18/38
2.0E-02
Colorectal cancer
20/44
2.0E-02
HTLV-I infection
69/208 2.2E-02
Regulation of actin cytoskeleton
55/160 2.3E-02
Proteoglycans in cancer
57/167 2.3E-02
Protein digestion and absorption
26/64
2.5E-02
Dilated cardiomyopathy
26/64
2.5E-02
Fc gamma R-mediated phagocytosis
25/61
2.6E-02
Amphetamine addiction
20/47
3.3E-02
Estrogen signaling pathway
27/70
3.6E-02
Adherens junction
22/54
3.7E-02
Endometrial cancer
16/36
4.1E-02
Vasopressin-regulated water reabsorption
14/30
4.1E-02
Hippo signaling pathway
40/115 4.2E-02
Bacterial invasion of epithelial cells
22/55
4.2E-02
Wnt signaling pathway
37/105 4.3E-02
Pertussis
21/52
4.3E-02
Prolactin signaling pathway
21/53
5.0E-02
Osteoclast differentiation
33/93
5.0E-02
Neurotrophin signaling pathway
32/90
5.2E-02
Renal cell carcinoma
19/47
5.3E-02
FoxO signaling pathway
35/101 5.6E-02
Hedgehog signaling pathway
15/35
5.8E-02
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2.5

Discussion
The experimentation in this chapter has resulted in a number of observations

based on three key experiments (Figure 2.1). The first set of experiments are related to
gene (mRNA) expression. PAE, an early life exposure, was associated with long-term
alterations to the adult brain (Figures 2.2 & 2.3 and Table 2.1). Overall, the top upregulated genes were primarily uncharacterized while the top down-regulated reflected a
variety of functions (Table 2.1). The genes with long-term alterations share ontologies
and pathways related to immune processes, synaptic events, nucleotide metabolism,
protein synthesis, ion transport, and the cell membrane (Table 2.2). The observation of
such long-term alterations to gene expression in adult PAE mice raises two questions. The
first question is are they contributing to FASD related behaviours? The results suggest the
possibility that some alterations may be playing an active role, but require gene specific
functional confirmation. The second question is what is initiating and maintaining the
long-term alterations gene expression? To this end, the next two experiments of this
chapter tested the hypothesis that miRNAs and DNA methylation are involved in
maintaining the long-term alterations and may contain a footprint that is informative of
the events initiating these alterations.
In the second set of experiments different ncRNA species were examined. First,
the CPD PAE model was examined for reciprocal alterations to the expression of
miRNAs and predicted target genes (Table 2.4). These results revealed several
interactions and aided in the identification of candidate biomarkers by providing
additional layers of support for their deregulation (Figure 2.4). Second, alterations to
ncRNA in the CPD paradigm, which represents moderate exposure were compared to
ncRNA alterations in binge exposure paradigms that represent different developmental
time points. The results show that PAE by any of the paradigms alters the expression of a
number of ncRNAs in the adult brain (Appendix B). The results also show that long-term
changes in miRNA expression are dependent on the treatment paradigm (Appendix C).
The exception to this pattern is Snord115 (MBII-52) snoRNA expression, which is
affected regardless of the timing of exposure (Appendix D). The connection of the
ncRNA expression to loci of genomic imprinting then raised the question: are alterations
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to methylation responsible for maintaining the long-term alterations to ncRNA and
mRNA expression?
In the third set of experiments, long-term alterations to DNA methylation were
examined. At the general level, the examination revealed a genome-wide scale of change
(Figure 2.5). However, the alterations were non-random. The ontologies (Tables 2.5 &
2.7) and pathways (Figures 2.6 & 2.7 and Table 2.8) altered are related to calcium
signaling, ion transport, stem cell signaling, cell adhesion, synaptic events, immune
processes, and the cell membrane. The alterations were seen in predicted and known
CTCF binding sites (Figure 2.8) including those of H19, which was previously shown to
be deregulated by PAE (Haycock & Ramsay 2009) and provides further evidence for the
sensitivity of genomic imprinting to PAE.
Finally, because gene expression, miRNA expression, and DNA methylation were
all examined in the CPD paradigm, the different datasets were integrated to observe any
biological relationships. Notably, a larger scale of alteration was seen to DNA
methylation as compared to gene and ncRNA expression. Furthermore, few genes and
ncRNAs showing altered expression also showed altered DNA methylation. This lack of
correlation between altered epigenetic marks and transcription has been reported in the
literature (Veazey et al. 2015). The lack of correlation presumably reflects on the
combinatorial nature of the epigenome, where multiple modifications are needed for
effect. Furthermore, the lack of correlation also reflects on the fact that the gene
expression tested is from mice in a resting steady state and that differential expression
could be seen under other activating conditions (Lussier et al. 2015). However, despite
the complexity of the relationship of the epigenome to transcription, three key
observations that warrant further examination for both biomarker and therapeutic
development have emerged. First, are imprinted clusters of ncRNA, second are select
gene clusters, and third is cellular signaling.

2.5.1

Imprinted ncRNA Clusters
Approximately 20% of the miRNAs and some snoRNAs showing differential

expression are encoded by one of three imprinted regions of the mouse genome: SnrpnUbe3a (murine 7qC/human 15q11-q13), Dlk1-Dio3 (murine 12qF1/human 14q32.2), and
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Sfmbt2 (murine 2qA1) regions. Genes within these regions displayed differential
methylation. The Sfmbt2, Snrpn-Ube3a, and Dik1-Dio3 regions are of special interest to
PAE because they are also known to affect a range of endophenotypes seen in FASD.
These include impaired growth, craniofacial abnormalities, and a range of cognitive and
behavioral deficits (May & Gossage 2001). The detailed biological consequences and
evolutionary relationship of these imprinted clusters have been previously reviewed
(Laufer & Singh 2012); however, their connection to FASD endophenotypes is briefly
described below.
Snrpn-Ube3a expresses a neuron-specific polycistronic transcript. The SnrpnUbe3a transcript is processed into two clusters of snoRNAs, H/MBII-52 (Snord115) and
H/MBII-85 (Snord116) (de los Santos et al. 2000; Runte et al. 2001; Le Meur et al. 2005)
that were deregulated by PAE. This transcript also codes for a number of alternative
ncRNA species (Kishore et al. 2010; Bortolin-Cavaille & Cavaille 2012; Falaleeva &
Stamm 2012). For example, a long non-coding RNA (lncRNA) transcribed from SnrpnUbe3a undergoes alternative splicing where the introns are processed into SNORD116
snoRNAs, while the spliced exons form a functional lncRNA (116HG) (Powell, Coulson,
Crary, et al. 2013; Powell, Coulson, Gonzales, et al. 2013). 116HG forms a lncRNA
cloud that modulates genes involved in circadian rhythm and energy expenditure, which
notably includes mTOR, (imprinted) Ifg2r, and Crebbp. Notably, Snord116 and Ipw, both
of which are in the Snrpn-Ube3a locus, showed significant (p<0.002) alterations to
methylation in the updated (2016) analysis.
Furthermore, the array results from this chapter follow those of Liu et al., who
have reported that PAE causes differential methylation at Ube3a, which also has an
antisense transcript (Liu et al. 2009). The Snrpn-Ube3a locus is involved in the classic
sister imprinting disorders Prader-Willi syndrome (OMIM: 176270) and Angelman
syndrome (OMIM: 105830), both of which display developmental delay and deficits in
cognitive function (Knoll et al. 1989; Wagstaff et al. 1992). Interestingly, H/MBII-52
(Snord115) and H/MBII-85 (Snord116), are believed to be key players in these disorders
(Buiting 2010; Bieth et al. 2015). Furthermore, overexpression of Snord115 in a paternal
duplication mouse model results in poor social interaction, behavioral inflexibility,
abnormal ultrasonic vocalizations, and anxiety (Nakatani et al. 2009). SNORD115

77

changes the alternative splicing of the serotonin receptor 5HTR2C (Kishore & Stamm
2006; Glatt-Deeley et al. 2010), which is a G-protein coupled receptor involved in
calcium signaling (Nakatani et al. 2009). Snord115 also regulates the splicing of genes
(Dpm2, Taf1, Ralgps1, Pbrm1, and Crhr1) involved in the cell cycle, chromatin
modification, and development (Kishore et al. 2010). Further investigation has also
revealed that SNORD115 and SNORD116 can regulate a large number of genes, as well
as modify each other’s activity (Falaleeva et al. 2015).
The Dlk1-Dio3 locus expresses over 40 miRNAs contained in two clusters,
including a cluster of snoRNAs that contains Snord113 and Snord114 that were
deregulated by PAE (Appendix E) (Seitz et al. 2004). Notably, Meg3 (also known as
Gtl2) showed significant differences in methylation in both the original (2012) and
updated (2016) analyses (Figure 2.8 & Table 2.6). Altering the dosage of the imprinted
genes at the Dlk1-Dio3 region has also been shown to cause a range of endophenotypes,
from growth deficiencies and developmental defects in the embryo and placenta, to
defects in adult metabolism and brain function (Rocha et al. 2008). Some of the Dlk1Dio3 miRNAs are involved in activity dependent dendritic outgrowth of hippocampal
neurons (Fiore et al. 2009). A rat model has also shown that PAE alters the expression of
Dio3 and antisense Dio3os in the hippocampus, as well as altering related behaviors and
physiology (Sittig et al. 2011; Dietz et al. 2012).
SFMBT2 is a polycomb binding protein that interacts with, or ‘reads’, histones
and transcriptionally represses HOXB13 (Lee et al. 2013). Sfmbt2 contains a rodentspecific large cluster of miRNAs that has led to it becoming genomically imprinted
(Wang et al. 2011). Sfmbt2 showed decreased methylation in the updated (2016) analysis
and its miRNAs were deregulated by PAE (Appendix E). Maternal disomy of the Sfmbt2
region results in fetal and placental growth retardation, whereas paternal disomy was
shown to result in normal fetal growth and placental overgrowth (Kuzmin et al. 2008).
Recently, another moderate and voluntary maternal PAE paradigm was shown to alter
adult levels of a vesicular glutamate transporter in the mouse hippocampus (Zhang et al.
2015). The glutamate transporter showed increased mRNA levels that were correlated
with decreased DNA methylation and increased (activating) H3K4me3 at the transporter
promoter. Notably, while mRNA (Slc17a6) levels of the transporter were increased, the
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protein (VGLUT2) levels were decreased by an imprinted miRNA (miR-467b-5p) from
the Sfmbt2 cluster, which was functionally confirmed to bind to the transporter mRNA.
Both the Snrpn-Ube3a and Dlk1-Dio3 regions undergo allele-specific chromatin
decondensation (or ‘unwinding’) during neuronal maturation (Leung et al. 2009; Leung et
al. 2011). These clusters are also shared between mice and humans and expressed in
embryo, placenta, and in the adult, in which their expression is confined mostly to the
brain (Seitz et al. 2004). The Snrpn-Ube3a and Dlk1-Dio3 regions have also been
associated with several neurodevelopmental disorders (Leung et al. 2009). Furthermore,
all three imprinted ncRNA clusters contain polycistronic transcripts, with some processed
transcripts initially showing similar levels of expression that then change as a result of
unequal stability (Seitz et al. 2004; Le Meur et al. 2005; Fiore et al. 2009; Wang et al.
2011).
The observations suggest that PAE might alter the regulation of not only
individual miRNAs or snoRNAs, but entire clusters of co-regulated ncRNAs. More
importantly, this process could involve differences in DNA methylation as DNA
methylation is a functional mark at imprinting control regions. The nature of imprinted
ncRNAs creates the potential for an environmentally responsive mechanism in the
regulation of neurodevelopmental gene expression. Ultimately, given the observation of
upregulated Snord115 in all four paradigms examined, the confirmation of results across
two independent array technologies, and the similar endophenotypes associated with
alterations to it, Snord115 may serve as an ideal candidate for future functional
experiments investigating PAE. Thus, the above observations suggest that the similarity
and variability in the manifestation of FASD could be in part attributed to the common
(Snord115) and different ncRNAs and genes affected as a result of variability in
exposure.

2.5.2

Gene Families
A number of gene families showed significant differential methylation as well as

expression and may contribute to the endophenotypes of FASD. Some of these results are
also supported by publications from independent groups. In terms of the histone genes,
Hist1h3b also showed altered methylation in a whole embryonic culture of C57BL/6J
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mice at early neurulation (Liu et al. 2009). The observation of altered methylation and
expression observed from this gene family suggests transcriptional repression of histone
protein production and, furthermore, a global deregulation of the cell cycle and epigenetic
landscape that remains long after PAE.
The Hox genes were also deregulated by PAE. In the T2 binge injection model
mir-10b showed a -1.5 fold change (p=0.002) (Mantha et al. 2014). Notably, mir-10 is
located within the Hox genes and also targets some of them (Lund 2010). Hox genes are a
subset of homeobox genes and encode transcription factors that regulate developmental
patterning, including in the brain (MacLean & Wilkinson 2010). The only unifying
feature of all homeobox genes is that they encode a homeodomain, a motif that binds to
specific DNA sequences, proteins, and even some RNAs (Shyu & Wilkinson 2000;
Svingen & Tonissen 2006). Homeobox transcription factors have important roles in
regulating the differentiation of cells during embryonic development by specifying the
spatial positioning of cells and controlling cellular proliferation, apoptosis, cell adhesion,
and cell migration (Pearson et al. 2005). Deregulation in the expression of homeobox
genes can result in drastic alterations in development and subsequently result in profound
changes in the identity of body segments (Duboule 2007; Krumlauf 1994).
At the genomic level, the vertebrate Hox gene clusters show a specific
organization (Duboule 2007). The four Hox clusters of mammals map to distinct
chromosomes, are termed HoxA through HoxD, and contain 9 to 11 protein-coding genes
that are transcribed from the same strand (Yekta et al. 2008). In many vertebrates the Hox
genes are organized on chromosomes in a linear way that matches their expression order
along the anterior-posterior axis. Furthermore, the Hox clusters are targeted by a number
of miRNAs, some of which originate within the Hox clusters and have also been
implicated in FASD (Yekta et al. 2008; Wang et al. 2009). Over 200 ncRNAs arise from
around the Hox clusters, including miRNAs and the long non-coding RNA HOTAIR,
which is transcribed from HoxC and results in repressive H3K27me3 at HoxD by
recruiting polycomb repressive complex 2 (Rinn et al. 2007). The Rhox gene family is a
set of homeobox genes clustered on the X chromosome (MacLean et al. 2005). The
mouse Rhox gene cluster is the largest homeobox gene cluster. Similar to most homeobox
genes, Rhox genes are expressed during embryonic development (MacLean et al. 2005;
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Hogeveen & Sassone-Corsi 2005; Zhan et al. 2005; Daggag et al. 2008). However, unlike
most homeobox genes, Rhox genes also show high gene expression levels after birth
(MacLean et al. 2005). Thus, Rhox genes are candidates to control postnatal and adult
developmental events, particularly those essential for male and female reproduction.
Rhox5 is the most characterized Rhox gene and is regulated by many different stimuli,
including differentiation signals, oncogenic signals, and hormones (Kobayashi et al.
2006). Recently, Rhox5 was demonstrated to be regulated by histone H1 and DNA
methylation (Maclean et al. 2011). Furthermore, alcohol dehydrogenase is critical for
converting retinol to retinaldehyde, which is competitively inhibited by ethanol, and then
later converted to the signaling molecule retinoic acid (Mezey & Holt 1971). As a
developmental signaling molecule in mammals, retinoic acid is used to activate the 3’
Hox genes (Duester 2008). Thus, the Hox genes appear to represent a connection between
acute alterations to developmental signaling and long-term alterations to the epigenome.
Deregulation of the keratin-associated protein (Krtap) gene family was also
observed. These results are similar to Marjonen et al., where a similar mouse model was
used and a significant (p=0.04) 2.1 fold increase in the expression of Krtap6-1 and a
significant (p=0.004) 1.7 fold decrease in the expression of Krtap27-1 was observed
(Marjonen et al. 2015). Notably, keratinocytes constitute the vast majority of the
epidermis (McGrath et al. 2004). It is tempting to speculate that these alterations in the
adult brain may reflect on earlier alterations to developmental stem cell identity during
neurulation where neural progenitor cells and the epithelium/epidermis begin to
differentiate from each other. This observation may also alternatively or additionally
reflect on the possibly of a premature exit from the cell cycle.
Adam (a disintegrin and metalloproteinase) and Adamts genes were also
deregulated by PAE. These peptidase gene families are involved in cleaving the extracellular portions of trans-membrane proteins and stimulate neural crest migration
(Prendergast et al. 2012; Kulesa & McLennan 2015). They have a role in cell adhesion
and cell signaling as they are used to cleave and thus regulate cell surface molecules, such
as Cadherin, Ephrin, EGF, TNF-α, and Notch (Reiss et al. 2005; Alfandari et al. 2009).
ADAM10 also processes APP, which is involved in Alzheimer’s disease (Haass et al.
2012). Furthermore, Adam13 has been shown to be required for 3 dimensional cranial
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neural crest cell migration and interact with Cadherin11 (Cousin et al. 2012). Finally,
another transmembrane protein family is the Tmem gene family, which is relatively
uncharacterized and be may representative alterations to cellular signaling.

2.5.3

Alterations to Cellular Signaling Genes
The most significantly altered (p=9.01E–7) canonical pathway identified by the

2012 analysis was Cdk5 signaling, where 60% of the genes involved showed significant
differential methylation (Figure 2.6). Cdk5 signaling is a sensory pathway that is
restricted to the nervous systems and plays a critical role in neuronal migration, neuronal
differentiation, neurite outgrowth, synaptic vesicle exocytosis and neurotransmission,
long-term potentiation, as well as the proteasome, autophagy, and apoptosis (Cheung &
Ip 2012). Notably, Cdk5 signaling has been implicated in neurodegenerative diseases and
circadian rhythm (Cheung & Ip 2012; Kwak et al. 2013).
Additionally, 57% of the genes involved in the Pten signaling pathway showed
significant (p=1.9E–06) differential methylation (Figure 2.7). Pten, was upregulated
(1.38-fold change and p=2.5E–03) and the three miRNAs (mir-369-5p, mir-25 and mir495) that were predicted to target it by IPA were downregulated, with mir-369-5p
belonging to the Dlk1-Dio3 cluster (Appendix A). This signaling pathway was also
identified in the updated (2016) analysis as the phosphatidylinositol signaling system
(Table 2.8). PTEN functions as a lipid phosphatase that counteracts the kinase function of
phosphatidylinositol-3-kinase (PI3K) and suppresses AKT activation (Maehama & Dixon
1998). Akt, which showed a gain of methylation at a predicted CTCF binding-site (Figure
2.8A), is a major mediator of signaling pathways in response to a large spectrum of
extracellular stimuli, which include PAE (Hard et al. 2005). Upon its activation in
neurons, AKT phosphorylates different substrates, which in turn regulate diverse
processes of neuronal development, including morphogenesis, dendritic development,
synapse formation and synaptic plasticity, all of which are altered in FASD (Yoshimura et
al. 2006). Furthermore, AKT is known to regulate autophagy/lysosome and
ubiquitination/proteasome systems, which recycle damaged proteins (Wang et al. 2012;
Xu et al. 2015). AKT has been shown to phosphorylate the GABAA receptor, which
increases the number of receptors on the plasma membrane surface, and thus promotes
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synaptic plasticity (Wang et al. 2003). Studies in mice with a targeted inactivation of Pten
in differentiated neurons showed abnormal social interaction and exaggerated responses
to sensory stimuli (Kwon et al. 2006). Given the integral role of Pten in
neurodevelopment, it is no surprise that it has been implicated in the developmental basis
of many major psychiatric disorders (Kim et al. 2009) and FASD (Green et al. 2007).
Overall, the alterations to all of the above clusters and signaling pathways suggests that
there may be a molecular footprint of alterations to developmentally important regions
that is sometimes but not always reflected in adult gene expression.

2.5.4

Considerations for Future Research
The research presented in this chapter highlights a number of considerations for

future experimentation. The first consideration is the confirmation of alterations to gene
expression. Although qPCR is the gold standard for confirmation, the technology used at
the time of experimentation contained a limitation related to experiments of this nature.
Specifically, it may not be sensitive enough to consistently detect low, but statistically
significant, fold changes (<2.0) (Peirson & Butler 2007; Vikalo et al. 2010) that are
typical of the fine-tuning nature of miRNAs (Moazed 2009). The results presented in this
chapter are similar to Marjonen et al., where a voluntary maternal consumption PAE
paradigm revealed alterations to similar gene families. They noted that, “The expression
levels of the differentially expressed genes observed in hippocampus were low and
impossible to verify by quantitative PCR (TaqMan)” (Marjonen et al. 2015). More
recently, the Singh lab has shown that digital droplet PCR (ddPCR), which is a more
sensitive technology capable of detecting low fold changes and low copy numbers, can be
used to confirm changes not found to be significant by standard qPCR (Chater-Diehl et al.
2016). Therefore, future PAE experimentation would benefit from utilizing ddPCR as a
method for confirming some alterations to gene expression.
The second consideration for future research is cell type heterogeneity. In this
chapter whole brain homogenate, which contains a number of cell types including
neurons and glia, was examined. Therefore, the observed differential gene and ncRNA
expression as well as DMRs may represent a combined epigenomic signature of depleted
vulnerable cell types as well as specific alterations to the epigenome of surviving cells
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(Kleiber, Diehl, et al. 2014). Future experimentation would benefit from single-cell
sorting techniques. The third technical consideration for future research is the functional
confirmation of predicted miRNA and target mRNA binding. This could be accomplished
by in vitro luciferase reporter assays (Zhang et al. 2015). The fourth technical
consideration is the utility of updating previous bioinformatic analyses. Bioinformatics is
a rapidly advancing field and over relatively short periods of time a number of new
annotations, algorithms, and software packages become available. Updated or new
bioinformatic methods can offer additional insight into previous analyses and allow for a
more direct comparison to more recent experiments utilizing the newer methods.
However, as the results of this research suggest, a newer analysis does not necessarily
invalidate a previous analysis as each bioinformatic method may be better suited for a
specific application. Ultimately, with all of the above considerations in mind, there are a
number of conclusions that can be drawn from the results of this chapter.

2.5.5

Conclusion
The results of this research demonstrate in vivo, long-term, and epigenome-wide

alterations in PAE mice. Furthermore, the changes in DNA methylation and ncRNAs may
maintain long-term alterations to gene expression following PAE, as the epigenomic
changes appear to begin at the time of PAE, where they may then be inherited through
successive cell proliferation and differentiation. Thus, the mouse model results presented
in this chapter offer the hypothesis that an ontogenetic ‘footprint’ of PAE exists long after
exposure (Kleiber et al. 2012) and provides novel evidence that was used to expand it into
the epigenetic landscape (Kleiber, Diehl, et al. 2014; Chater-Diehl et al. 2016). The
alterations in the epigenome and transcriptome are hypothesized to have arisen in
developmentally and/or functionally similar genes in early stem cells (Kleiber, Diehl, et
al. 2014; Marjonen et al. 2015). Finally, this footprint may undergo additional
modification throughout development and by other environmental exposures.
Ultimately, the results of this research provide a number of candidate genes and
pathways for future functional genomics studies and also provide a foundation for human
studies. Perhaps more importantly, the epigenomic hypothesis of FASD as proposed may
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be applied towards understanding the effect of neurodevelopmental exposures, which
includes insight into neurodevelopmental disorders.
Footnote
A modified version of this chapter has been published (Laufer et al. 2013).
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Chapter 3
Exploration of Differential DNA Methylation in
Children with FASD
3.1. Overview
The results included in chapter 2 show that prenatal alcohol exposure (PAE) in
mice involves changes to the DNA methylation of genes implicated in the manifestation
of a number of endophenotypes related to fetal alcohol spectrum disorders (FASD). The
results suggest that the differential DNA methylation in mice is caused by PAE.
Furthermore, the alterations to DNA methylation may maintain changes to gene
expression, which are present at adulthood and may result in the lifelong manifestation of
some FASD endophenotypes. The experiments included in this chapter examine young
children with a diagnosis of FASD whose mothers consumed alcohol during pregnancy.
The human experiments had a restriction in that post-mortem brains were not available.
Therefore, buccal swabs were utilized as they can be obtained non-invasively from
individuals of any age and buccal epithelial cells represent the closest peripheral lineage
related to cells incorporated in the brain.
This chapter analyzes data from human samples and characterizes the altered
genome-wide CpG methylation profile in buccal swabs from children with FASD as
compared to age, sex, and genetic background matched controls. Most, but not all, of
these results are published in Laufer et al. (2015). The results have revealed a set of
candidate genes and pathways that are altered by PAE in children with FASD. Select
CpGs from the methylomic profile of the discovery cohort (nFASD=5, ncontrol=6) were
further examined in a larger number of children. The results show heterogeneity that is
patient specific. As it stands, no single gene is consistently affected in all patients.
However, the results do suggest that, as in mice, children with FASD show non-random
changes in DNA methylation as compared to matched controls.
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3.2.

Introduction
The mechanisms of how PAE results in life-long FASD remains a major concern

in the medical community. The cause of FASD, PAE, is known (Williams et al. 2015)
and theoretically 100% preventable, yet the impact on society remains substantial.
Current preventive and ameliorative strategies are complex and ineffective. The best
strategy available is an early diagnosis that enables early therapeutic intervention (Paley
& O’Connor 2009; Chokroborty-Hoque et al. 2014). A reliable method for early
diagnosis of FASD is not yet available and will require understanding the underlying
long-term molecular mechanisms. For a variety of reasons, the best insight into FASD has
come from studies of animal models. Molecular results from rodent models of PAE have
suggested that epigenetic alterations underlie FASD (Kleiber et al. 2014) and have been
reproduced in a number of laboratories (Marjonen et al. 2015; Basavarajappa & Subbanna
2016). Unlike mouse model research, reports on the epigenetic profiles of humans with
FASD are rather limited.
In 2009, Ouko et al. examined the sperm of alcohol consuming adult men and
found hypomethylation at the two imprinted regions; H19 and DLK1-DIO3 (Ouko et al.
2009). In 2010, Krishnamoorthy et al. examined human embryonic stem cells and
observed that exposure to low amounts of alcohol altered a nicotinic acetylcholine
receptor subunit (CHRNA5), which is linked to the altered expression of GABA and
Glutamate (NMDA) receptors (Krishnamoorthy et al. 2010). In 2011, Taléns-Visconti et
al. examined neural differentiation in neuroepithelial progenitor cells, which were
induced from human embryonic stem cells (hESCs), and observed that alcohol alters the
survival, differentiation into neurons and glia, and expression of select genes related to
these processes (Talens-Visconti et al. 2011).
More recently, Khalid et al. examined the transcriptome and methylome of hESCs
exposed to alcohol (Khalid et al. 2014). They observed that the expression of genes
related to metabolic processes, oxidative stress, and neuronal properties of stem cells
were altered. The group also examined differential methylation and observed that
undifferentiated cells appear to be more vulnerable to alcohol than their differentiated
counterparts, the alterations are wide-spread with distinct regions of hypermethylation,
and that not all altered methylation corresponds to altered transcription. The top genes
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showing altered methylation were involved in neuroactive ligand–receptor interaction,
vascular smooth muscle contraction, calcium signaling pathways, and energy metabolism.
Additionally, Halder et al. and Mandal et al. examined the effect of alcohol on human
embryonic carcinoma cells that were induced to undergo neural differentiation (Halder et
al. 2015; Mandal et al. 2016). They observed alterations in pathways related to
neurodevelopment, cell-signaling (including PI3K/AKT/mTOR), and cell-adhesion.
At the time of this research, two other research groups had published in vivo
examinations of the association between FASD and DNA methylation at select loci in
humans. Lee et al. examined a Korean cohort of families, where it was found that there
are changes in the unsorted peripheral blood of parents and also the cord blood of FASD
children (Lee et al. 2015). There was a significant reduction of methylation to the
promoter of a dopamine transporter (SLC6A3) in heavy alcohol consuming fathers and
their offspring. The SLC6A3 promoter also showed a significant decrease of promoter
methylation in mothers who consumed both moderate and heavy amounts of alcohol. The
methylation of a serotonin transporter (SLC6A4) promoter was significantly decreased in
children from both heavy and moderate alcohol consuming mothers. Methyl CpG binding
protein 2 (MECP2) showed increased promoter methylation in the offspring of mothers
with moderate alcohol consumption. The other human report is by Masemola et al., who
examined saliva in a South-African cohort (Masemola et al. 2015). There is elegance to
the examination of saliva (buccal epithelial cells) in that the cells share an ontogenetic
relationship to neuronal cell types via the ectoderm. The aforementioned study only
focused on confirmed cases of FAS, and did not examine FASD, and the differential
methylation examined was limited to few selected imprinting control regions (ICRs).
Most of the pyrosequenced regions weren’t informative but there were significant
decreases of methylation in maternal ICRs. KvDMR1 showed a 7.09% decrease in
methylation and PEG3 showed a 1.49% decrease.
Taken together, the examinations into human cells shows similarities in alcohol
response to the mouse model presented in chapter 2. Also, at the time of this research, no
published study on humans had attempted genome-wide DNA methylation scans of
patients born with FASD. In this chapter, I will describe the results of experiments on
cheek swab DNA methylation from young children diagnosed with FASD as compared to
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unaffected (age, sex, and race) matched controls. The results are informative and argue
that the effects of PAE on DNA methylation are similar but not identical between the
mouse model and human patients. The results suggest that the mouse model used to study
the molecular underpinning of PAE is valid. They also show that the analysis of a single
gene cannot be used to identify FASD, which demonstrates the heterogeneity of this
complex disorder.

3.3. Materials & Methods
The results are primarily based on two cohorts [discovery (nFASD=5, ncontrol=6) and
replication (nFASD=6, ncontrol=6)] of young children clinically diagnosed with FASD by Dr.
J. Kapalanga in Ontario, Canada. All subjects of the discovery cohort had most features
of FASD and matched controls showed no sign of the disorders (Table 3.1A). The
patients were recruited from the same clinic while visiting for annual check-ups or
relatively minor non-neurodevelopmental or behavioural problems, which may include
asthma, allergies, musculoskeletal problems, or gastrointestinal problems. Following
ethical approval and informed consent from parents or guardians, the study subjects
contributed cheek swabs for analysis of buccal epithelial DNA. A second cohort of FASD
patients (replication cohort) was comprised of a different set of 6 children with FASD and
unaffected controls. Although four (E8, E13, E18, E19) of the six patients of the
replication cohort were 6 -10 year-old males and not on medication, two were older 7 and
9 year-old females (E7 and E17) and on psychotropic/stimulant medication (Table 3.1B).
Finally, a third cohort representative of the general population, and consisting in part of
the first two cohorts, from Owen Sound, Ontario was also examined (Appendix G). This
cohort primarily consisted of FASD patients that were much more heterogeneous. The
FASD patients and matched controls in the general population cohort were much more
variable in terms of age, sex ratio, ancestry, family history of mental illness, as well as
other medical conditions and required medication.
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Table 3.1. Clinical features of patients from the discovery (A) and replication (B) cohorts
with the diagnosis of FASD.
A

Discovery Cohort
Patient ID
Patient (Age) and Sex
Clinical Features
Developmental delay
Hyperactivity, poor impulse control
Learning disorders
Short attention span and inattention
Conduct disorder
Oppositional defiant disorder
Social difficulties
Nervousness and anxiety
Mood disorder
Macrocephaly/macrotia
Microcephaly/microtia
Distinctive facial features
Stimulant/Psychotrophic Meds

B

Replication Cohort
Patient ID
Patient (Age) and Sex
Clinical Features
Developmental delay
Hyperactivity, poor impulse control
Learning disorders
Short attention span and inattention
Conduct disorder
Oppositional defiant disorder
Social difficulties
Nervousness and anxiety
Mood disorder
Macrocephaly/macrotia
Microcephaly/microtia
Distinctive facial features
Stimulant/Psychotrophic Meds

E1
(6)
M

E2
(6)
M

E3
(5)
M

E4
(4)
M

E5
(3)
M

E6
(3)
M

x
x
x
x
x
x
x

x
x
x
x
x

x
x
x

x
x

x
x

x
x

x
x

x

x

x

x

x

x
x
x
x

x
x
x

No

x
x
No

x
x
No

x
No

E8
(6)
M

E13
(6)
M

E17
(9)
F

E18
(6)
M

E19
(10)
M

x
x

x
x
x
x
x
x
x
x
x

x
x
x
x
x

x
x
x
x
x

x
No

No

E7
(7)
F
x
x
x
x
x
x
x
x

x
x
x
x
x

x
x
x
x

x

x
x

Yes

x
x
No

x
x
Yes
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No

x
No

No

3.3.1.

Methylation Array
The Illumina HumanMethylation450 BeadChip (450K array) is a dual channel

SNP genotyping microarray that utilizes sodium bisulfite conversion and a targeted array
approach to examine DNA methylation. During sodium bisulfite treatment, cytosine is
converted by deamination to uracil, whereas 5-methylcytosine (5mC) is protected from
the conversion. During PCR amplification, uracil is paired with adenine and that adenine
is later paired thymine. Thus, bisulfite conversion creates a single nucleotide variant that
converts cytosine to thymine, whereas 5mC is detected as a cytosine. The 450K array
interrogates 485,764 sites at single nucleotide resolution across 99% of RefSeq genes
(Bibikova et al. 2011; Sandoval et al. 2011). There is an average of 17 CpG sites per a
gene that represent the promoter, 5’ UTR, first exon, gene body, and 3’ UTR. The 450K
array covers 96% of CpG islands and other features, as well as sites based on genomewide association studies (GWAS). Methylation levels, known as β-values, are determined
by comparing the ratio of C to T at the CpG site.
In order to analyze their DNA methylation, individual cheek swabs from FASD
and matched control children were used to isolate genomic DNA using the QIAamp DNA
Mini Kit following manufacturer’s protocol. This DNA was subject to sodium bisulfite
modification at The Centre for Applied Genomics (Toronto, Canada). The genome-wide
CpG methylation for each subject was assessed using the 450K array, following the
manufacturer’s protocol. The arrays were scanned using Illumina’s GenomeStudio at The
Centre for Applied Genomics (Toronto) that generated scan data (.idat files) for each
subject used in this analysis.
The .idat files were analyzed using Partek Genomics Suite® Version 6.6. A site
based DNA methylation workflow for Illumina BeadArray Methylation was utilized. Preprocessing using both control normalization and background subtraction was performed
using Illumina’s algorithm to generate β-values. β-values were then normalized,
converted to a fold-change and subjected to a one-way ANOVA analysis to identify
regions of differential methylation using annotations from Hg18. Custom genome dot
plots (also known as Manhattan plots) were generated from the ANOVA results.
Different stringencies of genes list were used for hierarchical clustering (p<0.005), gene
ontology (p<0.005) analysis using Enrichr (Chen et al. 2013), and bioinformatic pathway
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analysis via Partek Pathways (p<0.05). Additional annotations were added to top CpGs
using Ensembl (Flicek et al. 2014) (for novel ncRNAs) and Uniprot (UniProt-Consortium
2014) (for protein function and localization). The subset-quantile within array
normalization (SWAN) algorithm (Maksimovic et al. 2012; Fortin et al. 2014) from the
minifi bioconductor package was used within Partek to allow for the multi-batch analysis
(Pidsley et al. 2013).

3.3.2.

Pyrosequencing
Pyrosequencing® is a sequencing by synthesis method (Tost & Gut 2007; Nyrén

2007). When a deoxyribonucleoside triphosphate (dNTP) is incorporated a pyrophosphate
is released. The pyrophosphate is converted to ATP and used by luciferase to produce
light. The nucleotides are added a single base a time, and degraded by apyrase in-between
steps. Pyrosequencing enables absolute quantification of methylation levels without
depending on normalization to matched controls, and thus is ideal for obtaining
methylation in individual cases. While the gold standard for DNA methylation,
pyrosequencing is relatively limited by short reads and a high use of resources.
In order to confirm the results of the 450K array, the same bisulfite converted
buccal swab DNA from the discovery cohort array was pyrosequenced by EpigenDx on
the PSQ96 HS System (Qiagen) following the manufacturer’s instructions, using custom
assays (www.EpigenDx.com), and a gradient of controls with known methylation levels.
This allowed for the quantification of the absolute percent methylation of each CpG using
QCpG software (Qiagen) (Lim et al. 2014). The sequencing reads also allowed for the
analysis of SNPs known to be within or close to the CpGs of the 450K probes.
For the follow-up into the general population cohort, assays were developed based
on performance from the DNA methylation arrays, primarily from the discovery cohort.
A number of genes affected in arrays were examined by pyrosequencing. The gene
COLEC11 was selected based on results on the 450K arrays and the NGS panel.
PCDBH18 was selected based on performance on the human arrays and the results in the
trimester 3 binge exposure mouse model. HTT was selected due to performance on
previous DNA methylation arrays and pyrosequencing. Furthermore, a number of CpG
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sites located at 12q24.31, 10q26.12, and 2q22.1 were selected based on performance from
the NGS panel.

3.3.3.

NGS Panel
The Ion Torrent Personal Genome Machine (PGM)TM is a next-generation

sequencing (NGS) system that utilizes sequencing by synthesis and detects the release of
hydrogen ions from dNTPs during polymerization (Merriman et al. 2012). dNTPs are
added one at a time and the released hydrogen ion is detected by an ion sensor. While the
Ion Torrent PGM is less accurate than pyrosequencing, it is more resource effective and
thus can be used to create custom targeted bisulfite sequencing panels to screen a large
number of loci across relatively few samples. Therefore, a subset of the 268 CpGs
identified on the arrays were selected for further development on a next generation
sequencing (NGS) panel using the Ion Torrent PGM. Thirty of the top performing CpGs
from the 450K array were selected as loci for primer design based on the criteria of a
greater than 1.5 fold change and a preference against a large number of flanking CpGs.
Thirty gene and intragenic sequences +/- 5000 bases were acquired from the Ensembl
database or UCSC database. Target regions of each gene were selected based on the
methylation array results. The panel design, bisulfite conversion, sequencing, and
calculation of methylation values was performed by EpigenDx (Hopkinton, MA).
500 ng human genomic DNA was bisulfite treated using the EZ DNA Methylation
Kit (Zymo Research). Multiplex PCR was performed using 0.5 units of TaKaRa EpiTaq
HS (Takara Bio) in 2x master mix including primers (EpigenDx) in a 20 µl reaction. The
PCRs were performed using the following protocol: 95ºC 15 min; (95ºC 30s; 63ºC (or 56
ºC) 30 s, -1°C; 68ºC 30 s) 9x cycles; (95ºC 30s; 55ºC (or 50ºC) 30 s; 68ºC 30 s) 36x
cycles; 68ºC 5 min; 4ºC hold. Libraries were prepared using the KAPA Library
Preparation Kit (Cat# KK8310) for Ion Torrent and were quantified by real-time PCR
using KAPA Library Quantification (KAPA Biosystems). 344 million library molecules
were templated using the Ion PGM Template OT2 200 kit and sequenced using an Ion
PGM™ Sequencing 200 Kit v2 kit with Ion 316™ and Ion 318™ Chips (Life
Technologies) on the Ion Torrent PGM. FASTQ files from the Ion Torrent PGM were
aligned to the local database using open source Bismark Bisulfite Read Mapper with the
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Bowtie2 alignment algorithm. Methylation levels were calculated in Bismark by dividing
the number of methylated reads by the number of total reads, considering all CpG sites
covered by a minimum of 30 total reads.
The results presented include a total of 31 target PCRs designed by PyroMark
Assay Design Software (Qiagen, Pyrosequencing) for the assessment of the human
samples. During design and optimization 23 loci passed quality control for assay design,
leaving a total of 67 CpGs for analysis from the Buccal swabs of children. The CpG
methylation level was then analyzed using a one-way ANOVA.

3.4. Results
The results suggest that FASD is associated with a profile of differential DNA
methylation in buccal swabs. Using a stringent but not false discovery rate (FDR)
corrected CpG list (p<0.005), genome-wide differential methylation of children with
FASD was analyzed in the: (A) discovery cohort and (B) replication cohort (Figure 3.1).
In each case, the heatmaps show that children diagnosed with FASD clearly group
together and are distinct from matched non-FASD controls. From theses arrays a one-way
ANOVA was created to generate a list of CpGs and corresponding genes that showed
significant differential methylation between FASD children and matched controls (after
pre-processing and data normalization). The results of the discovery and replication
cohorts were analyzed separately in order to avoid any batch effects. This analysis of the
discovery cohort that represented established maternal drinking and relatively uniform
manifestation of FASD (developmental delays, hyperactivity/poor impulse control, and
mental deficits) identified 268 significantly (p<0.005) differentially methylated CpG sites
(Appendix H). Also notable is the differential methylation of genes that modify the
epigenome, such as EHMT2 (p=0.0002), PRDM6 (p=0.004), and HDCA4 (p=0.004).
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Figure 3.1. Differential DNA methylation in children diagnosed with FASD: A) Heatmap
of significantly (p<0.005) differentially methylated targeted CpG sites generated using
hierarchical clustering of standardized β-values from buccal epithelial DNA obtained via
swabs from FASD (n=6) and matched control (n=5) children from the discovery cohort;
B) Heatmap of significantly (p<0.005) differentially methylated targeted CpG sites
generated using hierarchical clustering of standardized β-values from buccal epithelial
DNA obtained via swab from FASD (n=6) and matched control (n=6) children from the
replication sample.
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3.4.1.

Gene Network and Ontologies Associated with FASD
Figure 3.2 shows the GeneMANIA network generated from the genes regulated

by the 268 CpG sites that showed significantly (p<0.005) altered methylation in the
discovery cohort. Among other genes it identified 11 sites that regulate the clustered
protocadherins genes located on 5q31 (Figure 3.3).
Next, the differentially methylated genes from the discovery cohort were used in
an analysis towards identification of specific biological processes, functions, and
pathways affected as a result of changes in methylation. The results (Table 3.2) show that
the major biological processes affected include cell adhesion and nervous system
development. There are alterations to relevant molecular functions including calcium ion
binding and channel activity. The genes code for proteins localized to synaptic vesicles
and the cytoskeleton. Notably, alterations to similar ontologies were observed in the gene
expression data from the mouse model binge injection paradigms (Kleiber et al. 2013).
There were also similar alterations to DNA methylation observed in the continuous
preference drinking (CPD) paradigm presented in chapter 2 and those results are
compared in chapter 4.
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Figure 3.2. GeneMANIA associative network analysis of genes annotated to
differentially methylated CpGs (p<0.005) from cheek swabs of the discovery cohort.

109

Figure 3.3. Manhattan plot of human chromosome 5 from the discovery cohort. Genomic location is plotted on the x-axis and –log10
(p-value) of differential CpG methylation from FAE is on the y-axis (Manhattan plot). Each dot represents a single CpG site. A red dot
indicates an increase in methylation and a blue dot indicates a decrease in methylation. A black arrow indicates the clustered
protocadherin locus.
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Table 3.2. Ontologies for genes with significant (p<0.005) differences in CpG
methylation from the discovery cohort.
Enrichr GO Biological Processes

Overlap

p-value

Homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156)

25/142

5.9E-24

Cell-cell adhesion (GO:0098609)

26/191

2.5E-22

Cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742)

26/190

2.2E-22

Nervous system development (GO:0007399)

12/277

1.0E-05

Replacement ossification (GO:0036075)

4/30

2.3E-04

Endochondral ossification (GO:0001958)

4/30

2.3E-04

Ossification (GO:0001503)

7/116

1.1E-04

Osteoblast development (GO:0002076)

3/19

9.4E-04

Vesicle localization (GO:0051648)
Calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules
(GO:0016339)

4/51

1.4E-03

3/28

2.6E-03

Overlap

p-value

Cytoplasmic vesicle membrane (GO:0030659)

8/229

7.2E-04

Cytoplasmic vesicle part (GO:0044433)

10/363

9.4E-04

Vesicle membrane (GO:0012506)

8/249

1.2E-03

Actin cytoskeleton (GO:0015629)

6/193

5.8E-03

Z disc (GO:0030018)

4/87

6.5E-03

Actin filament (GO:0005884)

3/44

6.6E-03

Voltage-gated sodium channel complex (GO:0001518)

2/15

8.3E-03

Sodium channel complex (GO:0034706)

2/18

1.1E-02

Synaptic vesicle membrane (GO:0030672)

2/22

1.6E-02

Integral component of plasma membrane (GO:0005887)

15/1066

2.9E-02

Enrichr GO Molecular Function

Overlap

p-value

Calcium ion binding (GO:0005509)

34/698

3.3E-15

Solute:proton antiporter activity (GO:0015299)

3/17

8.4E-04

Ion channel binding (GO:0044325)

5/80

1.3E-03

Solute:cation antiporter activity (GO:0015298)

3/28

3.1E-03

Monovalent cation:proton antiporter activity (GO:0005451)

2/10

5.5E-03

3',5'-cyclic-GMP phosphodiesterase activity (GO:0047555)

2/11

6.5E-03

Sodium ion transmembrane transporter activity (GO:0015081)

5/128

8.6E-03

Ligand-dependent nuclear receptor transcription coactivator activity (GO:0030374)

3/46

1.1E-02

Activating transcription factor binding (GO:0033613)

3/53

1.6E-02

Fibroblast growth factor binding (GO:0017134)

2/20

1.8E-02

Monovalent inorganic cation transmembrane transporter activity (GO:0015077)

8/343

1.8E-02

Voltage-gated sodium channel activity (GO:0005248)

2/22

2.0E-02

Cation:cation antiporter activity (GO:0015491)

2/22

2.1E-02

Enrichr GO Cellular Location
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3.4.2. The Top Canonical Pathways are Related to
Neurodevelopment and Neurotransmission
The top canonical pathways (Table 3.3) of the significantly (p<0.05) altered CpGs
identified are largely related to neurodevelopment as they are involved in stem cell
signaling, synaptic connections, metabolism, and immune processes. Hippo signaling
(Figure 3.4) had 25 out of 120 genes affected, which was the most significant enrichment
(p=0.0002) in the pathway analysis. The glutamatergic synapse pathway (Figure 3.5) was
the top synaptic pathway and showed a significant (p=0.001) enrichment with 18 out of
77 genes showing significant (less stringent list, p<0.05) alterations to CpG methylation.
Furthermore, there was a significant (p=0.005) alteration to the calcium signaling
pathway (Figure 3.6) with 23 out of 102 genes affected. Notably, a number of synaptic
pathways were enriched. The retrograde endocannabinoid signaling pathway (Figure 3.7)
was significantly (p=0.006) altered with 16 out of 60 genes affected and the serotonergic
synapse pathway (Figure 3.8) was significantly (p=0.009) altered with 16 out of 63 genes
affected.
The pathways presented in detail were selected due to their similarities to results
from the mouse model (chapter 2). Also notable is the overlap of the human methylation
results with alterations to gene expression observed in the mouse binge injection
paradigms (Kleiber et al. 2013). In the trimester 1 exposure paradigm calcium signaling
was altered. In the trimester 2 exposure paradigm serotonin receptor signaling was
altered. In the trimester 3 exposure paradigm glutamate receptor signaling, retinoic acidmediated apoptosis, and circadian rhythm signaling were altered. Finally, a role for
retrograde endocannabinoid signaling was also seen in the trimester 3 exposure model,
where a miRNA and target receptor were reciprocally deregulated (Stringer et al. 2013).
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Table 3.3. Pathway analysis for genes with significant (p<0.05) differences in CpG
methylation from the discovery cohort.
Partek KEGG Pathways

Overlap
25/85
Hippo signaling pathway
8/10
Other types of O-glycan biosynthesis
23/85
Phagosome
18/59
Glutamatergic synapse
33/152
HTLV-I infection
23/99
Calcium signaling pathway
16/60
Retrograde endocannabinoid signaling
10/29
Viral myocarditis
23/104
Viral carcinogenesis
16/63
Serotonergic synapse
17/71
Axon guidance
8/22
Allograft rejection
18/78
Cell adhesion molecules (CAMs)
23/109
Endocytosis
9/28
Lysine degradation
8/23
Graft-versus-host disease
10/34
Basal cell carcinoma
8/24
Type I diabetes mellitus
7/20
Fatty acid metabolism
13/53
Circadian entrainment
8/27
Autoimmune thyroid disease
8/28
Long-term depression
21/109
Focal adhesion
11/46
ECM-receptor interaction
5/14
Dorso-ventral axis formation
14/68
Cholinergic synapse
10/44
Apoptosis
9/38
Arrhythmogenic right ventricular cardiomyopathy (ARVC)
16/83
Wnt signaling pathway
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p-value
2.0E-04
2.9E-04
9.7E-04
1.1E-03
2.3E-03
5.1E-03
6.2E-03
7.0E-03
8.4E-03
9.2E-03
1.2E-02
1.2E-02
1.3E-02
1.3E-02
1.5E-02
1.5E-02
1.7E-02
1.8E-02
2.1E-02
2.2E-02
3.0E-02
3.5E-02
3.8E-02
3.9E-02
4.7E-02
5.5E-02
6.1E-02
6.1E-02
6.4E-02

HIPPO SIGNALING
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Figure 3.4. Genes in the hippo signaling pathway affected by altered CpG methylation in children from the discovery cohort. Genes
were identified and then assembled as protein complexes. Green marks a decrease in methylation and potentially increased gene
expression while red indicates a increase in methylation and potentially decreased gene expression.
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Figure 3.5. Genes in the glutamatergic synapse pathway that were affected by altered CpG methylation in children from the discovery
cohort.
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Figure 3.6. Genes in the calcium signaling pathway that were affected by altered CpG methylation in children from the discovery
cohort.
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Figure 3.7. Genes in the retrograde endocannabinoid signaling pathway that were
affected by altered CpG methylation in children from the discovery cohort. A list of
notable CpGs as well as related genes and functions is also presented.
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Figure 3.8. Genes in the serotonergic synapse pathway that were affected by altered CpG methylation in children from the discovery
cohort.
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3.4.3.

Confirmation of the 450K Array by Pyrosequencing
Next, microarray results were examined using an independent technology that

does not depend on the matched controls for modeling. For this, probes with different
performances from the carefully matched discovery cohort were chosen. First, one of two
CpGs to pass multiple testing at the FDR filtering level in this relatively small cohort was
chosen. The array analysis identified the enhancer of COLEC11 (FDR p=1.93x10-7).
Pyrosequencing analysis of the affected CpG (cg15730644) in COLEC11 revealed a
significant increase (p=0.002) with an average methylation of 94.2% in FASD compared
to 79.8% in matched controls (Figure 3.9A). It also shows that all children affected with
FASD consistently have higher methylation at this CpG site compared to their matched
controls. The sequencing run also examined SNP rs182514706 (T>G) and found that it
was not present in any members of either the exposed or control groups and thus would
not interfere with the confidence in the performance of this probe.
The next probe examined did not pass a FDR cut-off and is more representative of
the gene list used for higher level analysis, including heatmaps, ontologies, and pathways.
HTT (Huntington) is a hub gene involve in neurological disorders and showed a 1.5 fold
increase (p=0.003) in methylation in FASD patients. In the mouse trimester 3 binge
injection paradigm HTT showed a significant (p=0.001) 23% decrease in gene expression
in adult brains. Pyrosequencing analysis of the affected CpG (cg26128129) revealed that
the CpG in the enhancer of HTT shows a significant increase (p=0.001) with an average
methylation of 87.6% in FASD and an average of 50.7% in matched controls (Figure
3.9B). Interestingly, there is variation among the control samples as compared to the
FASD patients. This CpG is known to contain a SNP [rs362313 (C>T)] that causes a loss
of the CpG, as well as another SNP near the probe [rs147422679 A>G]; however,
pyrosequencing confirmed neither SNP was present in any of the individuals examined.
The available results support the suggestion that CpG specific DNA methylation is altered
in the cheek swab DNA of children affected with FASD.
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Figure 3.9. Pyrosequencing results for (A) COLEC11 and (B) HTT in the discovery
cohort. Patient ID represents the individuals from the discovery cohort and the metrics
represent percent methylation of the CpG from the sample.
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3.4.4.

Examination of Select Loci in the General Population
An average of 10 FASD and 7 Control patients were analyzed across 23 genes

(Table 3.4 and Appendix I). Chr12q24.3 showed a significant (p=0.036) decrease in
methylation (FASD = 2.7±1.2, Control = 7.4±1.5) at CpG 24, while CpG #26
(cg20313522) showed a trend (p=0.098) of decreased methylation (FASD = 2.7±1.3,
Control = 8.5±3.0). COLEC11 showed a trend (p=0.056) of decreased methylation
(FASD = 57.5±10.9, Control = 85.3±5.0) at cg15730644. Chr2q22.1 showed a trend
(p=0.080) of decreased (FASD = 91.5±1.0, Control = 87.5±2.0) methylation at CpG 19,
while CpG 20 (cg23885472) showed no significant (p=0.228) alteration. Chr10q26
showed a trend (p=0.107) of increased (FASD = 85.4±4.2, Control = 71.7±7.3)
methylation at cg03697076. The above 4 were loci were deemed informative across all
individuals and used for follow-up pyrosequencing in more members from the general
population. However, pyrosequencing analysis revealed no significant alterations once
applied to more individuals (Table 3.5 and Appendix J).
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Table 3.4. Summary of NGS panel results for an average of the same ten FASD and
seven control patients from Owen Sound, Ontario that were analyzed across 23 genes.
Gene Symbol

CpG

Mean FASD

Mean Control

p value

CpG#-701

12.3±1.8

13.4±2.0

0.69

CpG#-700 (cg10487998)

17.9±3.0

14.5±3.5

0.47

CpG#95 (cg24049468)

19.6±2.3

21.4±2.6

0.60

CpG#2

10.3±3.2

11.6±5.9

0.84

CpG#3

49.2±6.2

59.7±7.8

0.30

CpG#4

40.4±8.4

54.7±8.0

0.24

CpG#5 (cg21436544)

41.0±5.6

52.8±7.3

0.21

CpG#6

51.9±5.3

60.2±6.3

0.32

CpG#-68 (cg01450736)

66.7±5.3

71.8±1.9

0.43

CpG#-67

11.8±6.3

16.4±6.4

0.62

CpG#-66

83.3±4.4

86.4±1.3

0.55

CpG#602 (cg15730644)

57.5±10.9

85.3±5.0

0.06

CpG#603

81.5±2.1

83.7±0.9

0.41

CpG#604 (cg13811808)

90.9±2.2

93.0±0.6

0.46

CpG#605

88.5±3.0

91.1±1.3

0.48

CpG#19

91.5±1.0

87.5±2.0

0.08

CpG#20 (cg23885472)

67.9±11.6

47.6±11.3

0.23

CpG#79 (cg13578194)

18.6±5.1

11.3±3.1

0.26

CpG#80

43.9±6.3

38.3±3.3

0.47

CpG#81

61.6±4.3

62.4±3.7

0.90

CpG#82

45.8±7.8

42.0±4.5

0.69

CpG#6

60.8±7.4

60.1±4.9

0.94

CpG#7 (cg04452203)

7.7±0.9

10.2±2.4

0.37

NOTCH4

CpG #68 (cg17351927)

92.8±2.8

95.7±1.1

0.39

RUNX2

CpG#-5 (cg05996042)

34.3±5.1

33.3±6.0

0.91

GRB10

CpG#-322

34.7±2.3

32.0±3.5

0.51

ALPL

AK3L

Chr1p21.3

C1orf110

COLEC11

Chr2q22.1

LIMCH1

Chr4q26
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CpG#-321 (cg10335798)

15.5±1.3

14.2±2.1

0.60

CpG#7041

92.4±1.3

91.3±1.0

0.54

CpG#7042

93.3±0.9

90.5±2.0

0.18

CpG#7043

95.2±0.9

94.4±0.5

0.48

CpG#7044

84.2±1.4

82.9±2.0

0.59

CpG#7045

86.8±1.1

84.4±2.6

0.40

CpG#7046

68.0±3.2

68.4±3.0

0.94

CpG#7047 (cg11270017)

50.7±6.4

53.2±5.6

0.78

CpG#70 (cg19018267)

7.1±2.0

4.8±1.0

0.35

CpG#71

10.2±2.4

11.0±3.4

0.84

CpG#72

13.4±3.0

13.1±3.6

0.96

CpG#73

7.2±1.5

5.9±2.0

0.64

CpG#74

54.3±6.3

55.1±7.1

0.94

CpG#7 (cg03697076)

85.4±4.2

71.7±7.3

0.11

CpG #-52 (cg05237503)

48.7±11.3

59.3±8.4

0.48

CpG #-51

90.1±2.8

93.7±0.9

0.27

LMO2

CpG #177 (cg17408637)

18.0±4.7

26.2±5.3

0.28

Chr12p12.3

CpG#7 (cg05694021)

14.4±2.5

16.9±2.9

0.53

CpG#24

2.7±1.2

7.4±1.5

0.04

CpG#25

0.7±0.4

1.5±1.1

0.53

CpG#26 c(g20313522)

2.7±1.3

8.5±3.0

0.10

CpG#27

13.7±4.6

29.5±10.0

0.18

CpG#31

87.8±5.0

85.2±2.8

0.67

CpG#32 (cg17745575)

45.3±5.0

42.7±4.9

0.71

CpG#-6

25.4±3.4

29.6±5.0

0.49

CpG#-5 (cg25598400)

18.1±3.0

20.9±3.0

0.53

CpG#-4

68.5±4.5

65.3±6.2

0.68

CpG#481

11.2±2.1

13.2±3.1

0.59

CpG#482 (cg07507493)

13.9±2.2

14.9±3.7

0.82

CpG#483

5.0±1.8

3.4±1.2

0.50

ADARB2

PHYH

Chr10q26

FBXO3

Chr12q24.31

FAM106A

KRT32

UCKL1
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KRTAP27-1

ChrXp11.4

PCDHGA1

CpG#1

75.4±1.3

76.1±1.3

0.72

CpG#2

93.8±0.9

93.4±1.3

0.82

CpG#3

95.5±0.4

96.1±0.6

0.38

CpG#4 (cg05809586)

62.6±10.0

58.6±14.7

0.82

CpG #32 (cg11868078)

11.7±2.9

18.5±4.5

0.21

CpG #1774

71.9±2.4

77.6±2.9

0.15

CpG #1775
cg21915313

26.9±1.5

25.5±2.4

0.63

CpG #1776

47.5±1.7

51.1±3.3

0.34

CpG #1777

38.6±1.6

46.0±5.5

0.22

CpG #1778 (cg01544213)

57.8±2.5

60.8±2.9

0.46

CpG #1779

30.6±1.0

34.6±2.6

0.18
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Table 3.5. Summary of pyrosequencing results from children representative of the
general population of Owen Sound, Ontario.
Gene
and n

CpG

FASD

Control

p-value

COLEC11

CpG#602 (cg1573064)4

87.4±3.2

88.7±1.7

0.38

38 FASD
27 Control

CpG#603
CpG#605

60.3±2.3
78.9±2.3
77.6±2.2

57.5±2.2
79.7±1.2
76.9±1.9

0.20
0.39
0.40

PCDBH18

CpG#-5 (cg27086874)

16±2.2

19.9±5.7

0.23

8 FASD
4 Control

CpG#-4

CpG#-1

6.4±1.3
6.1±1.7
9.4±1.6
5.4±1.6

6.9±0.9
3.6±1.9
4.3±2.5
5.5±2.8

0.42
0.22
0.06
0.48

HTT

CpG#2310 (cg26128129)

75.6±7.7

63.3±6.1

0.12

15 FASD
12 Control

CpG#2311
CpG#2313

87±1.7
61±3.8
27.9±2.6

88±0.9
58.9±4.3
26.9±4

0.33
0.36
0.41

12q24.31

CpG#26 (cg20313522)

6.3±2.7

9.2±3

0.25

11 FASD
8 Control

CpG#27

23.1±6.3

32.9±8.1

0.17

10q26.12
11 FASD
8 Control

CpG#7 (cg03697076)

80.1±4

70±7.8

0.12

CpG#19

87.4±1.7

85.2±1.6

0.18

CpG#20 (cg23885472)

59.2±10.6

52.2±9.6

0.32

CpG#604

CpG#-3
CpG#-2

2q22.1
11 FASD
8 Control

CpG#2312

Results presented overlap with those from Figure 3.9.
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3.5. Discussion
The results of the research in this chapter provide a methylomic profile (Figure
3.1) of young children with FASD (Table 3.1). The genes identified are non-random as
they have a number of interactions identified by an associative gene network analysis
(Figure 3.2).

3.5.1.

Non-Random Genome-Wide Differential Methylation
The ontologies (Table 3.2) and pathways (Table 3.3) identified are related to

cellular and synaptic signaling, (neuro)development, immune processes, cell proliferation
and differentiation, and also represent non-neuronal tissues such as the heart and kidneys.
The analysis of human children has implicated a signaling pathway well-known to be
altered by alcohol: the glutamatergic synapse (Figure 3.5). The results have also
implicated the retrograde endocannabinoid signaling pathway (Figure 3.7), which is
known to be deregulated by PAE (Basavarajappa 2015). Endocannabinoids are
synthesized from the phospholipid membrane and are recognized by receptors that inhibit
calcium channels and suppress the release of glutamate or GABA. The serotonergic
synapse pathway was also deregulated (Figure 3.8). The aforementioned synaptic
pathways all utilize calcium signaling (Figure 3.6), are specifically relevant to
endophenotypes associated with FASD and related mental disabilities, and are an
unexpected result of easily obtained buccal swabs.
A novel pathway identified in the results is hippo signaling (Figure 3.4). Hippo
signaling is known to restrain cell proliferation and promote apoptosis in differentiating
epithelial cells (Saucedo & Edgar 2007). While hippo signaling has been primarily
studied in Drosophila melanogaster, it has been translated to Mus musculus and Homo
sapiens and identified as a highly conserved signaling pathway involved in the control of
cell growth, proliferation, and migration as well as apoptosis and organ size control
(Wang et al. 2009).
Hippo signaling contains conserved families of signal responsive transcription coregulators that transduce cytoplasmic signals into a response of transcriptional regulation
in the nucleus via kinase cascade (Wang et al. 2009). The hippo signaling components are
expressed in many tissues and co-regulate transcriptional enhancer factors [(TEFs) or
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transcription enhancer domain (TEAD) factors], runt-domain transcription factors
(Runxs),

peroxisome

proliferator-activated

receptor

gamma

(PPAR-γ),

T-box

transcription factor 5 (Tbx5), and several others. Notably, hippo signaling regulates the
growth of niche stem cell precursors (Sarikaya & Extavour 2015) and has recently been
linked to chromatin modification by recruiting a histone methyltransferase complex (Oh
et al. 2014). It has also been shown to regulate Wnt/β-Catenin signaling (Varelas et al.
2010).
A transcription factor analysis was also utilized on all the identified genes (Chen
et al. 2013). It revealed a significant (p<0.005) enrichment for CTCF insulator sites (Kim
et al. 2007), which are involved in establishing chromatin domains and boundaries and
result in a large-scale nuclear architecture that is specific to cell type. Another
transcription factor enriched for was RAD21, which cooperates with pluripotency
transcription factors, including CTCF, in the maintenance of embryonic stem cell identity
(Nitzsche et al. 2011). CTCF is known to be the master regulator of the clustered
protocadherins (Golan-Mashiach et al. 2012; Guo et al. 2012) where it influences
complex DNA looping.
The clustered protocadherins are located on 5q31 and showed a concerted increase
in methylation (Figure 3.3). The protocadherins are trans-membrane proteins with repeats
of the cadherin motif or the cadherin extracellular domain (Hirano & Takeichi 2012;
Chen & Maniatis 2013). This domain contains a conserved Ca2+ binding sequence and the
number of extracellular domains may vary across different cadherin molecules. The
protocadherins function as cell adhesion molecules with immense isoform diversity that is
used to create individual neuronal identities and allow for large-scale network formation
via controlling synaptic interactions. An increase in methylation in some, most, or all
gene promoters as observed in human FASD patients, is expected to reduce the isoform
diversity, thus limiting brain function. The clustered protocadherins were also represented
by many of the gene ontologies (Table 3.2). They have been implicated in a number of
brain disorders with similar endophenotypes to FASD, such as autism spectrum disorders,
bipolar disorder, and schizophrenia (Hirano & Takeichi 2012). The molecular functions
of the clustered protocadherins are further discussed in chapter 4, where the human
observations are compared to the mouse CPD PAE paradigm (chapter 2).
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3.5.2.

Comparison of Discovery and Replication Cohorts
The replication cohort (R) included six patients (3-10 years old) and six matched

controls (Table 3.1B) and their cheek swab DNA was used to generate genome-wide
DNA methylation profiles (Figure 3.1B). They were recruited from the same clinic and
diagnosed by the same Pediatrician (J. Kapalanga). However, the replication cohort was
also much more heterogeneous compared to the discovery cohort with respect to sex,
medication exposure, environment, and socioeconomic status. In order to compare the
cohorts across batches a different pre-processing algorithm was selected: the subsetquantile within array normalization (SWAN) algorithm (Maksimovic et al. 2012; Fortin et
al. 2014) from the minifi (Aryee et al. 2014) bioconductor package. When the two cohorts
were pre-processed separately by the Illumina algorithm or together with the SWAN
algorithm, they produced genome-wide results that had similarities but were not identical
to the discovery cohort. In general, there was decreased significance in the replication
cohort and greater levels of variation. Despite these differences, the main similarities
between the two cohorts were significant alterations in ontologies related to glutamate
and the canonical glutamatergic synapse pathway. Additionally, there was a clustered
protocadherin signal on the Manhattan plot, as well as replication of alterations to
imprinted regions also seen in the mouse models and the discovery cohort.
Next, the replication cohort was reanalyzed following removal of females and
children on medication (Table 3.1B; R1 and R4). Also, four controls of the replication
cohort were removed to better match age range and medical history. The selected scans
were then pre-processed using the Illumina algorithm. Upon removal, the groups cluster
much more closely and the signal is almost identical to what was observed in the
discovery cohort. Glutamatergic synapses, cell-adhesion, neuroactive ligand receptor
interactions, MAPK signaling, axon guidance, and a number of other pathways were all
significant (p<0.005) even though the ranking of specific pathways varied slightly. The
results argue that although DNA methylation is altered in patients with FASD, other
factors, including sex, age, and medication history, may affect the final outcome.
An independent group has also replicated some of this research (Laufer et al.
2015). Portales-Casamar et al. published an examination of genome-wide DNA
methylation patterns in the buccal epithelial cells of a Canadian cohort (Portales-Casamar
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et al. 2016). They compared 110 children with FASD to 96 control children between the
ages of 5 to 18. In addition to utilizing the 450K array and pyrosequencing, a genotyping
array was used to statistically correct for genetic background. Their analysis revealed 658
differentially methylated CpGs with 41 of those showing a >5% change in methylation.
They observed an enrichment for genes with functions related to neurodevelopment.
Furthermore, there was an increase of methylation in multiple probes from the clustered
protocadherins and also alterations to genomically imprinted regions, which included
H19. Overall, their observations confirm key findings from both the mouse and human
results presented in this thesis and expand them to a more diverse cohort.

3.5.3.

No Single Gene Examined Identifies FASD
The differential methylation observed was not replicated when examined at select

loci in a different cohort more representative of the general population (Tables 3.4 &
3.5). While it is possible that the marks examined are simply not informative of PAE,
there are also a number alternative possibilities that may account for the lack of
replication. First, individual sequencing is a more practical approach for clinical use as a
substantial change in methylation level at a biomarker locus would allow for the detection
of exposure without the need for carefully matched controls. However, individual
sequencing does not have the advantage of normalization of signal across matched
samples and reference genes.
These findings highlight the difficulty of expanding from the homogeneity of a
small carefully matched group to that of the heterogeneous general population. In the
follow-up pyrosequencing and NGS panel, FASD patients were more variable across a
number of factors including age, sex, drug exposure, and family history of mental health
disorders. The control patients were also in the clinic for a more heterogeneous mixture of
acute and chronic medical problems, which involved medication in some cases.
Ultimately, given the potential for variation across a number of factors, it appears that
each case of FASD may be represented in the epigenome as a complex signature that is
altered by other environmental factors. This large amount of heterogeneity would benefit
from future experimentation with much larger sample sizes, which would provide added
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statistical power. Furthermore, a regression could also be used to dissect the complex
environmental interactions that shape the general population.
One possible approach to dissect the heterogeneity of FASD would be to mirror
an array discovery approach and machine learning strategy used to detect prenatal
exposure to smoking. In this example, the cord blood from 1,062 newborn Norwegian
children prenatally exposed to maternal smoking during the second trimester was
analyzed on the 450K array, revealing 26 significantly altered CpGs that mapped to 10
genes (Joubert et al. 2012). The genes distinctly altered had functions related to
detoxification and development. A separate follow-up study utilized whole blood from an
American cohort (of 531 children) that were 3-5 years old and analyzed the same 26
CpGs using machine learning, where they found that 81% of the time they could predict
prenatal exposure to smoking (Ladd-Acosta et al. 2016). The above examples suggest that
larger sample sizes from interdisciplinary collaborative efforts increase statistical power.
However, given that 19% of cases were not identified, there are still limitations to the
approach of epigenetic epidemiology and the statistical approaches available need further
improvement, in terms of both loci examined and computational analysis, if they are to
properly model the heterogeneity of the human population and be used for public health
decisions (Ramsay 2015). To further expand on this point, a massive meta-analysis of
prenatal exposure to maternal smoking found that even a sustained and heavy exposure
results in a 450K profile with only nominal significance when applied to different cohorts
of older children with the same heavy prenatal exposure (Joubert et al. 2015). In the same
study, moderate exposure to any level of smoking, which made up a larger amount of
children, produced a much less distinct profile that wasn’t fully explored.
Ultimately, it appears that pyrosequencing of single loci is not suitable for use as a
diagnostic of FASD. Methodologies that allow for accurate, rapid, and inexpensive
quantification of DNA methylation levels across multiple loci in a single sample will
soon emerge. These future technologies could be used to further examine the sites
identified, as well as those identified by deeper epigenome wide screens, in a larger
number of samples that will allow for the dissection of the interaction of other
environmental and inherited variables. The above future improvements and a deeper
understanding of natural variation in the methylome may one day enable the possibility of
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diagnosing FASD from buccal swabs. Furthermore, this insight into DNA methylation
from buccal swabs would be particularly suited for use with other modern diagnostics
(Reynolds et al. 2011; Portales-Casamar et al. 2015), such as eye movement recordings
(Paolozza, Rasmussen, et al. 2014a; Paolozza, Rasmussen, et al. 2014b; Paolozza et al.
2015), diffusion tensor imaging (Paolozza, Treit, et al. 2014), and/or a robotic virtual
reality platform (Williams et al. 2014).

3.5.4.

Select Functions of Sequenced Genes
The genes examined by pyrosequencing and the NGS panel have a number of

functions that are biologically relevant to PAE. COLEC11 is involved in fundamental
developmental processes and serves as a guidance cue for neural crest cell migration
where aberrations are known to produce spectrum disorders with similar endophenotypes
to FASD known as 3MC syndrome (Rooryck et al. 2011). This biomarker was one of the
strongest performing on the 450K array and was also confirmed by pyrosequencing. In a
group of patients with intellectual disability and normal molecular karyotype COLEC11,
BLCAP, FAM50B, SHANK2, and GLI2 were identified as showing significant alterations
to methylation in peripheral blood by the 450K and confirmed by pyrosequencing
(Kolarova et al. 2015). Notably, a marker could not be found for general intellectual
disability and thus an individual based approach was taken. The hypermethylation of
COLEC11 was observed and confirmed in a single patient with a thin upper lip
vermillion, long flat philtrum, moderate developmental delay, generalized epilepsy,
cerebral movement disorder with ataxia, and blepharophimosis. The aforementioned
endophenotypes overlap with FASD.
Chr2q22.1 (Chr2:136120695-136120697) is a few kilobases downstream from
CXCR4 (Chr2:136114349-136118165). CXCR-4 is involved in neurogenesis, both
developmental and adult, where it has a role in neuronal guidance and is implicated in
epilepsy (Bagri et al. 2002). Chr10q26 is inside WDR11-AS, the antisense transcript for
WDR11. WDR11 is also known as bromodomain and WD repeat-containing protein 2. It
is involved in human puberty and in mouse and zebrafish models was found to have a role
in developmental neuroepithelial cell migration (Kim et al. 2010). Bromodomains
recognize monoacetylated lysine and the WDR domain allows for protein interaction.
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Members of this family are typically involved in cell cycle progression, signal
transduction,

apoptosis,

and

gene

regulation.

Chr12q24.31

(Chr12:124774899-

124774989) is close to numerous novel lncRNAs and SCARB1. SCARB1 functions as a
receptor for high density lipoprotein, its well known for its role in cholesterol
homeostasis, and could have a role for membrane and neurosteroid synthesis in neurons
of the eye (Provost et al. 2003).
Also, notable is ADARB2 an RNA editing enzyme involved in the posttranscriptional A-to-I modification and is a process. RNA editing results in the
recognition of the modified base (Inosine) as a Guanosine by cellular machinery. RNA
editing is enriched in the brain at 5htr2c and Glur2, which are serotonin and glutamate
receptors that are involved in neurological disorders (Li & Church 2013). In the mouse
models, the snoRNA gene families Snord115 and Snord116 were markers of PAE in the
brain across different exposure dose and timing (Laufer et al. 2013). SNORD115 is
involved in the alternative splicing of 5HTR2C (Kishore & Stamm 2006). Editing of
Glur2 by Adar2 alters calcium permeability and is involved in synaptic activity and drug
addiction (Lomeli et al. 1994; Schmidt et al. 2014).

3.5.5.

Considerations for Future Research
While this research generates a number results, there are also a number of

considerations for future studies. Unsorted peripheral tissue contains DNA methylation
patterns from a heterogeneous population of cells and is a limitation of studies that use
whole blood. Saliva is comprised of both buccal epithelial cells and a variable level of
leukocytes and microbes (Aps et al. 2002) that are minimized by using swabs of the check
pouch as opposed to mouthwashes (Thiede et al. 2000). The above mentioned variations
in cellular composition may have the potential to lead to spurious findings in some cases,
as alterations can reflect a shift in cell type composition as opposed to specific epigenetic
alteration (Souren et al. 2013). However, the buccal epithelium also shares a
developmental connection to the brain via the ectoderm and has led to novel insights into
the brain as it is an easily accessible peripheral tissue. Interestingly, studies have
indicated that the unsorted saliva appears to serve as a better proxy for the psychiatric
disorders than unsorted blood (Lowe et al. 2013; Abdolmaleky et al. 2014; Wilmot et al.

132

2015). While cell type sorting is an ideal standard it is not always practical, particularly in
cases where low amounts of DNA available and thus is a limitation to be considered
when interpreting the results presented. Furthermore, a study using a similar approach to
examine autism spectrum disorders noted that technical inter-array differences accounted
for the majority of confounding variation, even after the use of stringent pre-processing
algorithms to adjust for batch effects (Berko et al. 2014). The two arrays in this chapter
showed a similar outcome and were analyzed separately to minimize the major source of
confounding variation.

3.5.6.

Conclusion
In this research, it was observed that children (3-6 year olds) with a

comprehensive FASD diagnosis and a maternal history of PAE (termed the discovery
cohort) have non-random differences in genome-wide DNA methylation. This effect is
similar, but not identical, in a replication cohort collected 6 months after. The analysis
allowed for the identification of the clustered protocadherins as well as glutamate and
hippo signaling proteins as critical molecules. These results may also explain overlaps
involving FASD and other neurodevelopmental disorders of unknown etiology. However,
these associations were observed in a small sample of carefully matched children and
next generation sodium bisulfite sequencing of a larger sample suggests that the selected
differences may be influenced by sex, age, medication, and genetic background.
Ultimately, the results establish that DNA methylation is affected at specific
neurodevelopmental loci in children with FASD but may be altered by other variables.
Thus, despite the potential caveats, the results included have a number of
implications. First, the identification of specific loci and pathways, including the clustered
protocadherins and hippo signaling, may serve as a foundation for functional genomics
studies. Second, with future optimization, the methylomic profile may serve as part of a
diagnostic suite that enables early diagnosis and proper application of any corrective
therapies, which are most effective for FASD if applied as early as possible during
neurodevelopment (Paley & O’Connor 2009; Chokroborty-Hoque et al. 2014). The
identified loci may also be utilized towards the development of precision medicine by
somatic epigenome editing (Laufer & Singh 2015). Finally, the results of this research
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established that a complex epigenomic signature of PAE remains in the saliva of human
children.
Footnotes: A substantially modified portion of this chapter has been published (Laufer et
al. 2015).
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Chapter 4
Comparison of PAE Mice and Humans
4.1 Overview
The results presented in this thesis represent a number of novel observations. The
mouse model (chapter 2) revealed that long-term alterations to DNA methylation as well
as non-coding RNA and gene expression are induced by prenatal alcohol exposure (PAE)
in the brain. Observations of saliva (chapter 3) show that there is a heterogeneous profile
of non-random differential DNA methylation characteristic of young children with Fetal
Alcohol Spectrum Disorders (FASD). In this chapter, I highlight that there are some
comparable alterations in DNA methylation between the brains of adult male mice and
the buccal epithelium of human children. A portion of this chapter has been previously
published in Laufer et al. 2015. Together, the results of this research suggest that while
different genes are altered, a long-term profile exists in diverse cell types with an
ontogenetic relationship stemming from the ectoderm. The candidate loci identified in the
two species belong to related non-random ontologies and pathways as well as complex
epigenetically regulated syntenic loci. The results of this research may be used to guide
future functional genomics studies examining the development of FASD following PAE.
The novel results are also expected to aid the future development of strategies for early
diagnosis and protocols for amelioration.

4.2 Introduction
The mouse model results presented in chapter 2 are in agreement with research
using human cells. For example, Khalid et al. examined the transcriptome and methylome
of human embryonic stem cells (hESCs) exposed to alcohol (Khalid et al. 2014). The top
deregulated hub genes were SCUBE3 and SLC22A5, which showed decreased gene
expression. Notably, SLC22A5 was ranked as the 3rd gene showing the highest differential
hyper-methylation in the mouse model presented in this thesis. The SLC22A5 gene codes
for a solute carrier protein (OCTN2) that has a role in TGF-β signaling and transports
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carnitine, which is involved in transporting fatty acids from the cytosol to the
mitochondrial matrix, where they can be used for metabolism (Sonne et al. 2012).
SCUBE3 also codes for a protein that has a number of functions, which include TGF-β
signaling and the complement system (Yang et al. 2013). In the analysis of gene
expression in the mouse model, the complement system was the top deregulated
canonical pathway and also enriched in the gene ontology analysis. Finally, as noted by
Khalid et al., the two hub genes identified are expressed in a number of non-neuronal
tissues including the heart. These similarities highlight the translational potential of the
PAE mouse model, which I used as a comparison point for the observations from human
children with FASD.
The experiments involving mice were based on a MeDIP-Chip tilling array that
analyzes CpG islands with greater than 2 methylated cytosines per a 50-75 base pair
probe, which are then tilled into a larger contiguous sequence to represent a differentially
methylated region (DMR) (Figure 2.7) (Laufer et al. 2013). For the human analysis, the
450K methylation array was used to analyze alterations to single CpG sites via sodium
bisulfite conversion and an (epi)genotyping approach (Figure 3.1A) (Laufer et al. 2015).
The translational comparison of results allowed for the identification of specific
ontologies, pathways, and loci that are concordant between the independent array sets,
which may be further developed as robust biomarkers of PAE.

4.3 Methods
The mouse model results are described in chapter 2. Briefly, the updated (2016)
methylation analysis was used for the comparison of ontologies and pathways, as this
analysis was generated using a workflow more similar to the human results and thus
allowed for a more direct comparison. However, the updated analysis is from software
with limited support for the array, which did not provide complete genomic location
annotations for the tiled sequence, and thus the original (2012) methylation analysis was
used for comparative alignment. The analysis of the human observations is described in
chapter 3. The observations from the discovery cohort were used for the comparison to
mice. Alignment of reference genomes for both species was carried out using the UCSC
genome browser (www.genome.ucsc.edu).
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4.4 Results
Of the 190 CpGs from the human discovery cohort that were annotated to genes,
36 (19%) overlapped with the 2898 annotated genes identified from the updated 2016
mouse analysis. However, the ontologies and pathways identified in the human discovery
cohort (Tables 3.2 & 3.3) are similar to those identified in adult PAE mouse brains
(Tables 2.7 & 2.8) and related to cellular and synaptic signaling, (neuro)development,
immune processes, cell proliferation and differentiation, and also represent non-neuronal
tissues such as the heart and kidneys. The observations represent a number of diverse
ontogenetic events that are altered long after their initial deregulation by PAE. The most
common and clearly connected are cellular signaling events related to development and
neurotransmission, which are responsive to the external environment. For instance, the
top pathway identified in the human results was hippo signaling (Table 3.3; 25/85
molecules and p=0.0002), which was also altered in the mouse model (Table 2.8; 40/115
molecules and p=0.04). Calcium signaling was also altered in the children’s swabs (Table
3.3; 99/475 molecules, p=0.005) and mouse brains (Table 2.8; 50/136 molecules,
p=0.01). Calcium signaling has numerous diverse roles, including in neurotransmission,
where it contributes to depolarization of the cell membrane and resulting action
potentials. Also notable are the only two genes that passed the FDR filtering on the 450K
array. Both showed increased methylation, and AHNAK2 was 1.7 fold (p=1.93E-07) and
COLEC11 was 1.6 fold (p=6.61E-08) (Appendix D). AHNAK2 is a type of giant
propeller-like protein linked to calcium channels (Komuro et al. 2004). COLEC11
encodes a guidance cue for neural crest migration (Rooryck et al. 2011). The CL-K1
protein encoded by COLEC11 is part of the lectin complement pathway, which functions
in complement activation (Wallis et al. 2010), an immune process represented in the
ontologies and as the top pathway of mouse gene expression (Table 2.2).
The comparison of mouse and human results has enabled the identification of not
only ontologies and pathways deregulated by PAE, but also genomic loci. Some genes
showing differential methylation in children belonged to genes families with altered
methylation in mice [PHOX2B (p=0.0009), ADAMTS17 (p=0.002), KRT32 (p=0.004),
TMEM229A (p=0.004)]. As another example, complex epigenetically regulated syntenic
loci were also identified in both mice and humans. Alterations to imprinted ncRNA from
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the SNRPN-UBE3A locus [SNORD116 (HBII-85) (p<0.005) and SNORD115 (HBII-52)
(p<0.01)] were also present in the human buccal DNA, which was the most ubiquitously
expressed marker for PAE that was identified in the mouse model chapter of this thesis
(Appendix D). SNORD115 changes the alternative splicing of the serotonin receptor
5HTR2C (Kishore & Stamm 2006; Glatt-Deeley et al. 2010), which is a G-protein
coupled receptor involved in calcium signaling (Nakatani et al. 2009). Calcium signaling
was deregulated in both the mouse model and human model, and the serotonergic synapse
pathway was altered in human children (Table 3.3).

4.4.1 Increased Methylation at the Clustered Protocadherins
In both humans with FASD and PAE mice, the clustered protocadherins showed a
broad increase in methylation at select regions (Figure 4.1). An increase in methylation
in some, most, or all gene promoters (Tables 4.1 & 4.2) is expected to reduce the isoform
diversity, thus restraining brain function. Table 4.1 contains a list of genes, genomic
position, and the functional CpG site that is differentially methylated in the buccal swabs
of FASD patients from the discovery cohort as compared to their matched controls.
Similarly, Table 4.2 contains corresponding protocadherin genes that were differentially
methylated in adult mouse brains long after PAE. Figure 4.1A includes a plot of the raw
Illumina β values, which correspond to percent methylation, for significant (p<0.005)
CpGs in the differentially methylated region of the protocadherin γ cluster of humans and
also how they align with alternate transcripts choice. The differential methylation appears
to correspond to the first variable exon and preceding promoter of an alternative
transcript. Protocadherins are involved in the generation of synaptic complexity in the
developing brain and evolved primarily by tandem duplications and divergence. This
complex locus contains three clusters (α, β, and γ) of protocadherin gene families that are
transcriptionally complex and very similar between humans and mice (Figure 4.1B). The
clustered protocadherin locus generates comparable transcripts in the two species and has
relatively conserved CpG sites. More importantly, a number of the CpG sites/islands are
specifically prone to increased methylation following PAE in both species.
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Table 4.1. Nucleotide-specific analysis of CpGs in the protocadherin gene family clusters
showing significant (p<0.005) alterations to CpG methylation in human buccal epithelial
DNA from children of the discovery sample.
Family

p-value

CpG ID

CpG
Coordinate

Fold
Change

Average β

α
α
α
α
α
β
β
γ
γ
γ
γ
γ
γ
γ
γ
γ
γ
γ
γ
γ
γ

2.24E-03
4.90E-03
4.07E-03
4.42E-04
3.79E-03
1.90E-03
1.99E-03
1.37E-03
8.85E-04
6.14E-05
3.24E-03
1.36E-04
4.86E-03
1.08E-03
8.46E-04
4.98E-03
6.18E-04
4.41E-03
4.36E-04
8.56E-04
8.64E-04

cg03318614
cg16234335
cg25225155
cg15122993
cg13619597
cg27086874
cg05941060
cg01561869
cg25657261
cg24922090
cg02074191
cg06757405
cg26856475
cg22087053
cg18297751
cg24633027
cg18705909
cg08854987
cg21117330
cg03831054
cg21915313

140154796
140168303
140202437
140236606
140237001
140549040
140594004
140704042
140705331
140720687
140731690
140731792
140734108
140734498
140749183
140752470
140754610
140759645
140769634
140769892
140779155

1.10
1.11
1.23
1.17
1.54
1.14
1.43
1.22
1.34
1.24
1.60
1.35
1.38
1.27
1.31
1.32
1.58
1.26
1.20
1.53
1.50

0.55
0.60
0.64
0.49
0.68
0.19
0.46
0.29
0.33
0.37
0.46
0.35
0.42
0.35
0.39
0.55
0.45
0.34
0.28
0.48
0.39
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Table 4.2. Tiling-based analysis of promoters from the protocadherin gene clusters
showing significant (p<0.01) increases in methylation in adult brain tissue from a mouse
model of prenatal alcohol exposure.
Family

Peak Start

Peak End

α
37090887
37091731
α
37099823
37099982
α
37100493
37101082
α
37120628
37121169
α
37121813
37122462
α
37128647
37129396
α
37148470
37149114
α
37153966
37154515
α
37159353
37160304
α
37166096
37167215
α
37181780
37182430
37456114
37456763
β
37603162
37603321
β
37645176
37646223
β
37657621
37657881
β
37674825
37674994
β
37678546
37679275
β
γ
37828934
37831185
γ
37835333
37836297
γ
37840948
37841597
γ
37850740
37850974
γ
37854441
37854897
γ
37868606
37868955
γ
37886555
37887889
γ
37892011
37893005
γ
37922706
37922835
Data based on the original 2012 analysis.

Peak
Length
844
159
589
541
649
749
644
549
951
1119
650
649
159
1047
260
169
729
2251
964
649
234
456
349
1334
994
129
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Figure 4.1. Broad profile of increased methylation at the clustered protocadherins in
children with FASD and PAE mice: (A) Representative methylation patterns in 14 CpGs
of the gamma cluster in the discovery cohort. Red represents children with FASD and
blue represents matched controls. (B) Significantly (p<0.005) increased methylation in
the clustered protocadherin region of patients (red dots), known CpG island (green dots)
and potential transcripts (blue lines) along with their similarity to the mouse model
(p<0.01). Figure is not to scale as non-informative regions have been removed for clarity.
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4.5 Discussion
The similarities between mice and humans are striking because the arrays are
designed to investigate different regulatory sequences: the mouse arrays are tiled regions
of larger change in CpG islands, whereas the human arrays are focused on single CpG
sites that could be in a CpG island shore/shelf and up to 2 kilobases away from the
corresponding island (Yasui et al. 2007; Irizarry et al. 2009; Doi et al. 2009). Although,
some CpG islands are represented on the human array, as exemplified by the clustered
protocadherins. Thus, the clustered protocadherin signal is a more direct comparison.
While some of the results may not appear related, most can be connected
parsimoniously. For example, the enrichment for cancer pathways is related to
developmental events. Many cancers have been redefined as disorders of the epigenome
that stem from epigenetic alterations related to stem-cell programming pathways used in
development (Feinberg et al. 2006; Feinberg et al. 2016). These results are presumably
present due to a larger focus from the research community on cancer rather than
development. There are also alterations to genes involved in immune events, which
suggest that some alterations may be occurring in glia as well. For instance, microglia
induce apoptosis in stressed-but-viable neurons by phagocytosis, which is signaled for by
complement components (Brown & Neher 2014). The complement system was
implicated in both mouse (Table 2.2) and human (COLEC11) results, and differential
methylation of phagocytosis related genes was observed in both mice (Table 2.8) and
children (Table 3.3). The above example also suggests that the long-term profile informs
on not only past alterations to the epigenome, but also active differences in transcription.
However, the most striking shared signature was the preferential methylation of the
clustered protocadherins, which is similar in mice and children.

4.5.1 Functions of the Clustered Protocadherins
The increased methylation of protocadherin genes from the cheek swab DNA of
FASD patients is supported by comparable results in the brains of adult mice prenatally
exposed to alcohol (Figure 4.1B). These results have the potential to cause a downregulation of specific gene products depending on the specificity of methylated promoters
in neural cells of mice as well as humans. Notably, a number of exposure paradigms in
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the previously developed mouse model showed alterations to clustered protocadherin
gene expression. Pcdhb2 was down-regulated (1.2 fold, p=0.02) in the voluntary maternal
continuous preference drinking (CPD) PAE paradigm. Pcdhb3 was up-regulated (1.2 fold
change, p=0.005) in the trimester 1 (T1) binge exposure paradigm, while Pcdhb7,
Pcdh15, Pcdhb11, Pcdhb16, and Pcdhb18 were down-regulated (~1.3 fold, p<0.003)
(Kleiber et al. 2013). In the trimester 3 (T3) exposure paradigm Pcdhb18 showed a 21%
increase after acute exposure and 43% decrease in adult brain gene expression (Kleiber et
al. 2013). Furthermore, such changes are expected to affect function because Pcdhb18 has
been demonstrated to control axon growth and arborization in zebrafish (Biswas et al.
2014). Finally, the clustered protocadherins also showed increased histone methylation in
the hippocampus of adult PAE mice from the T3 binge exposure paradigm (Chater-Diehl
et al. 2016). Both (activating) H3K4me3 and (repressive) H3K27me3 were increased.
While the enriched histone post-translational modifications typically act in opposing
fashions, this enrichment may also represent bivalent chromatin, which allows for genes
silenced in embryonic stem cells to be poised for later activation during differentiation
(Bernstein et al. 2006; Vastenhouw & Schier 2012). Finally, some of the clustered
protocadherins are proteolytically processed by the metalloprotease ADAM10, which
releases an extracellular fragment for signaling (Reiss et al. 2006). ADAM10 and number
of other ADAM(S) genes showed differential methylation in the mouse model. Thus, the
mouse models provide further support for the existence of a complex epigenetic signature
in the clustered protocadherins that is associated with PAE.
The protocadherins are the largest subgroup of the cadherin gene superfamily of
homophilic cell-adhesion proteins (Hirano & Takeichi 2012; Chen & Maniatis 2013).
They are primarily expressed in the developing nervous system where they are
stochastically involved in a neuronal self-avoidance that allows neurons to interact with
the same neuronal subtype but not themselves (Sano et al. 1993). Protocadherins have
been observed mediating cell-to-cell interactions in dendrites, axons, synapses, growth
cones, and neuronal soma (Kohmura et al. 1998; Wang et al. 2002; Kallenbach et al.
2003; Phillips et al. 2003; Junghans et al. 2008; Lefebvre et al. 2012; Chen et al. 2013). In
vertebrates, the majority of protocadherin genes are organized in 3 clusters: α, β, and γ.
Intriguingly, the cell specific variation in transcripts created by this locus parallels the
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complexity of the immune system. Unlike the immune system, which relies on genetic
recombination, the protocadherin complexity is realized by epigenetic mechanisms that
parallel the act of recombination via promoter choice and splicing. The transcriptional
initiation of the α and γ families is dependent on the methylation status of numerous
promoters in the variable regions of the families that end in shared exons. β, on the other
hand, does not contain a shared exon and each gene appears to be under the control of its
own promoter. The α and γ gene families contain CTCF binding sites that families form a
DNA loop structure, which is proposed to bring the isoform specific promoters into the
proximity of flanking enhancers and transcriptional machinery (Guo et al. 2012; GolanMashiach et al. 2012; Chen & Maniatis 2013; Guo et al. 2015). This allows stochastic
expression of several different alternative isoforms from each chromosome, while also
enabling both chromosomes to express constitutive isoforms. Thus, it appears that CTCF
serves as a master transcription factor for this locus and is used to determine the isoform
expression of protocadherins (Figure 4.2). Furthermore, stochastic isoform expression
from the α cluster is dependent on epigenetic priming by de novo methylation patterns
established at promoters by Dnmt3b during early embryonic stages, which goes on to
influence isoform expression in subsequent differentiated cells (Toyoda et al. 2014).
The isoform diversity created by the clustered protocadherins creates a molecular
signature on the cell surface of individual neurons that is used to interact in trans (Chen et
al. 2013). This diversity is accomplished by individual neurons expressing different
combinations of the protocadherin isoforms on their cell surface and forms even more
diversity by creating multimers (in cis). Ultimately, each neuron could have its own
unique identity amongst other individuals of the same subtype (Bonn et al. 2007;
Schreiner & Weiner 2010). This is believed to be critical for the specific and yet
enormous

network

formation

of

precise

neuronal

connections

required

for

neurodevelopment.
The clustered protocadherins function in neurite self-avoidance (Lefebvre et al.
2012), dendritic patterning (Suo et al. 2012), and axonal projection (Katori et al. 2009).
Given their essential role underlying neurodevelopment, it comes as no surprise that the
protocadherin gene family clusters have been implicated in a number of
neurodevelopmental disorders (Kalmady & Venkatasubramanian 2009). Furthermore,
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DNA methylation of the clustered protocadherins is known to be environmentally
responsive. A broad profile of increases and decreases in DNA methylation, H3K9
acetylation, and gene expression in the hippocampus of the rat revealed that the clustered
protocadherins show the largest differential response in adult offspring that received
altered maternal care (McGowan et al. 2011). A further comparison to the hippocampus
of humans that were abused as children revealed increased methylation in promoters of
the clustered protocadherin locus (Suderman et al. 2012). It is notable that the mouse and
human results of this thesis displayed a profile more similar to humans who were abused
as children, rather than the rodent model of altered maternal care that contained both
increases and decreases in methylation. Finally, increased methylation and decreased
expression of the γ protocadherins has been observed in fetal Down syndrome cortex
(Hajj et al. 2016).

151

Transcription Hub
Complex

Figure 4.2. A hypothetical model of gene regulation by CTCF at the clustered
protocadherin locus. DNA looping mediated by CTCF/Cohesin may regulate gene
expression by bringing alternative promoters of select clustered protocadherins into the
proximity of enhancers and transcriptional machinery.
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4.5.2 Conclusion
The comparison of changes to DNA methylation following PAE shows that there
are similarities between the buccal epithelium of children with FASD and the whole
brains of PAE adult mice. The similarities typically do not occur in the same genes but
are evidenced by alterations to similar ontologies and pathways. These alterations to
methylation occur in genes with functions related to cellular and synaptic signaling,
(neuro)development, the cell cycle, immune processes, and genomic imprinting (SNORD
115 & SNORD 116). Furthermore, there is a broad profile of increased methylation at the
clustered protocadherins in PAE mice and human children. The similarities observed
come from functionally diverse tissues that share a stem cell progenitor and suggest an
ontogenetic footprint of PAE is maintained by the epigenome. Thus, the findings
demonstrate that for translational human studies, rodent models may be used as a
reference point to help decipher the complex signature of select life experiences amongst
the epigenetic variation that shapes every individual.
Footnote
A modified portion of this chapter has been published (Laufer et al. 2015).
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Chapter 5
Discussion
5.1 Overview
The research presented in this thesis has identified differential DNA methylation
in prenatal alcohol exposed (PAE) mice (chapter 2) and in children with fetal alcohol
spectrum disorders (FASD) (chapter 3). The mouse results revealed alterations to gene
and non-coding RNA (ncRNA) expression as well as DNA methylation in adult whole
brains. The human observations revealed alterations to DNA methylation from the buccal
swabs of children with FASD. When the mouse and human results are compared (chapter
4) they show that many alterations occur in genes involved in the same ontologies and
pathways. Furthermore, the comparison of alterations has also allowed for the
identification of increased methylation in the clustered protocadherins. In this chapter the
results of these studies are synthesized and collectively show that the long-term
alterations from PAE represent a ‘footprint’ of cellular signaling events altered at the time
of exposure. The results of this thesis also offer a number of considerations for future
epigenomic research.

5.2 Towards an Inductive Mechanism: PAE Alters Cellular
Signaling
The mechanisms that initiate the altered long-term profile of PAE remain
unknown. While the systems biology approaches used in this thesis are suited for
discovery, they are not mechanistic and offer only an assessment of the downstream
effect. Although the mechanism initiating the long-term profile was not directly
examined, the results overlap with literature investigating PAE at the time of exposure.
The pleiotropic effects of ethanol appear to be derived from its ability to alter a
number of developmental cellular signaling pathways and a preferential effect on certain
multipotent cell types that later undergo coordinated apoptosis (Kiecker 2016). For
instance, cell fate and migration depends on signaling pathways with cell surface
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receptors that activate downstream transcriptional programming. Examples of these
signaling pathways are bone morphogenic protein (BMP)/transforming growth factor-β
(TGFβ)/, PI3K/AKT/mTOR, Wnt/β-catenin, retinoic acid/Hox genes, Delta/Notch, SHH
signaling, and MAPK/ERK (Kandel et al. 2000; Lamouille et al. 2014). Notably,
members from a number of these pathways have been found to show altered gene
expression and epigenetic marks in PAE mice across development (Green et al. 2007;
Resendiz et al. 2014). The neural crest is a stem cell population that appears to be
particularly impacted by PAE (Smith, Garic, Flentke, et al. 2014). Apoptosis of neural
crest cells is driven by elevated reactive oxygen species (ROS) and the binding of alcohol
to a G-protein-coupled receptor (GPCR). The activation of GPCRs by ethanol results in
the release of phosphoinosityl phosphate, which triggers the release of intracellular
calcium. This calcium transient prevents β-catenin from activating transcription related to
trophic support and cell adhesion, which ultimately results in apoptosis (Smith, Garic,
Berres, et al. 2014).
Ethanol

acts

directly

on

neurotransmitter

system

receptors

including

neuropeptides, amino acids, biogenic amines, and others (Valenzuela et al. 2011;
Basavarajappa 2015). Ionotropic receptors are part of a channel pore whereas
metabotropic receptors result in signal transduction by secondary messengers and are
often GPCRs (Bear et al. 2007). PAE alters a number of neurotransmitter systems but
appears to primarily interfere with synaptic signaling involving amino acids and biogenic
amines (serotonin and dopamine) (Valenzuela et al. 2011). γ-aminobutyric acid (GABA)
is the main inhibitory neurotransmitter, while the amino acid glutamate is the most
abundant excitatory neurotransmitter. Ethanol has been shown to directly bind to an
allosteric site on the GABAA receptor, which is an ionotropic receptor for a ligand-gated
ion channel, and increases the inhibitory effect (Santhakumar et al. 2007). Ethanol also
binds to an allosteric site on the N-methyl-D-aspartate receptor (NMDAR), which is a
glutamate receptor subtype, and inhibits excitatory function (Möykkynen & Korpi 2012).
Neurotransmitter systems are extensively utilized throughout development. Even before
synapses are formed, both glutamate and GABA regulate the migration, proliferation, and
differentiation of neural stem cells (Manent & Represa 2007; Valenzuela et al. 2011).
Both GABA and glutamate encourage the migration of cortical neurons across the
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different layers of a developing embryo’s cortex as they pattern it in an inside first,
outside last fashion (Luhmann et al. 2015). When GABA or glutamate receptors are
activated they trigger calcium transients that remodel the cytoskeleton and result in
cellular migration (Luhmann et al. 2015). In neonatal rats, which are the equivalent of the
third trimester of human pregnancy, both acute and repeated PAE inhibits the long-term
potentiation and thus maturation of GABAA receptor synapses by temporarily inhibiting
L-type voltage-gated calcium channels (Zucca & Valenzuela 2010; Morton & Fernando
Valenzuela 2016). These channels result in calcium transients in response to action
potentials and are involved in the retrograde release of BDNF (Zucca & Valenzuela 2010;
Morton & Fernando Valenzuela 2016). Notably, GABA has an excitatory function that
encourages neuronal growth, migration, and synaptogenesis until the end of the rodent
equivalent of the third trimester of human pregnancy (Ben-Ari 2002; Valenzuela et al.
2011). Furthermore, glutamate is involved in synaptogenesis and the maturation of
neurons (Cline & Haas 2008; Valenzuela et al. 2011). Overall, PAE appears to alter the
epigenetic remodeling of embryonic stem cells, neural progenitor cells, and maturing
neurons

by

interfering

with

a

number

of

cell-adhesion,

synpatogenic,

and

neurotransmission systems (Resendiz et al. 2014). However, PAE also alters other
signaling systems upon exposure.
The oxidation of ethanol by alcohol dehydrogenase results in acetaldehyde.
Acetaldehyde is more toxic than ethanol and creates an abundance of ROS, which induce
oxidative stress (Brocardo et al. 2011). ROS are signaling molecules critical for proper
neurodevelopment and a number of cell signaling pathways. One example of a redox
sensitive pathway is phosphatidylinositol 3-kinase (PI3K)/AKT/mammalian target of
rapamycin (mTOR) signaling, where the antagonist, PTEN, can be inactivated by
oxidation (Ostrakhovitch & Semenikhin 2013). The PI3K/AKT/mTOR pathway is an
intracellular signaling pathway that regulates the cell cycle and thus proliferation and
apoptosis. When activated by growth factors binding to various GPCRs and tyrosine
kinase receptors at the cell surface, PI3K phosphorylates phosphatidylinositol on the cell
membrane and signals for the activation of AKT. AKT then activates mTOR, inhibits
FoxO, and regulates a number of transcription factors to ultimately prevent cell death and
promote cell survival (Brunet et al. 2001). However, PTEN inhibits PI3K and therefore
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promotes apoptosis. In neural stem cells PI3K/AKT/mTOR promotes cell proliferation,
whereas PTEN promotes cell differentiation. Neural stem cells utilize PI3K/AKT/mTOR
signaling to carefully balance maintaining a stem cell pool while also providing enough
differentiated cells, which can no longer proliferate (Peltier et al. 2007).
PI3K/AKT/mTOR signaling is also required for the strengthening of synaptic
connections, which is known as long-term potentiation and is the basis for learning and
memory (Man et al. 2003; Sui et al. 2008). Overall, the long-term profile of PAE
observed in both mice and humans contains many members of the above signaling
pathways and suggests that their disruption is maintained as an ‘ontogenetic footprint’.

Alternative Hypotheses

5.2.1

The results suggest that a shared stem cell precursor connects the observations in
whole brains and buccal swab DNA. However, there are also a number of possible
alternative explanations to the observed footprint. First, the differential epigenomics
observed may represent alterations to cell populations as well as alterations to epigenetic
marks. This would explain some of the genome-wide alterations, as they could be related
to cellular profile; however, the cell line studies reviewed in the introduction of this thesis
also establish that genome-wide alterations occur in homogenous populations. Second,
not all the observed alterations are connected ontogenetically at the level of the ectoderm.
There also appears to be a preferential disturbance of cells dependent on calcium
signaling, such as the brain, heart, kidneys, and skeletal structures. Third, and perhaps
most likely, is that footprint is a combination of the above possibilities.

5.3 Considerations for Future Experimentation
The field of epigenomics is rapidly advancing, however, as a discipline a number
of limitations must be overcome. These challenges are highlighted by the approaches
used in this thesis and represent important considerations for future research. They are as
follows:
1. Cell type heterogeneity. Both the whole brains and the saliva examined contain
heterogeneous mixtures of cell types. Thus, the epigenomic signals analyzed
represent a mixed profile that may be representative of alterations to a single cell
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type or even be heterogeneous within single cells themselves. A deeper
understanding this heterogeneity will aid in the knowledge of cell types to be
targeted for functional studies, diagnostics, and/or therapeutics.
2. Whole genome coverage. The mouse arrays utilized were designed to study CpG
islands, specifically promoters, while the human arrays utilized were designed to
study individual CpG shores. Future studies would benefit from the use of
unbiased designs that allow for the investigation of a number of other features,
such as enhancers and gene bodies, or preferentially the whole genome.
3. Direct comparisons. This research made use of adult mouse whole brains and
buccal swabs from children. To allow for a more direct comparison, future
research would benefit from also examining buccal cells in mice and human postmortem brains. This additional characterization would provide a reference point to
identify which alterations are tissue specific and which are species specific.
4. Integrated analysis. This thesis has demonstrated the utility of genome-wide
scans for both gene expression and DNA methylation in identifying candidate
genes. Approaches examining a number of epigenetic marks alongside gene
expression would help prioritize candidates.
5. Larger sample sizes. The results of this thesis are limited by sample size and
genetic diversity. An increase in both would increase statistical power.
6. A developmental reference epigenome. The epigenome appears to create more
variation than the genome alone. Therefore, an understanding of the extent of this
variation across tissues would allow for the determination of modifications that
are inherited, stochastic, and/or environmentally induced.
7. Functional confirmation of candidate loci. While systems biology based
approaches are suited for discovery, they also require functional confirmation
experiments to show causation of a candidate in producing an endophenotype.
Functional experiments could be carried out by epigenome editing with
CRISPR/Cas9 biotechnology (Day 2014; Laufer & Singh 2015). First, mouse
models without PAE would be used to establish causation by recreating key
marks, which include differential methylation in imprinting control regions for
Snrpn-Ube3a and Dlk1-Dio3 as well as the clustered protocadherins, Colec11, and
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Htt. Then, a series of experiments could be carried with the opposite effector that
targets the same regions in PAE mice. These causative confirmation experiments
could be used to develop therapeutic interventions for FASD patients that are
based on somatic epigenome editing of the brain (once the technology is
developed for the clinic).

5.4 Conclusions
The results of this thesis present a number of conclusions, which are derived from
observations in adult PAE mice and human children with FASD. The similarities come
from functionally diverse tissues that are derived from a common stem cell progenitor.
The analysis of adult PAE mice shows that:
1. PAE results in long-term alterations to gene and ncRNA expression as well as
DNA methylation in the adult brain.
2. While genome-wide, the alterations to the epigenome are non-random and occur
in:
o Imprinted clusters of ncRNA: Snrpn-Ube3a and Dlk1-Dio3.
o Functional sites of genes related to neurodevelopment, stem cell signaling,
and immune processes.
3. Chronic and moderate PAE or acute and binge PAE at any time point in
pregnancy distinctly alters the epigenome.
The observations in children with FASD reveal that:
1. DNA from buccal swabs of children with FASD contains a genome-wide DNA
methylation signature related to neurodevelopment, which distinguishes children
with FASD from matched controls.
2. Targeted sequencing of a select gene does not identify FASD in a random child
from the general population.
The comparison of adult PAE mice to human children with FASD shows that:
1. The alterations to methylation occur in functionally related genes and pathways;
however, the specific genes altered are generally not identical.
2. The clustered protocadherins display a large-scale increase in methylation in both
PAE mice and humans.
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In conclusion, the results of this thesis provide foundational evidence for the longterm effects of gene-by-environment interactions. They suggest that deregulation of the
epigenome can be inherited across cell divisions and maintain long-term alterations that
originate from developmental exposures. The results also suggest that non-invasively
obtained buccal swab DNA contains a signature of neurodevelopmental exposure in
humans. Furthermore, the results demonstrate that rodent models may be used as a
reference point when analyzing the complexities of the human epigenome. Aside from the
relevance of the results to FASD, the results also provide insight into basic biological
principles. Chromatin is a dynamic molecule that enables a static linear sequence of DNA
to maintain a molecular memory of developmental events and form distinct tissues.
Disruption of this programing by adverse environmental experiences can result not only
in immediate consequences to the exposed stem cells but may also be inherited across cell
division and maintained in resulting differentiated cells. As the epigenome is more
dynamic than the genome, therapeutic treatment of disorders through novel epigenetic
avenues represents a frontier in personalized medicine.
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Appendix A – IPA® miRNA target filter analysis of CPD PAE adult mouse brains.
miRNA
let-7d*
mir-124*
mir-133b
mir-369-5p
mir-25
mir-27a
mir-495
mir-331-3p
mir-34b-3p
mir-500
mir-124*
mir-369-5p
mir-25
mir-30a*
mir-495
mir-34b-3p
mir-362-5p
mir-489
mir-124*
mir-369-5p
mir-495
mir-340-5p
mir-200a*
mir-27a
mir-30a*
mir-200a*
mir-369-5p
mir-495
mir-369-5p
mir-30a*
mir-124*
mir-15a*
mir-369-5p
mir-199b*
mir-25
let-7d*
mir-15a*

Fold Change
Gene
Fold Change
-1.5
Aak1
1.2
-1.3
Aak1
1.2
-1.4
Aak1
1.2
-1.3
Aak1
1.2
-1.2
Aak1
1.2
-1.4
Aak1
1.2
-1.2
Aak1
1.2
-1.2
Aak1
1.2
-1.3
Aak1
1.2
-1.3
Aak1
1.2
-1.3
Adamts9
1.2
-1.3
Adamts9
1.2
-1.2
Adamts9
1.2
-1.3
Adamts9
1.2
-1.2
Adamts9
1.2
-1.3
Adamts9
1.2
-1.2
Adamts9
1.2
1.2
Ankrd49
-1.2
-1.3
Cspp1
1.3
-1.3
Cspp1
1.3
-1.2
Cspp1
1.3
1.2
Ddit4l
-1.3
1.2
Ddit4l
-1.3
-1.4
Dnajc13
1.3
-1.3
Dnajc13
1.3
1.2
Eapp
-1.2
-1.3
Ephb1
1.3
-1.2
Ephb1
1.3
1.3
Fam155a
1.3
-1.3
Fam155a
1.3
-1.3
Gpatch8
1.2
-1.2
Gpatch8
1.2
-1.3
Gpatch8
1.2
-1.2
Gpatch8
1.2
-1.2
Gpatch8
1.2
-1.5
Hmga2
1.2
-1.2
Hmga2
1.2
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mir-369-5p
mir-25
mir-146b
mir-19b
mir-151-5p
mir-152
mir-369-5p
mir-25
mir-495
mir-743a
mir-15a*
mir-27a
mir-17*
mir-17*
mir-146b
mir-340-5p
mir-369-5p
mir-30a*
mir-495
mir-369-5p
mir-199b*
mir-27a

-1.3
-1.2
1.2
1.4
1.2
1.2
-1.3
-1.2
-1.2
1.3
-1.2
-1.4
1.5
1.5
1.2
1.2
-1.3
-1.3
-1.2
-1.3
-1.2
-1.4

Hmga2
Hmga2
Nuak1
Nuak1
Nuak1
Otx2
Pten
Pten
Pten
Rps27l
Slc24a1
Slc24a1
Slitrk2
Tbc1d17
Tmem19
Tmem19
Trdn
Trdn
Trdn
Ypel1
Ypel1
Ypel1

1.2
1.2
-1.3
-1.3
-1.3
-1.3
1.4
1.4
1.4
-1.2
1.2
1.2
-1.2
-1.3
-1.2
-1.2
1.2
1.2
1.2
1.2
1.2
1.2

Results were obtained from gene and miRNA expression arrays respectively. They are filtered based on
confidence of interaction, brain specificity, and an inverse miRNA (p<0.3, fold change 1.15) to target
mRNA (p<0.05, fold change 1.2) relationship.
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Appendix B – Individual heatmaps of differential miRNA expression generated using
hierarchical clustering of the four PAE paradigms (p<0.05 and 1.2-fold change cut-off).
Experimental mice are labelled red and control mice are labelled blue.
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Appendix C – Venn diagram of common and unique differentially expressed miRNAs
identified by four PAE models (p<0.05 and 1.2-fold change cut-off).
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Appendix D – Differentially expressed snoRNAs in the Snrpn-Ube3a region (chromosome 7) identified by miRNA and gene
expression arrays in all PAE paradigms (p<0.05 and 1.2-fold change cut-off).
Snrpn-Ube3a

CPD

Trimester 1

miRNA array
*No Significant ncRNAs*

Trimester 2

Trimester 3

ID

FC

p

ID

FC

p

ID

FC

p

HBII-52-48

1.2

0.049

HBII-52-2

1.2

0.044

HBII-52-15

1.5

0.001

HBII-85-7

-1.3

0.037

HBII-85-22

-1.3

0.001

HBII-85-29

1.4

0.026

HBII-85-23

-1.8

0.050

HBII-85-26

-1.2

0.039

HBII-85-24

-1.4

0.039

HBII-85-28

-1.4

0.009
Ensembl ID

FC

p

ENSMUST00000102015

1.5

0.003

Expression Array

Ensembl ID

FC

p

Ensembl ID

FC

p

MBII-52

ENSMUST00000101805

1.4

0.019

ENSMUST00000097244

1.4

0.009

ENSMUST00000101980

1.2

0.003

ENSMUST00000101805

1.2

0.050

ENSMUST00000102017

1.3

0.017

ENSMUST00000101860

1.3

0.035

ENSMUST00000101861
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0.001
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0.038
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1.3

0.017
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1.3

0.017

ENSMUST00000101935

1.5

0.029

ENSMUST00000101896

1.2

0.0002

ENSMUST00000101980

1.3

0.028

ENSMUST00000101932

1.2

0.0002

ENSMUST00000102037

1.3

0.038

ENSMUST00000101816

1.4

0.004

*No Significant ncRNAs*
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Appendix E – Differentially expressed ncRNAs from Dlk1-Dio3 and Sfmbt2 (p<0.05 and 1.2-fold change cut-off). A) Dysregulated
ncRNAs from the Dlk1-Dio3 region (chromosome 12) identified by miRNA and gene expression arrays in all PAE paradigms. B)
Dysregulated imprinted miRNAs encoded in the Sfmbt2 region (chromosome 2) identified by miRNA expression arrays in all PAE
paradigms.
A)

B)

Dlk1-Dio3

CPD

miRNA array

ID

Trimester 1
p

ID
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p

ID

FC

p

miR-679

1.2

0.03

miR-665

1.2

0.05

miR-666-5p
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miR-300
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0.05

miR-369-5p
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Ensembl ID
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p
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ENSMUST00000082553
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Expression Array
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p

0.003

miR-665

-1.2

0.03

0.003

miR-434-3p
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0.01

1.3

0.021

miR-376b

-1.7

0.04

-1.2

0.031

miR-544

-1.3

0.02

hp_mmu-mir-485
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Ensembl ID
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p
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1.6
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-1.3
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*No Significant ncRNAs*

*No Significant ncRNAs*
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0.002
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